Mapping protein-protein interactions in the <i>Escherichia coli</i> Twin Arginine Translocase by Moore, Kristoffer
                                                                          
University of Dundee
DOCTOR OF PHILOSOPHY
Mapping protein-protein interactions in the Escherichia coli Twin Arginine Translocase
Moore, Kristoffer
Award date:
2016
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 22. Jan. 2021
i	
	
Mapping protein-protein interactions in 
the Escherichia coli Twin Arginine 
Translocase 
	
	
by 
 
Kristoffer Moore 
 
School of Life Sciences 
 
August 2016 
 
	
	
	
	
Thesis submitted to the University of Dundee in partial fulfilment of 
the requirements for the degree of Doctor of Philosophy 
ii	
	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
	
Copyright © Kristoffer Moore, August 2016. 
All rights reserved. This copy of the thesis has been supplied on condition that anyone, who 
consults it, is understood to recognise that its copyright rests with the author and that no 
quotation from the thesis, nor any information derived therefrom, may be published without the 
author’s prior, written consent. 
iii	
	
Declaration 
I declare that I am the author of this thesis and that, unless otherwise stated, all references cited 
have been consulted; that the work of which this thesis is a record of has been performed by 
me, and that it has not been previously accepted for a higher degree: where the thesis is based 
upon joint research, the nature and extent of my individual contribution is defined. 
 
Kristoffer Moore 
 
 
  
iv	
	
Abstract 
The Twin Arginine Translocase (Tat) system is a membrane-bound transport system 
present in plants and bacteria that has the remarkable ability to export fully folded 
proteins across a lipid bilayer, powered by the protonmotive force. In Escherichia coli 
the Tat system is composed of only three essential membrane proteins, the 
homologous TatA and TatB proteins, and the highly hydrophobic TatC core subunit. 
The transport mechanism involves a TatBC recognition complex which binds 
substrates through their signal peptides, with TatA being recruited to form an 
oligomeric structure that facilitates protein transport. Current models suggest that TatA 
oligomers locally disrupt membrane lipids allowing the substrate to move from the 
cytoplasm to the periplasm. Here, biochemical methods were used to further 
understand interactions between these components. 
Affinity purification experiments in detergent solution, using a His-tagged TatC variant, 
resulted in co-purification of TatB along with a small amount of associated TatA. The 
amount of co-purifying TatA was notably increased when TatB was absent, suggesting 
that the proteins may compete for the same binding site on TatC.  
Disulphide crosslinking experiments performed in vivo identified a binding site for TatA 
at the sixth transmembrane helix of TatC occupied in the resting state, indicating that 
TatA interacts constitutively with the TatBC recognition complex. Further crosslinking 
experiments found that the protonmotive force was required for TatA to occupy this 
constitutive site, explaining the poor yields of TatA co-purifying with TatC in detergent 
solution.  
In response to increased substrate flux through the Tat pathway, disulphide 
crosslinking demonstrated that TatA no longer occupied its constitutive site, instead 
binding at the fifth transmembrane helix of TatC, a site previously shown to be 
occupied by TatB. This supports the proposition that TatA and TatB occupy this site 
differentially, with TatB potentially acting as a “gatekeeper” to modulate TatA 
polymerisation. Interaction sites were identified between the transmembrane regions of 
TatA and TatB when substrate was overexpressed. 
Using these crosslinking data, a model was produced which presented interfaces 
between TatA, TatB and TatC in the resting state and how these change during 
interaction with a Tat substrate.   
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Chapter 1: Introduction  
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1.1 Escherichia coli as a model organism 
E. coli is a bacterial model organism used to study a great number of biological 
processes. The relatively simple and cheap requirements for laboratory-based 
culturing, its short multiplication time and well-characterised genetics mean it is well 
suited to this role and is often a host for the production of recombinant proteins.  
Specifically, E. coli belongs to the family Enterobacteriacae and is facultatively 
anaerobic, rod-shaped and found naturally in the gastrointestinal tract of endothermic 
organisms where, with the exception of some pathogenic strains (such as E. coli 
O157:H7), it lives commensally. Indeed, the ability of some E. coli strains to cause 
disease, such as gastroenteritis, provides another dimension to research using this 
organism. 
1.1.1 The E. coli cell envelope 
Gram-negative bacteria, such as E. coli are bounded by two membranes, a 
cytoplasmic (or inner), membrane and an outer membrane. The space between the 
inner and outer membranes is the periplasm (Fig. 1.1), which is the site of a number of 
important cellular processes, such as electron transfer reactions involved in respiration, 
the acquisition of nutrients and the synthesis of peptidoglycan, composed of N-
acetylglucosamine and N-acetylmuramic acid, which forms a layer in the periplasm that 
assists in maintaining the cell shape (Fig. 1.1) (Vollmer & Holtje, 2004). 
The outer membrane of Gram-negative bacteria is asymmetric and mainly consists of 
lipopolysaccharide (LPS) in the outer leaflet. LPS is composed of lipid A, a hydrophobic 
part of the molecule which allows it to anchor in the outer membrane. This is linked via 
an inner and outer core region to the O-antigen, an oligosaccharide with a repeating 
pattern which can be modified across strains upon the addition of hexose, heptose and 
phosphate groups. Indeed, the O-antigen as a whole serves a protective role in 
bacteria defending against harmful agents such as antibiotics and bile salts, and is 
known to promote immune responses in animals (Raetz & Whitfield, 2002). The O-
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antigen tends to be missing in laboratory strains of E. coli, which therefore display 
decreased virulence; such is the case in this work.  
Porins in the outer membrane allow passive diffusion of small molecules into the 
periplasm, while the inner membrane is much less permeable. Indeed, the inner 
membrane of bacteria is reminiscent of the mitochondrial equivalent, with lipid 
compositions of both showing a high phosphatidylglycerol:phosphatidylcholine ratio, 
likely required for oxidative phosphorylation, and the presence of ~20% cardiolipin, 
which exists in no other eukaryotic membrane (Osman et al., 2011, Mileykovskaya & 
Figure 1.1) The typical cell envelope of a Gram-negative bacterium- The outer lipopolysaccharides are 
shown, with lipid A in orange in the outer membrane. Porins embedded in the outer membrane are shown 
as green cylinders, along with a green oval represening lipoproteins, some of which link the peptidoglycan 
to the outer wall. The cytoplasmic membrane is shown with green cylinders representing transport 
systems that facilitate movement of susbtrates across this bilayer. N- acetylglucosamine acid is 
represented by “MurNac”, and N-acetlymuramic acid “GlcNac” in the peptidoglycan. 
Pyrophosphoethanolamine is represented by “PPEtn”, 3-deoxy-D-manno-octulosonic acid is represented 
by “Kdo”. “n” represents repeats in the O-antigen (Esko J. D., 2009) 
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Dowhan, 2000, Nishibori et al., 2005). This is consistent with the endosymbiotic theory 
of mitochondrial origin, with the membrane composition of mitochondria being similar to 
that from the bacteria they descended from.  
1.1.2 Protein transport in E. coli 
Compartmentalisation of biochemical processes via the formation of lipid membranes 
was critical for the evolution of cellular organisms. For example, in E. coli such 
biochemical processes can occur in the cytoplasm, periplasm or indeed either the inner 
or outer membranes themselves, all of which have discrete chemistries. While many 
small molecules are able to traverse in and out of cells across the membranes, 
generally speaking protein translocation across, or insertion into, a membrane has 
required the evolution of transport systems.  
Four generally conserved mechanisms to facilitate this have been discovered to date, 
these are: The general secretory (Sec) system, YidC dependent membrane insertion, 
the signal recognition partical (SRP) dependent pathway and the twin arginine 
translocase (Tat system). 
This introduction will discuss all these transport mechanisms, but particular emphasis is 
placed on the Tat system, which is the subject of this work. 
1.2 The Sec system 
In E. coli most proteins are transported across the inner membrane as unfolded 
polypeptides via the Sec pathway. The core membrane-bound Sec machinery is 
composed of SecY, SecE and SecG, and the substrate traverses the membrane by a 
threading mechanism through the SecY channel. The substrate is targeted to Sec via a 
signal peptide at the N-terminus of the protein composed of an n-domain region, 
followed by a hydrophobic section and ending in a c-domain, which contains the signal 
peptidase cleavage site (this will be discussed in detail in the context of the Tat signal 
peptide in Section 1.6). Targeting can happen after translation or co-translationally (see 
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section 1.3), and post-translational targeting involves cytoplasmic proteins SecA and 
SecB, with the translocation event powered primarily by ATP hydrolysis. Non-essential 
accessory proteins SecD, SecF and YajC are also thought to be in involved in Sec 
translocation and will be discussed in Section 1.2.5. 
1.2.3 The SecB chaperone 
Once a Sec substrate has been translated in the cytoplasm, it must be prevented from 
folding. The cytoplasmic protein, SecB, has been shown to form a tetramer (Xu et al., 
2000) and to bind precursor Sec substrates (Gannon et al., 1989, Liu et al., 1989), 
preventing their folding prior to transport across the cytoplasmic membrane (Collier et 
al., 1988, Bechtluft et al., 2010). This binding of the substrate is thought to be mediated 
through hydrophobic patches of SecB seen in the crystal structure of the E. coli and 
Haemophilus influenzae proteins (Xu et al., 2000, Dekker et al., 2003). After binding 
the substrate, SecB targets the substrate to the Sec machinery via an interaction with 
the C-terminus of SecA (Zhou & Xu, 2003).  
1.2.4 The SecA ATPase 
Essentially SecA is a superfamily 2 helicase which has adapted to translocate proteins, 
(Koonin & Gorbalenya, 1992) containing a DEAD helicase motor domain in the N-
terminal region of the protein, required for protein export (Sianidis et al., 2001). A 
Walker A and B motif form a high affinity nucleotide binding site which is essential for 
SecA function (Schmidt et al., 1988, Lill et al., 1989). In bacteria, SecA is cytoplasmic 
and associates with the membrane-bound SecYEG complex to mediate post-
translational export of proteins across the cytoplasmic membrane (Brundage et al., 
1990). 
Overall SecA is composed of a number of domains, including the polypeptide cross-
linking domain (PPXD), the helical wing domain (HWD), the helical scaffold domain 
(HSD) and nucleotide binding domains 1 and 2 (See Fig. 1.2). The crystal structure of 
SecA has been obtained from a number of organisms and when crystallised in the 
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absence of SecYEG it is usually in an “open” conformation (Osborne et al., 2004, 
Zimmer et al., 2006, Papanikolau et al., 2007) with structures of the “closed” 
conformation also observed with SecYE (Zimmer et al., 2008). Molecular dynamics 
simulations, free-energy calculations and structural analysis of SecA from Thermotoga 
maritima have demonstrated that the protein may behave in a clamp-like manner, with 
large scale conformational changes holding the substrate in place as it traverses 
through SecYEG. The energy barrier in closing SecA is potentially overcome by 
insertion of the TM6/7 cytoplasmic loop of SecY into the region separating PPXD and 
HSD/HWD (Chen et al., 2015). Specifically, it is proposed that in the first step of clamp 
closure PPXD, HSD and HWD move towards NBD2 with the second step involving a 
separation of PPXD from HSD and HSW as it moves further towards NBD2.	 
A controversy exists regarding the oligomeric state of SecA with crystal structures 
suggesting both monomeric (Osborne et al., 2004) and dimeric (Hunt et al., 2002, 
Sharma et al., 2003) forms. The latter studies are supported by crosslinking showing 
that a SecA dimer can support Sec transport (de Keyzer et al., 2005, Jilaveanu & 
Figure 1.2) Crystal structure of the open conformation of Thermotoga maritima SecA- Solved to 
1.9 Å resolution, the T. maritima SecA is shown in an open conformation with each domain labelled 
separately. ADP is shown bound at the nucleotide binding site 1 (NBD1 in blue and NBD2 in cyan). The 
polypeptide crosslinking domain (PPXD) is shown in green, the helical wing domain (HWD) is shown in 
orange, the helical scaffold domain (HSD) is shown in red and ADP is show in magenta. Taken from Chen 
et al. (2015). 
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Oliver, 2006) while conversely other work shows a monomeric derivative of SecA can 
also support transport. (Or et al., 2002, Or et al., 2005).  
Two domains on SecA have been found to interact with the pre-protein via crosslinking 
the PPXD and the 2 helix finger (2HF) domain in the HSD (Bauer & Rapoport, 2009). 
Further details on how SecA may mediate transport through the SecY channel will be 
discussed in Section 1.2.5. 
1.2.5 The SecYEG machinery: structures and mode of translocation 
The structure of the Methanococcus jannaschii Sec translocon (SecYEβ, homologous 
to E. coli SecYEG) was obtained in the resting state, showing SecY, composed of 10 
transmembrane (TM) helices, forming a channel with two halves of the protein in 
similar folds (one half, TM1-5 and the other, TM6-10 linked with a hinge region 
between TM5-6 giving the overall shape of a crab claw). The SecY channel was found 
to have an hourglass shape, with a ring of hydrophobic amino acids at its narrowest 
point and a short “plug” helix blocking the channel. At the cytoplasmic side, this cavity 
is 2-2.5 nm in diameter, gradually narrowing to a close at the centre of the membrane. 
Helices 2 and 7 at the end of each half of SecY can move apart, exposing the channel 
of SecY to the membrane - this is referred to as the lateral gate (LG) (Van den Berg et 
al., 2004) (Fig. 1.3). Once a secreted protein engages with the Sec machinery, the 
signal sequence is inserted into the membrane near the SecY LG (Gold et al., 2013, 
Briggs et al., 1986). It is proposed that this interaction leads to a conformational change 
within SecY, whereby the TM7 straightens to contact TM10, displacing the plug which 
blocks the channel to unlock the complex (Hizlan et al., 2012). 
Experiments examining mutations in SecY found the SecYF286Y/I408N substitution was 
“hyperactive” due to its ability to facilitate translocation of substrates with defective 
signal peptides. This was thought to be due to complex destabilisation which leads to 
the two halves of SecY separating (Duong and Wickner 1999). To build on this, more 
recent work was able to generate a mutant of SecY which formed a disulphide bridge 
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Figure 1.3) Crystal structures of SecYEG/SecYEβ complexes showing helix rearrangements 
proposed to occur during substrate translocation: Top left shows the structure of M. jannaschii 
SecYEβ viewing from the equivalent of the periplasm, with SecY helices TM1-5 shown in white and TM6-
10 shown in blue, indicating the two domains. SecE is show in yellow bracing SecY with Secβ (equivalent 
to E. coli SecG) also associated with SecY. TM7 of SecY is shown in turquoise, with the plug shown in 
red. The plug is blocking the channel, with positions I284 and T404, shown as orange and green circles 
far apart in this proposed resting conformation. Top right shows the E. coli SecYEG bound to a Sec 
signal sequence (magenta) (Hislan et al., 2012) with the SecY residues I284 and T404 moving to a close 
proximity- forming a disulphide linkage which holds the channel in an unlocked conformation. Arrows 
denote the proposed movement of helices moving the plug to open the SecY channel. Bottom right and 
left both show more clearly TM6-10 of SecY with movement of TM7 displacing the plug. Taken from 
Corey et al. (2016).	
between TM7 and TM10 through introduction of Cys-substitutions in these regions, 
holding the complex in an “unlocked” conformation. Strikingly, when this “unlocked” 
mutant was compared to the SecYF286Y/I408NEG complex, it was found that they both 
displayed this hyperactive behaviour in transporting substrates, compared to a wild-
type Sec system. This supports the hypothesis that TM7 straightening towards TM10 
unlocks the complex allowing translocation (Corey et al., 2016), this is outlined in detail 
in Fig. 1.3.  
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SecE is an integral membrane protein that stabilises SecY in vivo (Kihara et al., 1999). 
Within the SecYEG complex, SecE braces SecY, with a TM lying diagonally across the 
membrane and an amphipathic helix at the cytoplasmic side (Van den Berg et al., 
2004). It is thought that this arrangement of SecE holds together the two domains of 
SecY, whereby it relaxes its conformation to allow SecY to open. Studies observing 
disulphide crosslinked SecY and SecE showed that even when they are linked 
covalently transport is still facilitated, indicating that the SecY-E interaction is stable 
(Lycklama a Nijeholt et al., 2013). The latter work also observed decreased Sec 
transport upon cleavage of SecE, suggesting that it holds the two domains of SecY 
together.  
SecG is located peripherally in the E. coli SecYEG complex, with fewer contacts to 
SecY than those found for SecE (Van den Berg et al., 2004). Although SecG is not 
essential for transport, it may play a role in promoting transport efficiency (Hanada et 
al., 1994). In addition to this, it has been shown that SecG can facilitate transport at low 
temperatures in the absence of PMF (Hanada et al., 1996).  
Very recently, a crystal structure of the SecA-SecYE complex was solved with a 
translocating protein segment; here it was observed that the substrate peptide 
displaced the plug domain in SecY, with the complex presumably in the unlocked form 
(Fig. 1.4). Contacts between SecA and SecY were at the cytoplasmic loop between 
SecY TM8 and TM9, along with the C-terminal tail. The hydrophobic section of the 
signal sequence was found to form an alpha helix which sits outside the SecY lateral 
gate with the successive section of polypeptide intercalating with the gate itself (Li et 
al., 2016). The substrate in the structure was derived from OmpA, and fused to the 2 
helix finger (2HF) of SecA, which was informed by a previous structure of SecA from 
Thermotoga maritima which noted that the 2 helix finger (2HF) of SecA inserted into 
the cytoplasmic section of the SecY channel (Zimmer et al., 2008). In this recent 
structure SecA is in its closed conformation with the 2HF at the cytoplasmic side of the 
SecY channel (see Fig. 1.4). 
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SecD, SecF and YajC have been shown to form a trimeric complex which can interact 
with SecYEG in a transient fashion (Duong & Wickner, 1997). While not essential for 
Sec secretion, their absence at cold temperatures has a strong negative effect on 
translocation (Pogliano & Beckwith, 1994). All three subunits are integral membrane 
proteins, with the periplasmic domains proposed to play a role in releasing substrates 
from the Sec channel (Nouwen & Driessen, 2005, Matsuyama et al., 1993). The role of 
these accessory proteins, along with YidC, will be detailed in section 1.4. 
 
Figure 1.4) Crystal structure of E. coli SecA bound to the SecYE complex, with a translocating 
peptide- The core structure of Sec during translocation was solved to a 3.70 Å resolution. SecA (shown 
in blue) is bound to SecY (shown in pink) within the SecYE complex  - helices in SecY are labelled, with 
helices 2 and 7 forming the lateral gate. SecE (purple) is shown bracing SecY and a translocating peptide 
(green) is shown within the SecY channel. The nanobody used during crystallisation is shown in cyan. 
Taken from Li et al. (2016). 
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1.2.6 Powering movement of the Sec substrate across the membrane 
How the polypeptide chain moves through the Sec machinery complex is contentious, 
with two different models being proposed. The “power stroke” model in which the 
polypeptide chain is bound and pulled forward in sequential steps of ATP hydrolysis 
and a diffusion based model, whereby ATP hydrolysis biases a forward movement of 
diffusing substrate polypeptide through the channel (Collinson et al., 2015). These are 
demonstrated in Fig 1.5. The power stroke model is supported by translocation 
intermediates of the Sec system being observed, thought to be reflection of successive 
movement of a disordered polypeptide through the SecYEG pore (Schiebel et al., 
1991, Tani et al., 1989). The ratcheted diffusion model relies on the Brownian diffusion 
of the polypeptide at physiological temperatures- a key advantage being that it would 
not require sequence specificity of the transported polypeptide.  
Figure 1.5) A comparison of the powerstroke and ratcheted diffusion model of polypeptide 
translocation- SecA, shown in red, binds the substrate after translation (SecB chaperone not shown) and 
delivers it to SecYEG. On the left the power stroke model is shown where the two helix finger (2HF) of 
SecA pushes the substrate polypeptide through the SecYEG channel in cycles of ATP hydrolysis.  
Conversely the ratcheted diffusion model shows SecA facilitating forward diffusion of the PP through 
SecYEG and disallowing backsliding, thereby allowing the entirety of the substrate to pass through- taken 
from Collinson et. al. (2015). 
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Aside from ATP hydrolysis, the protonmotive force (PMF) seems to play a role in the 
stages of Sec translocation where it can complete the translocation of trapped 
substrates and may be used in re-orientating the signal sequence (Schiebel et al., 
1991, van Dalen et al., 1999). In addition to this, Ismail and co-workers observed 
recently that charged residues in a nascent chain (co-translation transport is covered in 
section 1.3) were subject to a biphasic electrical force during translocation, this force 
could be modified by dissipating the PMF using indole as an uncoupler (Ismail et al., 
2015).  
1.3 Signal recognition particle (SRP) dependent protein transport 
Proteins can be transported co-translationally via a pathway dependent on the signal 
recognition particle (SRP) which consists of a GTP binding Ffh (fifty-four homologue) 
protein in complex with a 4.5S RNA (Bernstein et al., 1993). Most of the substrates 
targeted to this system are inner membrane proteins (de Gier & Luirink, 2001) where 
the SRP binds the hydrophobic signal sequences of the nascent chains as they exit the 
ribosome, preventing further translation. A ribosome nascent chain complex is formed, 
which is targeted to the FtsY receptor protein. FtsY is a GTPase which associates with 
the SecYEG complex (Angelini et al., 2005, Kuhn et al., 2011), upon which the SRP 
and FtsY subunits dissociate and the nascent chain is fed through the Sec machinery 
as translation is restored (Luirink et al., 2005).  
1.4 YidC-dependent membrane protein insertion 
In E. coli, YidC is essential for growth, and is composed of three domains, with a P1 
(periplasmic) domain, a TM (transmembrane) region and a small cytoplasmic region 
(Kumazaki et al., 2014). A hydrophilic groove was observed in the transmembrane 
domain, which has been implicated in binding of some substrates. 
In E. coli, YidC is essential for growth (Samuelson et al., 2000) and has been shown to 
co-purify with SecYEG (Scotti et al., 2000). Indeed while YidC can act with the Sec 
YEG forming a holo-translocon complex for the insertion of membrane proteins 
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(Samuelson et al., 2000, Schulze et al., 2014), it has been shown to work alone in 
some cases (Facey et al., 2007). Interactions between the P1 (periplasmic) domain of 
YidC and SecF have also been observed, which implied an interface between YidC, 
SecYEG and SecDFYajC when the substrate is delivered into the membrane.  
It has been shown that the lateral gate of SecY opens to release hydrophobic helices 
into the membrane (Luirink et al., 2005, Dalbey et al., 2011) with YidC being involved in 
this release process (Urbanus et al., 2001, Beck et al., 2001). Furthermore, 
crosslinking data has shown interactions between YidC and the lateral gate region of 
SecY (Sachelaru et al., 2015). 
1.5 The discovery of the Tat protein transport system 
The origins of the Tat system as a protein translocase existing independent of the 
universal ATP-driven Sec system were conceived in 1991 when Mould and Robinson 
identified subunits of the photosynthetic oxygen-evolving complex from wheat plants, 
which necessitated a proton gradient (∆pH) for transport across the thylakoid 
membrane (Mould & Robinson, 1991). This was supported by data published shortly 
after showing similar thylakoid proteins which not only depended on ∆pH for 
translocation, but could also be localised in the complete absence of ATP (Cline et al., 
1992). Chaddock and co-workers that discovered a motif common to all the proposed 
substrates. While similar to the Sec targeting motif, it had the distinctive presence of 
two arginines near the N-terminus (Chaddock et al., 1995). 
The pertinence of this system in prokaryotes was recognised when signal sequences 
containing this “double-arginine” were identified in bacterial periplasmic proteins, 
providing an indication that this pathway was conserved (Berks, 1996). Notably, many 
of these bacterial proteins contained oxygen-sensitive cofactors, which may present a 
problem for insertion in the periplasm. Coupled with the inability of the Sec “pore” to 
accommodate folded proteins, this led to the proposition that these cofactor-containing 
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proteins were transported in a folded state, requiring a specialised translocation 
pathway.   
The concept that a prokaryotic homologue exists for the plant ∆pH pathway was 
furthered by the discovery of a bacterial gene related to the plant hcf106. In plants, a 
mutation of the hcf106 gene was shown to impair protein export via the ∆pH dependent 
pathway and analysis of bacterial genomes identified homologues to hcf106, further 
strengthening the premise of conserved export pathway in bacterial and plants (Settles 
et al., 1997). A specific gene in E. coli, homologous to the plant hcf106 was later 
identified by Weiner and co-workers. Designated mttA (membrane targeting and 
translocation) in the mttABC operon, mutations in this gene were found to prevent 
export of twin arginine redox enzymes to the periplasm (Weiner et al., 1998). 
Further analysis of these mttABC genes by Sargent and co-workers led to correction of 
the genome sequence, and the identification of a four cistron operon, tatABCD (tat 
standing for twin arginine translocase) along with an unlinked gene, tatE (Sargent et 
al., 1998). 
1.6 Tat signal peptide 
The structural organisation of the Tat signal peptide is broadly similar to that of the Sec 
signal, containing n-, h- and c-regions with a cleavage site for leader peptidase LepB. 
Though a key difference, and where the Tat system acquires its name, is the presence 
of two usually invariant arginine residues in the n-region (Fig. 1.6).  
While almost consistently present, a double arginine is not always part of the Tat 
consensus sequence in nature, with examples of “KR”, “RN” and “RQ” (Widdick et al., 
2008) motifs sometimes being found. Additionally, laboratory manipulation of the signal 
peptide of SufI in E. coli demonstrated that conservatively exchanging of either one of 
the twin arginine residues with lysine still supported low level export into the periplasm, 
with dual arginine to lysine mutations abolishing transport altogether (Stanley et al., 
2000). In addition exogenous green fluorescent protein (GFP) fused to a Tat signal 
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peptide was successfully exported to the periplasm with signal sequences containing a 
substitution of the first arginine with basic lysine and the second arginine with either 
lysine, glutamine or asparagine (DeLisa et al., 2002). 
 
 
 
 
 
 
 
 
 
Much of the work examining the importance of individual residues in the Tat signal 
sequence involves mutagenesis and subsequent analysis of translocation efficiency. 
The position of the first arginine residue in the consensus sequence is often referred to 
as position +1, with other residues numbered relative to this. Position -1, before the first 
arginine, is very often either a threonine or serine (Berks, 1996), the significance of 
which is unclear since its substitution has a detrimental effect on the translocation of 
some substrates but not others. It has been proposed that this residue stabilises a 
potential alpha helix formed by the h-region (Mendel et al., 2008, Stanley et al., 2002). 
The residue at +3 is very poorly conserved (Stanley et al., 2002) (noted as “X” in the 
consensus sequence) and as a consequence is thought to be a linker residue just after 
the twin arginines (Buchanan et al., 2001). A phenylalanine residue at position +4 
occurs fairly frequently (up to 70% of signal peptides (Berks, 1996)) with substitutions 
to less hydrophobic residues impairing the transport of E. coli SufI (Stanley et al., 
Figure 1.6) A schematic comparison of the Sec and Tat signal peptides- The N-terminal region is 
shown in blue, with the Tat consensus sequence and Twin arginines noted. The hydrophobic region of 
each signal peptide is shown in orange, ending in the pink C-terminal region with the LepB cleavage site 
noted on for both Tat and Sec. “+” denotes regions of positively charged residues and “X” denotes any 
amino acid. 
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2000). Furthermore, secretion of the Tat substrate, Xylanase C in Streptomyces 
lividans, was reduced by 75% when the phenylalanine at +4 was replaced with any 
amino acid except tryptophan, which had a more modest effect at 50% reduction (Li et 
al., 2006). Similar experiments observing the effect on Tat transport in response to 
substitution of amino acids a position +5 indicate that hydrophobicity is also important 
for this position (Stanley et al., 2000). Position +6 is most frequently occupied by a 
lysine residue (Berks, 1996) and is thought to act as a boundary before the 
hydrophobic stretch of the signal peptide. 
The h-region of the Tat signal peptide starts after the Tat consensus sequence and has 
been found to be less hydrophobic than its Sec counterpart. This important distinction 
is highlighted by experiments showing that Tat substrates can be re-targeted to the Sec 
machinery if the h- region hydrophobicity is increased (Cristobal et al., 1999).  
The final section of the Tat signal peptide, and the part furthest from the N-terminus, is 
the c-region. In Tat signal peptides this region often contains positively charged 
residues, thought to act as a Sec avoidance signal (Bogsch et al., 1997, Cristobal et 
al., 1999). Both Tat and Sec c-regions contain a LepB cleavage site, where the signal 
peptide is removed subsequent to translocation (Yahr & Wickner, 2001).  
1.7 Tat Substrates 
The requirement for a specialised Tat transport system to work alongside the universal 
Sec system reflects the need for a protein export system to accommodate substrates 
not compatible with transport as an unfolded polypeptide. There are a number of 
reasons behind this, for example, hydrolysis of cytoplasmic nucleotides may be needed 
for the cofactor insertion step, as in the case of GTP hydrolysis coupled to nickel 
insertion into E. coli hydrogenases (Maier et al., 1995). Additionally, highly oxygen 
sensitive metallo-cofactors may require insertion in the reducing conditions of the 
cytoplasm prior to export (Berks, 1996). Even if substrates are able to fold prior to 
cofactor insertion in the periplasm, competition from other cofactors outside the 
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cytoplasmic membrane is also a factor. For instance the Mn2+ binding protein MncA in 
the cyanobacterium Synechocystis PCC 6803 requires cofactor insertion prior to 
transport outside the cell, where erroneous metallo-cofactors such as Cu2+and Zn2+ can 
compete for binding (Tottey et al., 2008). 
It should be noted, however, that cofactor-containing proteins being exported via Tat is 
not a stringent rule, with exceptions including the c-type cytochromes in E. coli, which 
are transported via Sec prior to haem cofactor insertion in the periplasm (Thony-Meyer 
& Kunzler, 1997). Conversely, proteins such as the cell wall amidases AmiA and AmiC 
contain no cofactors but also utilise the Tat system for transport across the cytoplasmic 
membrane (Ize et al., 2003).  
Aside from cofactor insertion, some Tat substrates have been demonstrated to be 
exported as a heterodimeric complexes whereby only one of the constituent proteins 
contains a signal peptide. This is known as “hitchhiking” or “piggy-backing” and is 
exemplified by protein subunits HybO and HybC of Hydrogenase-2 in E. coli. These 
proteins are exported as a heterodimer and if either subunit is expressed without the 
other, they accumulate in the cytoplasm. Of the two subunits, only HybO contains a Tat 
signal peptide, with HybC devoid of any signal peptide at all, suggesting HybO and 
HybC are exported as a complex, with the Tat machinery recognising HybO (Rodrigue 
et al., 1999).  
With regard to E. coli, there are approximately 27 predicted Tat substrates, shown in 
Table 1.1 (Palmer et al., 2010) (not including proteins which are co-translocated with 
Tat signal peptide containing proteins) involved in a host of processes such as 
anaerobic respiration, cell wall metabolism, iron uptake and copper resistance. Though 
the complete absence of a Tat system in E. coli is not fatal, loss of Tat activity causes 
cells to exhibit a number of detrimental phenotypes such as cell chaining and increased 
sensitivity to detergents, with both of these phenotypes due to the mislocalisation of 
cell wall amidases (Ize et al., 2003). This characteristic has been exploited to identify 
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strains expressing a damaged Tat system, through the impaired or absence of growth 
on media containing SDS, as Δtat cells are less able to cope with envelope stress 
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Protein Physiological role Cofactor/s Co-exported partner Signal peptide sequence 
HyaA Hydrogen oxidation 3 x Fe-S 
clusters 
HyaB MNNEETFYQAMRRQGRRSFLKYCSLAATSLGLGAGMAPKIAW
A 
HybO Hydrogen oxidation 3 x Fe-S 
clusters 
HybC MTGDNTLIHSHGINRRDFMKLCAALAATMGLSSKAAA 
HybA Hydrogen oxidation 4 x Fe-S 
clusters 
Unknown MNRRNFIKAASCGALLTGALPSVSHA 
NapG Nitrate reduction 4 x Fe-S 
clusters 
Unknown MSRSAKPQNGRRRFLRDVVRTAGGLAAVGVALGLQQQTARA 
NrfC Nitrate reduction 4 x Fe-S 
clusters 
Unknown MTWSRRQFLTGVGVLAAVSGTAGRVVA 
YagT Aldehyde 
oxidoreductase 
2 x Fe-S 
clusters 
YagR (MCD) and YagS 
(FAD) 
MSNQGEYPEDNRVGKHEPHDLSLTRRDLIKVSAATAVVYPHST
LAASVPA 
YdhX Potential Component 
of aldehyde ferredoxin 
oxidoreductase 
4 x Fe-S 
clusters 
Potentially YdhV (tungsten) MSWIGWTVAATALGDNQMSFTRRKFVLGMGTVIFFTGSASSLL
A 
TorA TMAO reduction MGD None MNNNDLFQASRRRFLAQLGGLTVAGMLGPSLLTPRRATAAQA 
TorZ TMAO reduction MGD None MTLTRREFIKHSGIAAGALVVTSAAPLPAWA 
NapA Nitrate reduction MGD, 1 FE-
S cluster 
None MKLSRRSFMKANAVAAAAAAAGLSVPGVA 
DmsA DMSO reduction MGD, 1 FE-
S cluster 
DmsB MKTKIPDAVLAAEVSRRGLVKTTAIGGLAMASSALTLPFSRIAHA 
YnfE Selenate reduction MGD, 1 FE-
S cluster 
YnfG MSKNERMVGISRRTLVKSTAIGSLALAAGGFSLPFTLRNAAA 
YnfF Potentially DMSO 
reduction 
MGD, 1 FE-
S cluster 
YnfG MMKIHTTEALMKAEISRRSLMKTSALGSLALASSAFTLPFSQMV
RA 
Table 1.1) Substrates of the Tat system in E. coli -showing physiological role, cofactors which are inserted and co-exported partners, if any. The twin arginines are highlighted 
within the signal sequence ((Palmer et al., 2010) 
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FdnG Formate oxidation MGD, 1 FE-
S cluster 
FdnH MDVSRRQFFKICAGGMAGTTVAALGFAPKQALA 
FdoG Formate oxidation MGD, 1 FE-
S cluster 
FdoH MQVSRRQFFKICAGGMAGTTAAALGFAPSVALA 
YedY Potentially 
TMAO/DMSO 
reduction 
MPT None MKRRQVLKALGISATALSLPHAAHA 
CueO Cu(I) oxidation 4 x Cu ions None MQRRDFLKYSVALGVASALPLWSRAVFA 
PcoA Copper resistance 4 x Cu ions None MLLKTSRRTFLKGLTLSGVAGSLGVWSFNARSSLSLPVAA 
SufI Cell division None Unknown MSLSRRQFIQASGIALCAGAVPLKASA 
YahJ Putative deamidase 1 X Fe ion Unknown MKESNSRREFLSQSGKMVTAAALFGTSVPLAHA 
WcaM Colanic acid 
biosynthesis 
Unknown Unknown MPFKKLSRRTFLTASSALAFLHTPFARA 
MdoD Glucan biosyntheisis Unknown Unknown MDRRRFIKGSMAMAAVCGTSGIASLFSQAAFA 
EfeB Iron extraction from 
heme 
Heme None MQYKDENGVNEPSRRRLLKVIGALALAGSCPVAHA 
YaeI Potential 
phosphodiesterase 
Unknown Unknown MISRRRFLQATAATIATSSGFGYMHYC 
AmiA Cell wall amidase 1 x Zn2+ Unknown MSTFKPLKTLTSRRQVLKAGLAALTLSGMSQAIA 
AmiC Cell wall amidase Potentially 1 
x Zn2+ 
Unknown MSGSNTAISRRRLLQGAGAMWLLSVSQVSLA 
FhuD Ferrichrome binding None Unknown MSGLPLISRRRLLTAMALSPLLWQMNTAHA 
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YcbK Peptidase M15 
superfamily 
Unknown Unknown MDKFDANRRKLLALGGVALGAAILPTPAFA 
Pac Penicillin amidase Ca2+ None MKNRNRMIVNCVTASLMYYWSLPALA 
C3736 Potential diene 
lactone hydrolase 
Unknown Unknown MPRTAKDFPQELLDYYDYYAHGKISKREFLNLAAKYAVGGMTA
LA 
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brought about by detergents. Likewise, a lack of growth anaerobically with DMSO or 
TMAO as the sole electron acceptor identifies strains unable to export Tat-dependent 
substrates TMAO/DMSO reductase (Buchanan et al., 2001). 
The Tat system is essential for viability in a number of other organisms, such as the 
nitrogen-fixing Sinorhizobium meliloti, the predator bacterium Bdellovibrio bacteriovorus 
and some Halophiles (Pickering & Oresnik, 2010, Chang et al., 2011, Dilks et al., 2005, 
Thomas & Bolhuis, 2006). Notably however, with regard to antimicrobial drug 
development, is the reliance of the human pathogens Mycobacterium tuberculosis and 
Helicobacter pylori on the Tat system for viability (Saint-Joanis et al., 2006, Benoit & 
Maier, 2011). In addition, it was found that deletion of the Tat substrate cj0379c 
(homologous to E. coli YedY) in zoonotic pathogen Campylobacter jejuni impaired the 
organism’s ability to colonise chickens and conferred increased sensitivity to reactive 
nitrogen species (Hitchcock et al., 2010). 
This presents a potential avenue for antibiotic development, given the absence of a Tat 
system, or indeed any homologues in humans. Viability aside, the Tat system is usually 
required for virulence of those bacterial pathogens found to possess it (De Buck et al., 
2008).  
1.8 Tat proofreading 
While no chaperones have been found which are common to all Tat substrates, 
individual substrates have been found to be associated with discrete chaperones in the 
cytoplasm. These “proofreading chaperones” are able to bind the Tat signal peptide 
and in some cases the mature domain of co-factor-containing proteins, preventing 
targeting to the membrane before folding and cofactor insertion is completed (Fig. 1.7).  
Examples of this include the chaperone DsmD which binds to the Tat substrate, 
dimethyl sulfoxide (DMSO) reductase (DmsA), a molybdopterin cofactor-containing 
protein. Typically E. coli is able to grow anaerobically with DMSO as the terminal 
electron acceptor due to the effective export of functional DmsA, however when DmsA 
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is expressed in the absence of DmsD, growth is prevented (Oresnik et al., 2001). This 
is complemented with data showing a direct interaction between DmsD and the signal 
peptide of DsmA (Winstone et al., 2006). A similar relationship has been identified 
between TorD and the molybdenum-containing Tat substrate, TorA. A binding site at 
the C-terminus of TorA was identified for TorD (Jack et al., 2004, Hatzixanthis et al., 
2005) and further to this a direct interaction has been shown through two high affinity 
sites characterised using SAXS (small angle X-ray scattering) (Dow et al., 2013). 
Notably, TorD is still able to interact with cofactor-free TorA even in the absence of the 
signal peptide. It is proposed that once the C-terminal domain of TorA is correctly 
folded, TorD is displaced prior to transport through Tat. Likewise the chaperone NapD  
is thought to bind nitrate reductase NapA at the Tat signal peptide in a similar manner 
to TorA (Grahl et al., 2012), with SAXS data showing NapD bound to NapA in a 
partially folded state (Dow et al., 2014).    
 
   
 
 
 
 
 
 
 
 
 
Figure 1.7) Diagram showing chaperone binding to a Tat substrate- 1) Bespoke protein chaperones 
(blue) bind to the Tat signal peptide (black) and the passenger domain (green) to prevent translocation 
until cofactor insertion occurs as in step 2). Once correctly folded with the cofactor the chaperones are 
released and the substrate is translocated by the Tat system into the periplasm. Adapted from (Palmer 
& Berks, 2012). 
24	
	 	 	
1.9 Tat quality control 
The ability of the Tat system to distinguish between folded and unfolded protein 
substrates (i.e. quality control) has been demonstrated through experiments studying 
the transport of PhoA. Normally PhoA is a Sec substrate which is exported as a 
disordered polypeptide, whereby structural disulphide bonds, catalysed by the DsbAB 
system, drive its folding in the periplasm (Akiyama & Ito, 1993). Replacing the native 
signal peptide with a Tat signal does not result in export to the periplasm, presumably 
because it is incapable of forming disulphide bonds in the cytoplasm and is therefore 
not fully folded. Indeed, when PhoA is expressed with the Tat signal peptide in an E. 
coli strain engineered to have an oxidising cytoplasm (an environment that 
accommodates disulphide bond formation), it is exported to the periplasm indicating 
that the Tat system recognises folded PhoA (Panahandeh et al., 2008, Stanley et al., 
2002). A similar situation was encountered when Tat signal peptides were fused to 
antibody fragments, where transport to the periplasm was only observed with prior 
heterodimerisation of antibody fragments in the cytoplasm (DeLisa et al., 2003).  
The mechanism behind Tat’s ability to discriminate unfolded and folded proteins in 
these instances has not been identified and is complicated somewhat by the Tat 
system’s ability to transport some unfolded proteins, as long as they are small and 
hydrophilic (Richter et al., 2007, Cline & McCaffery, 2007). It has been shown that long 
hydrophobic stretches in Tat substrates hinder their export, though this may be due to 
the hydrophobic residues interacting with the lipid bilayer directly, stalling movement 
through the Tat translocase (Richter et al., 2007). This may account for the lack of 
transport for unfolded proteins which have their hydrophobic core exposed. More 
recently, however, mutations in the Tat translocase have been identified which allow 
misfolded substrates to be translocated, indicating a potential role in recognising folded 
substrates which is intrinsic to the Tat system (Rocco et al., 2012).  
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1.10 The Tat machinery 
In E. coli two separate loci encode Tat components, with a four cistron operon at 86 
min on the chromosome encoding tatABCD along with an unlinked tatE gene at 14 
minutes (Sargent et al., 1998) (Fig. 1.8). Due to the presence of a stem loop on the 
mRNA between tatC and tatD, the major transcript from the tatABCD operon is tatABC. 
Expression studies using transcriptional and translational fusions show tatA is 
produced greatly in excess of the other subunits, with a predicted ratio for 
TatA:TatB:TatC of 50:2:1 (Jack et al., 2001). It was also observed that tatA was 
expressed at levels 50-200 times in excess of that seen for the unlinked gene, tatE 
(Jack et al., 2001). This TatA:TatE ratio, coupled to the homology between the two 
proteins, and presence of tatE on a separate locus has led to the proposition that tatE 
is a functional duplication of tatA (Sargent et al., 1998). Indeed, deletion of tatA has a 
much more drastic effect on transport than deletion of tatE. The tatA, tatB and tatC 
were genes found to be critical for Tat transport, demonstrating that the core gene 
components for the system are tatA, tatB and tatC (Sargent et al., 1998, Sargent et al., 
1999, Weiner et al., 1998, Bogsch et al., 1998).  
Generally, plant chloroplasts and Gram-negative organisms, such as E. coli, harbour a 
Tat system containing three core subunits, TatA and TatB which belong to the TatA 
family and a third subunit belonging to the TatC family. In Gram-positive bacteria (with 
the exception of the actinobacteria) and archaea a separate TatB is not usually found. 
Figure  1.8) E. coli tat genes- The polycistronic tatABCD locus is at 86 min on the E. coli chromosome, 
with a predicted RNA step loop separating tatC and tatD. Monocistronic tatE is located at 14 min. 
Neighbouring genes are shown in white. 
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However these organisms frequently code for more than one copy of TatA and TatC, 
for example the Tat system in Gram-positive Bacillus subtilis is encoded by tatCd and 
tatCy and three tatA paralogues (tatAd, tatAy and tatAc) (Jongbloed et al., 2004). 
Though it appears that TatA and TatB share a common ancestor, which accounts for 
their structural and sequence similarities (Yen et al., 2002), where present they have 
been found to serve functionally distinct roles in the Tat translocase (Sargent et al., 
1999). Indeed, while deletion of tatB is extremely detrimental to the function of the E. 
coli Tat system, single amino acid substitutions in the N-terminal region of TatA can 
compensate for the loss of TatB (Sargent et al., 1999, Blaudeck et al., 2005). This has 
led to the proposition that TatA and TatB are functionally distinct and TatA subunits 
found in Gram-positive and archaeal TatAC systems are “bifunctional”, able to fulfil the 
roles of both TatA and TatB. To further substantiate this, TatA from the TatAC system 
of Bacillus subtilis has been shown to substitute for both TatA and TatB in the E. coli 
TatABC system (Barnett et al., 2008). Finally, it should be noted that deletion of tatB 
from TatABC-based translocase systems does not always prevent Tat activity, with 
Gram-negative bacterium Helicobacter pylori able to carry out Tat transport without 
TatB (but not TatC) (Benoit & Maier, 2003). 
1.10.1 The homologous TatA, TatB and TatE proteins 
E. coli encodes three components of the TatA family; TatA itself, TatB and TatE. All 
three proteins have a similar topology, with a periplasmic-facing N-terminus followed by 
a short transmembrane helix linked via a hinge region to a longer, perpendicular 
amphipathic helix at the cytoplasmic side of the inner membrane. Each protein is also 
thought to have a C-terminal disordered region which protrudes into the cytoplasm 
(Koch et al., 2012) (Fig 1.9A). Truncation experiments with TatA and TatB show that 
this C-terminal disordered region is not essential for Tat function (Lee et al., 2002).		
The E. coli TatA and TatE proteins share 53% sequence identity, and are more closely 
related to each other than to TatB. TatE itself is thought to function in a similar manner 
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to TatA, but is present at much lower levels (Sargent et al., 1998, Jack et al., 2001) 
(Fig. 1.9B). TatB has both a larger amphipathic helix and C-terminal disordered region 
than both TatA/E with its N-terminal region sharing 20% identity with TatA (Sargent et 
al., 1999, Hicks et al., 2003). The notable presence of polar amino acids in the TM of 
TatA family proteins, such as Q8 in TatA, will be discussed in Section 1.11. 
	
	
	
	
	
 
 
 
1.10.2 TatA and TatE  
E. coli TatA is a small protein with a molecular mass of 8.9 kDa. The NMR structure of 
TatA was obtained in 2013, showing the transmembrane helix (TM) perpendicular to 
the amphipathic helix (AP) linked by a hinge region holding them at around 90 degrees 
to each other (further conformations will be outlined in section 1.10.6). The flexible 
transmembrane hinge amphipathic C-terminal 
TatA 
TatB 
TatE 
Figure 1.9) Solution NMR structures of homologous TatA and TatB with alignment of E. coli TatA 
family proteins- A- Amino acid number and region of each protein is noted above the sequences and grey 
cylinders denote alpha helical regions of the protein- adapted from Frobel et al., 2012b B- Sequence 
alignment of TatA family proteins transmembrane (TM) and amphipathic (AP) helices of each protein are 
noted, along with a dashed region at the C-terminus representing the non-essential disordered region of 
each protein. TatA structure: Rodriguez et al. (2013), PDB: 2LZR and TatB structure: Zhang et al. (2014). 
PDB: 2MI2. (PDB- Protein Data Bank ID) 
A 
B 
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region at the N- and C- terminus of the protein was observed (Fig. 1.10A). The last 40 
non-conserved amino acids in the disordered C-terminal region were removed to aid in 
structure derivation. TatA is known to self-interact, which will be expanded on in detail 
in Section 1.10.6. 
Residues in the AP of TatA have been found to be more sensitive to substitution than 
in the TM (Hicks et al., 2003, Greene et al., 2007). Highly conserved residues in the 
hinge/amphipathic region include F39, G21, F20 and a charged amino acid at position 
41 (Hicks et al., 2003) (Fig. 1.10B). The F39A substitution was found to abolish 
transport completely and to show dominant negative behaviour. Additionally, screening 
random mutant libraries for defective TatA proteins highlighted a number of residues 
important for Tat transport, all located in the amphipathic or hinge region. In particular 
mutations T22A in the hinge region and D31G, A42T and G33S/G33D in the AP were 
all found to prevent self-interaction when TatA self-crosslinking experiments were 
performed (Fig.1.10B) (Hicks et al., 2003, Hicks et al., 2005).   
Figure 1.10) Solution NMR structures of TatA with transport-defective residues highlighted- A- 
shows structure ensemble of TatA with the 10 lowest energy states derived from solution NMR, 
demonstrating flexibility in the C and N-terminal regions, note- Tat was truncated, removing the longer, 
disordered, nonessential C-terminal tail not displayed in the structure (Rodriguez et al., 2013, B- Notes 
amino acids in orange found to negatively impact Tat function from Hicks et al. (2003; 2005) mapped onto 
solution NMR structure for TatA. Residues with * were demonstrated to prevent TatA self-interaction via 
crosslinking (Hicks et al., 2005). TM- transmembrane helix, AP- amphipathic helix, PDB: 2LZR 
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Data concerning the function of TatE is scarce, likely due to TatE being regarded as a 
lower abundance, non-essential, functional duplication of TatA (Sargent et al., 1998). 
TatE has been found to substitute for TatA in restoring transport of some substrates 
when overexpressed (Sargent et al., 1999, Baglieri et al., 2011) and restore activity to a 
transport-defective TatA-YFP fusion when they are co-expressed (Alcock et al., 2013). 
Indeed very recently it has been proposed to be a regular constituent of the Tat 
complex in E. coli based on crosslinking experiments (Eimer et al., 2015). Though 
whether these data show that TatE occasionally substitutes for TatA in the Tat 
machinery or it has a discrete function of its own is not fully understood.  
1.10.3 TatB  
TatB is the largest member of E. coli TatA protein family with a molecular mass of 18.5 
kDa. While it has a larger amphipathic helix (AP) and C-terminal disordered region, 
TatB is oriented in the membrane in a similar manner to TatA (Koch et al., 2012, Zhang 
et al., 2014). From the NMR structure, TatB has the two additional helices (α3 and α4) 
in the C-terminal region. Flexibility was pronounced in the C-terminal region with the α4 
helix in particular found to be floppy (Zhang et al., 2014) (Fig. 1.11).  
 
 
 
 
 
 
 
Figure 1.11) Solution NMR ensemble structures TatB- upper- 15 lowest energy conformers of TatB 
aligned to backbone residues 1-100 and lower- aligned to backbone atoms of residues 6-47. Taken from 
Zhang et al. (2014), TMH- Transmembrane helix, APH- Amphipathic helix. 
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As with the solution NMR experiments for TatA, TatB is truncated in the structure 
derivation, with non-conserved amino acids at the C-terminal region (the last 70 on 
TatB) not present. 
In E. coli membrane fractions, chemical crosslinking demonstrated that TatB self-
associated into at least homodimers (De Leeuw et al., 2001), with site-specific 
crosslinking later identifying oligomers of up to six TatB units under similar conditions 
(Lee et al., 2006a). The latter study observed one self-interacting face of TatB in the 
transmembrane helix through residues involving residues in the TM (Lee et al., 2006a)  
TatB multimerisation within the TatBC complex will be discussed in section 1.10.5.  
1.10.4 The TatC core 
TatC is the largest component of the Tat system, at 28.9 kDa in E. coli, and is essential 
for Tat function (Bogsch et al., 1998). Topologically, TatC has six transmembrane 
helices with the N- and C- termini both located in the cytoplasm (Drew et al., 2002, 
Behrendt et al., 2004, Punginelli et al., 2007a)). The crystal structure of TatC from 
thermophile, Aquifex aeolicus was obtained in 2012, and used to build a homology 
model for the structure of E. coli TatC, shown in Fig. 1.12A. This presents the predicted 
six transmembrane helices (TMs) forming a concave arrangement centred around 
TM4, with a short TM5 and 6 causing a pinching effect on the membrane lipids. The 
periplasmic loops 1 and 2 were found to form a cap, referred to as the “periplasmic 
cap”, which overhung the concave face of TatC (Rollauer et al., 2012). 
One of the most notable features of A. aeolicus TatC is the conserved residue E165 
which appears to protrude out of the concave face into the hydrophobic lipid bilayer. 
The significance of this ionisable amino acid was supported by molecular dynamic 
simulations which observed bilayer perturbations as E165 attracted the lipid head 
groups. Due to this it was proposed that the E165 is likely buried through interactions 
with another component with candidates and is explored in Section 1.10.6 (Rollauer et 
al., 2012, Ramasamy et al., 2013). In E. coli the equivalent residue is located at 
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position 170 (see Fig. 1.12A). A map of conserved residues in TatC is presented in Fig. 
1.12B, with regions at the cytoplasmic side of TM1 and TM2, along with residues at the 
top of TM5 forming patches of conservation (Rollauer et. al., 2012).  
Although TatC from A. aeolicus crystallised as a dimer, with contacts observed through 
two TM5 regions, the orientation is not considered topologically reasonable given that 
one monomer was flipped vertically (Rollauer et al., 2012). Self-contacts were also 
observed in the crystal structure between the TM1 however with the lack of 
conservation in this region (Fig. 1.12A and B) it was considered unlikely to be a native 
interaction site (Rollauer et al., 2012). TatC is able to support Tat transport when 
expressed as a fused dimer (Maldonado et al., 2011) and in E. coli membrane 
fractions, was found to self-interact via disulphide crosslinks across all six helices 
(Punginelli et al., 2007b, Kneuper et al., 2012, Rollauer et al., 2012, Lee et al., 2006a). 
Figure 1.12) Crystal structure of Aquifex aeolicus TatC- A- Ribbon diagram of the A. aeolicus TatC 
crystal structure solved at a 3.5 Å resolution with transmembrane helices labelled TM 1-6 superimposed 
on a lipid bilayer representation (grey). Adapted from Rollauer et al. (2012). B- Surface diagram of TatC 
with conserved residues identified with maroon representing high and cyan representing low conservation. 
Areas of high conservation are labelled (i) and (ii). Consurf model taken from Rollauer et al. (2012). 
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This is supported by photo-crosslinking experiments in E. coli inside-out inner 
membrane vesicles (INVs), where similar extensive self-interaction of TatC was found, 
specifically in the first periplasmic loop (Zoufaly et al., 2012), TM5, TM4 and TM2, with 
weaker associations at TM3 (Blummel et al., 2015). This extensive self-crosslinking 
across the whole protein makes it difficult to identify an exact interaction face of TatC.  
Of the self-crosslinks seen in TatC, the body of literature so far has consistently 
identified a TM5-TM5 self-interaction, which has been frequently observed in vitro (with 
the two monomers presumed to be in the same orientation as opposed to the crystal 
structure packing) (Kneuper et al., 2012, Rollauer et al., 2012, Punginelli et al., 2007, 
Blummel et al., 2015) however a recent study showed that in living E. coli cells, with 
Tat subunits expressed from low copy vector, self-interaction in this region was only 
detected in the presence of an overexpressed substrate (Cleon et al., 2015). From this 
it appears that protein amount and experimental conditions (i.e. membrane fractions 
and INVs as opposed to living cells) may have a bearing on the crosslinks seen, 
perhaps suggesting that while TatC can self-interact at many positions, at least some 
may be specific to certain circumstances. TatC TM5 is of particular interest because it 
has also been shown to crosslink TatB and the Tat signal peptide, which will be 
explored further in section 1.10.5. 
The periplasmic cap, composed of periplasmic loops 1 and 2, is also a candidate site 
for TatC self-interaction based on disulphide crosslinking in E. coli membrane fractions 
(Punginelli et al., 2007b) and photo-crosslinking in INVs from the same organism 
(Zoufaly et al., 2012). Unlike self-crosslinks in the TM5, crosslinks in this region were 
also seen in living cells from a low copy number vector (Cleon et al., 2015). 
Furthermore, the latter study also identified dominant negative mutations in the 
periplasmic cap which ostensibly abolished the TM5-TM5 self-interaction site, while 
maintaining periplasmic loop contacts. These substitutions included P48L, M59K, 
S66P, V145E and D150Y. Indeed, it appears that there is more than one self-contact 
site on TatC that may be relevant at different points during transport of substrate. 
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Support for the E. coli TatC self-interactions is provided by self-crosslinks observed in 
the plant homologue, cpTatC, at helix 5, and luminal (analogous to periplasmic) loops 1 
and 2 (Aldridge et al., 2014) with co-purification experiments suggesting the plant 
equivalent to the periplasmic cap was important for self-interaction (Aldridge et al., 
2014, Ma & Cline, 2013). 
Thus TatC likely acts as an obligate oligomer, with multiple self-contact sites within the 
TatBC recognition complex. Higher order oligomers of TatC will be discussed as part of 
the TatBC complex in section 1.10.5. 
1.10.5 The TatBC recognition complex  
 
Affinity purification and BN-PAGE (blue native-polyacrylamide gel electrophoresis) 
analysis of Tat subunits shows that TatB and TatC interact as a stable hetero-oligomer 
with a stoichiometry of 1:1 (Bolhuis et al., 2001, Orriss et al., 2007, Tarry et al., 2009, 
Oates et al., 2005), with an analogous complex also detected in plants (Cline & Mori, 
2001). TatA has been found to be weakly associated with this complex in numerous co-
purification experiments (Bolhuis et al., 2001, Oates et al., 2003, Porcelli et al., 2002, 
de Leeuw et al., 2002), and has been found to co-purify with TatC in the absence of 
TatB (Fritsch et al., 2012). The culmination of this data has led to the alternate 
designation of the TatBC complex as Tat(A)BC. The molecular weight estimation of this 
Tat(A)BC complex varies depending on the purification method used, with 
approximations of 370-700 kDa derived (Bolhuis et al., 2001, Cline & Mori, 2001, Oates 
et al., 2005, McDevitt et al., 2006). 
It has been demonstrated that in the absence of TatA, this discrete TatBC complex is 
still able to form, with no detectable size change on BN-PAGE (Orriss et al., 2007). 
Indeed, immunoprecipitation of native level Tat subunits failed to detect any association 
of TatA with TatBC (McDevitt et al., 2006). However it should be noted that the 
presence of TatA has been found to modulate TatBC-substrate interactions in 
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Figure 1.13) 3D maps of TatBCHis recognition complex from single-particle electron microscopy, A- 
Smaller (light blue) and larger (blue) TatBCHis complexes, with lipid bilayer representation in gray added 
on the small complex. B- TatBC complex (green) bound to 1 (left) and 2 (right) SufIHis substrates. Taken 
from Tarry et al. (2009). 
fluorescence-based experiments (Whitaker et al., 2012). Therefore when this study 
refers to the TatBC complex, this potential role of TatA is taken into account.   
The TatBC complex, purified without TatA, has been visualised directly by single 
particle electron microscopy- yielding a low resolution structure with a hollow 
hemicircular arrangement containing an estimated 6-8 copies of each subunit (Fig. 
1.13). Up to two bound SufI substrates were also observed at adjacent sites- leading to 
the hypothesis that the complex is multivalent and that there are stronger and weaker 
binding sites on the complex (Tarry et al., 2009).  
 
 
 
 
 
More recently, in vivo experiments with TatB-YFP and TatC-YFP protein fusions have 
been able to probe associations using fluorescence microscopy. Here, as in detergent 
solution, it was observed that TatBC forms a stable complex (Alcock et al., 2013). 
Further to this the same study found that TatB formed lower order oligomers (outlined 
in section 1.10.3) in the absence of TatC, with the oligomerisation state of TatC 
unaffected by the absence of TatB, consistent with previous data (Orriss et al., 2007, 
Behrendt et al., 2007). Other fluorescence-based studies observed fluorescence 
resonance energy transfer (FRET) between substrate, pre-SufI, and both TatB and 
TatC, which was reversible upon the addition of non-fluorescent pre-SufI, further 
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supporting the TatBC complex’s role in recognising substrate and suggesting a 
reversible binding step to TatBC (Whitaker et al., 2012). 
A host of genetic studies in E. coli have been able to isolate mutations in tatB and tatC 
which can rescue binding of defective signal peptides. From these it was discovered 
that amino acid substitutions in the first and second cytoplasmic loops of TatC and the 
N-terminal region of TatB could successfully facilitate transport of a passenger domain 
attached to a defective Tat signal peptide (Fig. 1.14A) (Kreutzenbeck et al., 2007, 
Strauch & Georgiou, 2007, Lausberg et al., 2012).  
Mutations in TatC have been found that prevent the recognition of Tat signal peptides. 
Specifically it was found that amino acid substitutions P48A in TM1 at the periplasmic 
facing side, F94A, Y100A and E103A at the cytoplasmic facing region at TM1 and TM2 
including the cytoplasmic loop 2 and Y126A at the top of TM3 prevented substrate 
binding (Holzapfel et al., 2007). Of these mutations P48A, F94A and E103A had 
identified previously to independently have a negative impact on Tat function (Allen et 
al., 2002, Barrett et al., 2005, Buchanan et al., 2002). Indeed Buchanan and co-
workers noticed that F94A and E103A mutations in E. coli were able to block transport 
of both TorA and SufI substrates (Fig. 1.14A). A more recent fluorescence study was 
able to expand on the effect of some of these substitutions by showing that signal 
peptide binding and transport was blocked when TatC contained the F94A and E103A 
substitutions (Alcock et al., 2013). Indeed it appears that the regions of TatC that have 
been found to mediate signal peptide binding overlap when using various genetic 
studies, solidifying the importance of the TatBC complex itself in recognising signal 
peptides and particularly residues in or near the cytoplasmic loops of TatC. 
In agreement with the genetic data, interactions have been observed between the 
signal peptide and TatBC. Photo-crosslinks, whereby a Bpa residue 
(benzoylphenylalanine) is engineered into TatC which can crosslink nearby molecules 
upon exposure to UV light, have demonstrated that regions in TatC interact directly 
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with the signal peptide in E. coli INVs at the cytoplasmic facing regions of TM1 and the 
first cytoplasmic loop (Zoufaly et al. 2012) and at a distal site at TatC helix five 
(Blummel et al., 2015). The observation of separate signal peptide binding sites at TM1 
and cytoplasmic loops 1 and 2 with a distal site at TM5 are also in agreement with plant 
Tat models, which observed crosslinks between the stromal (analogous to cytoplasmic) 
 
 
 
 
 
 
 
 
 
 
 
 
regions 1 and 2 and the substrate RR sequence (Ma & Cline, 2010) with subsequent 
data showing crosslinks between cpTatC TM5 and the hydrophobic region of the signal 
peptide (Fig. 14A) (Aldridge et al., 2014).  
Identifying interactions from the perspective of the signal peptide, it has been shown 
that the consensus sequence in the n-region of the Tat signal peptide binds TatC, while 
the hydrophobic h-region and precursor protein are in the vicinity of TatB (Alami et al., 
Figure 1.14) Homology structures of E. coli TatC highlighting residues important for signal peptide 
and TatB binding- A- Residues shown as green spheres are shown to photo-crosslink the Tat signal 
peptide, with residues shown as sticks shown to be important in signal peptide binding directly in 
fluorescence based (Alcock et al., 2013) and genetic studies (Holzapfel et al., 2007) – amino acids in the N-
terminus but not in the structure are listed- which were all shown to crosslink signal peptide. B- TatC as on 
the left with residues as blue spheres shown to be in the proximity of TatB via photo and disulphide 
crosslinking (Kneuper et al., 2012, Rollauer et al., 2012, Zoufaly et al., 2012, Blummel et al., 2015) with 
TM1-6 denoting transmembrane helices, P1-3 periplasmic loops and C1-4 cytoplasmic loops. Figures 
created using PyMol. 
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2003, Gerard & Cline, 2006, Maurer et al., 2010). The signal peptide binding site on 
TatC at TM5 may reflect the deep insertion of the signal peptide into the recognition 
complex that was previously proposed in plant and bacterial models (Gerard & Cline, 
2007, Frobel et al., 2012). Further to this, molecular dynamics simulations have 
suggested that the signal peptide may interact within the concave face of TatC, 
involving the E. coli E170 residue at TM4 (Ramasamy et al., 2013) with further studies 
proposing that the signal peptide binds deeply in the TatBC complex as a hairpin loop 
in the concave face of TatC (Blummel et al., 2015). 
When expressed as a single fusion protein, TatBC is able to support Tat transport, 
suggesting that TatB and TatC act together as an individual unit within the TatBC 
complex (Bolhuis et al., 2001). Photo-crosslinking in INVs show that a Bpa residue in 
TM5 of TatC was able to crosslink with TatB (Zoufaly et al., 2012), while Bpa 
incorporation at positions in the flexible N-terminal region of TatB (see Fig. 14B) formed 
crosslinks with TatC (and TatA, which will be discussed in section 1.10.6) (Blummel et 
al., 2015). Disulphide crosslinks between the TM of TatB and the TM5 of TatC have 
also been observed in E. coli membrane fractions (Rollauer et al., 2012, Kneuper et al., 
2012) whereas a D211A substitution in TatC at the nearby P3 loop abolished TatB co-
purification with TatC (Buchanan et al., 2002) providing further biochemical evidence 
for the importance of this region on TatC for TatB-C interactions.  
More recently however, a second binding site for the TatB TM was proposed around 
the TM2/4 of TatC based on photo-crosslinks (Blummel et al., 2015), with TatB 
simultaneously in the proximity of another TatC TM5 (see Fig. 14B and 15A). As 
mentioned in section 1.10.3 TatB is able to form oligomers in E. coli membrane 
fractions (Lee et al., 2006a) and when the crosslinking pattern is combined with self-
crosslinking observed with TatC in similar conditions (Punginelli et al., 2007b) it seems 
likely that TatB forms an oligomer in the TatBC complex with TatC on the outside. 
Further to this multiple TatB units have been shown to form adducts which crosslink 
one Tat substrate which suggests, in the context of a TatBC complex, that the 
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substrate may localise to the TatB oligomer at the centre prior to transport (Maurer et 
al., 2010). 
Taking into account the two sites for TatB on TatC, a recent model for the TatBC 
recognition complex has been presented, with an adapted version presented in Fig. 
15B and C, showing a tetramer of TatB within a tetramer of TatC (Blummel et al., 
2015). Blummel et al. (2015) acknowledge in their work that tetramerisation was merely 
based on the tetramer units of TatB in their photocrosslinking and the TatBC units in 
the model could be accommodated to incorporate further TatBC units. Indeed, photo-
crosslinked TatC oligomers up to hexamers have been observed proposed to be joined 
via a bifunctional linker through Cys residues incorporated at D63 (in the first 
periplasmic loop) and A163 (at the periplasmic region of TM3) (Blummel et al., 2015) 
(Fig. 1.15A and C). Furthermore this arrangement of TatC subunits does not account 
for all the self-interaction of TatC residues outlined in section 1.10.4, given that the 
TatC TM5-TM5 interaction was only observed in the presence of increased substrate 
flux through the Tat pathway (Cleon et al., 2015). While this model is presumed to 
represent the resting Tat system, it seems more information is required as to the stage 
of Tat transport associated with each self-interacting site before they can be mapped 
directly onto a model.  
Disulphide-crosslinking studies between plant homologue cpTatC and Tha4 (TatA) 
draw similar conclusions to that observed in E. coli, with Hcf106 positioned at the 
cpTatC TM5 in close proximity to a nearby Tha4 which will be discussed in section 
1.10.6. The signal peptide of the substrate has the consensus twin arginine motif 
interacting near the thylakoid (stromal) regions at the bottom of cpTAtC TM1 and TM2 
with the rest of the signal peptide in the proximity of Hcf106 and the TM5 of another 
cpTatC forming as dimer (Aldridge et al., 2014). Although Aldridge et al. present a 
dimeric cpTatC-cpTatC they acknowledge that questions still need to be answered 
regarding higher order states (Aldridge et al., 2014). The Tat signal peptide interacts 
with TM5 of TatC even in the presence of TatB, and this appears to be accounted for in 
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the model presented in Blummel et al. (2015) with TM5 near the centre of the TatBC 
complex (Fig. 1.15C). Additional accessibility studies of a Tat substrate precursor 
protein signal peptide in E. coli INVs using the membrane-impermeable probe, 
PEGMAL, suggested that the peptide was inserted into the TatBC complex in a hairpin  
 
 
 
 
 
 
 
 
 
 
 
 
 
conformation (Blummel et al., 2015). This is consistent with data suggesting a deep-
insertion of the signal peptide into the recognition complex (Gerard & Cline, 2007, 
Frobel et al., 2012). Indeed, it seems that the Tat signal peptide interact initially at the 
cytoplasmic facing side of TatC TM1 and TM2 before moving deeper into the complex 
at TM5.  
 
Figure 1.15) Summary of proposed TatB-C interactions in the recognition complex-A- Diagram 
representing proposed TatB-C interaction sites on a monomer of TatC, “a” represents a proposed TatB site 
on TatC (in red) at transmembrane helix 5 (TM5) with the TatB transmembrane helix shown as a blue 
ribbon. Residues shown as spheres in TatB and TatC TM5 were demonstrated to interact via disulphide 
crosslinking in E. coli membrane fractions (Kneuper et al., 2012, Rollauer et al., 2012). “b” represents the 
more recent proposed TatB site with  residues noted by * shown to photo-crosslink TatB but be too far from 
the “a” site be accounted for by one TatB interacting at both sites. A second TatB is shown as a blue 
rectangle. Residue A133 was found to crosslink to D63 of another TatC (Blummel et al., 2015) using a 
bifunctional linker, these are both shown as magenta sticks. B- Viewed from the periplasm, a dimer of TatC 
showing the arrangement of TatC TM helices and the positioning of sites “a” and “b”. C- A schematic 
diagram of the TatBC complex adapted from Blummel et al. (2015), with the tetrameric state of TatB and 
TatC and self-crosslinking residues from A- shown as purple circles.  
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1.10.6 The role of TatA 
Detergent-solubilised E. coli TatA has been observed to form ladders on BN-PAGE 
with bands separated by a step size of around 34 kDa. This size difference works out 
as units of tetramers, taking into account the monomeric size of TatA (8.9 kDa) (Oates 
et al., 2005) and the scale of these oligomers ranges from ~100 kDa to over 700 kDa. 
(Gohlke et al., 2005, McDevitt et al., 2006, Oates et al., 2005, Porcelli et al., 2002, 
Bolhuis et al., 2001, Sargent et al., 2001, de Leeuw et al., 2002).   
This tetrameric state of TatA was further supported by disulphide crosslinking 
experiments of Tha4 (TatA) in plants (Dabney-Smith & Cline, 2009) and fluorescence 
data in E. coli tracking a TatA-YFP fusion at native level expression, which found 
assembly of the protein into average units of four when expressed in the absence of 
TatBC, with larger TatA complexes of varied size only forming in the E. coli membrane 
only when TatBC was present, (Leake et al., 2008). Interestingly, it appears that in 
detergent solution TatA can still self-associate into larger oligomers both in the 
absence of TatBC and with transport-blocking mutations in TatC (Porcelli et al., 2002, 
Oates et al., 2005), suggesting differential behaviour of TatA in native membranes and 
detergent solution. 
It is likely that TatA exists in a tetrameric state when free in the membrane, to be 
recruited to the TatBC complex in response to substrate binding the latter (Leake et al., 
2008), though it should be noted that solid state NMR diffusion measurements of 
Bacillus subtilis TatAd in a bicellular environment are at odds with this, suggesting a 
monomeric state prior to oligomerisation (White et al., 2010). 
Crosslinking studies in E. coli INVs have suggested that TatA is only in the proximity of 
substrate when a PMF is present (Frobel et al., 2011). TatA oligomerisation has been 
observed directly in living cells using TatA fused to fluorescent proteins, with bright 
fluorescent foci being observed (Leake et al., 2008, Rose et al., 2013, Alcock et al., 
2013). Alcock and co-workers found that when TatA-YFP was expressed in the 
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absence of TatBC it showed diffuse fluorescence around the edge of the E. coli cell, 
only concentrating into the characteristic bright foci in response to the presence of both 
TatBC and overexpressed substrate. TatA was unable to form oligomers when the 
overexpressed substrate contained a signal peptide with “RR” substituted for non-
functional “KK”. The dependence of TatA oligomerisation on PMF was also probed 
through the use of the uncoupler carbonyl cyanide m-chlorophenyl hydrazone (CCCP), 
whereby the dissipation of PMF blocked TatA oligomerisation in a reversible manner. 
Notably, TatA oligomerisation was also prevented when TatC was mutated to prevent 
substrate binding (TatC F94A in combination with E103A, as outlined in section 1.10.5) 
providing a direct link between substrate and TatA recruitment. Rose and co-workers 
also observed the TatA oligomerisation dependence on TatBC, PMF and functional 
substrate using a TatA-GFP fusion and overexpressed substrate, with co-localisation of 
TatA-GFP and TatB-mCherry also reported in the bright foci/clusters (Rose et al., 
2013). 
Studies with plants support these E. coli studies as the TatA homologue, Tha4, was 
shown to associate with Hcf106-cpTatC (TatBC) after the latter is triggered by 
substrate binding (Mori & Cline, 2002, Cline & McCaffery, 2007). This was also 
demonstrated by increased self-crosslinks between Tha4 that have been observed 
upon recruitment to the recognition complex indicating it undergoes large-scale 
reorganisation (Dabney-Smith et al., 2006, Dabney-Smith & Cline, 2009). 
 Negative stain electron microscopy images of the TatA complex have been observed, 
which have a cylindrical shape, proposed to constitute protein-conducting channel of 
the Tat system (Sargent et al., 2001) (Fig 1.16). This study was expanded by further 
electron microscopy experiments which presented a more detailed low resolution set of 
structures of ring purified ring-shaped TatA oligomers of varying sizes. In these 
structures the ring was apparently sealed with a “lid”, presumed to be formed by the 
TatA amphipathic helices (Gohlke et al., 2005). It was proposed that TatA was 
recruited to the TatBC complex, whereby it formed a ring shape to mediate transport of 
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the substrate by acting as a “trap door” through the membrane, with the amphipathic 
helices bending inwards allowing the substrate to translocate through the lipid bilayer. 
More recent data, however, has shed further light on the TatA behaviour, challenging 
this trap-door hypothesis. Indeed, the NMR structures for both E. coli TatA and B. 
subtilis TatAd show that the hinge region that links the transmembrane and 
amphipathic helices in TatAd is highly rigid, precluding such a conformational change 
(Hu et al., 2010, Rodriguez et al., 2013). Furthermore, accessibility studies of E. coli 
TatA found no periplasmic exposure to support the amphipathic helix flipping in whole 
cells which are able to transport Tat substrates (Koch et al., 2012).  
 
 
 
 
 
 
 
 
 
 
 
A more recent study of TatA self-interaction has modelled the NMR structure of an E. 
coli oligomeric conformer of TatA (Rodriguez et al., 2013) (Fig. 1.17A, B and C). This 
proposes a ring-like arrangement of subunits, as in the EM structure (Gohlke et al., 
2005) with interactions between the transmembrane helices forming a wall. In this case 
Figure 1.16) Low resolution electron microscopy structures of TatA oligomer- The electron 
microscopy structures obtained in Gohlke et al. (2005) showing varying sizes of the TatA oligomeric 
complex, from smaller “class 1” through to larger “class 10”, proposed to accommodate differently size 
substrates, A- View of the complex from the cytoplasm, showing the ring shape formed by TatA oligomers 
is sealed, B- The complex from the periplasmic face, C- Cross-section through the complex and D- with 
lipid bilayer represented diagrammatically. 
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the amphipathic helices were positioned facing outwards from the centre of the ring 
(consistent with electron spin resonance distance measurements) with the polar Q8 
residue in the transmembrane helix (TM) is facing inwards towards the centre of the 
ring (Hu et al., 2010, Rodriguez et al., 2013). This arrangement was supported by EPR 
measurements which show that detergent solubilised TatA oligomers interact through 
the TM via V14 with the I12 of another TatA as a repeating unit (Fig. 17B) (White et al., 
2010) but seemingly contradicted crosslinking data from Greene and co-workers that 
showed self-interactions of TatA via L9 and I12 on one face of the TM, and L10 and I11 
on the other face (Greene et al., 2007). As White et al. (2010) notes, however, this 
could be due to the fact the Greene et al. (2007) crosslinks were performed in native 
membrane fractions and not solubilised in detergent where the large scale oligomers 
are found – leading tothe proposition that some crosslinks may be found in the free un-
recruited TatA (perhaps as tetramers) and others in the large oligomeric ring.  
 
Figure 1.17) Higher resolution proposed arrangements of the TatA complex- A- shows an oligomer 
created in silico using the NMR structure of E. coli TatA (Rodriguez et al. (2013), PDB: 2LZs) showing a 
ring of transmembrane (TM) helices with the polar residue, Q8 facing inwards towards the and the 
amphipathic helices (AP) pointing outwards. This complex is shown viewed from the periplasm (Rodriguez 
et al., 2013). B- As with A- viewed side-on in the membrane with residues I12 and V14 in the TM, which 
are shown to interact via EPR, in the oligomer (White et al., 2010), C- Course-grain molecular dynamics 
simulations adapted from Rodriguez et al. (2013) which show TatA (yellow) making complexes of 
increasing size from left to right, showing the membrane thinning effect of the complex pulling on the 
phospholipids (gray) and water (green) accessibility that happened during this process. A- and B- were 
created in Pymol. 
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Rodriguez and co-workers also proposed a mechanism for the transport of substrate 
through the TatA ring. From chemical shift perturbations derived from solving the TatA 
solution NMR structure in oligomeric and monomeric states, it was suggested that TatA 
can adopt two conformations. In the resting state, where TatA is not part of any higher 
order oligomers, the transmembrane helix (TM), which is barely long enough to span 
the membrane itself, is moved upwards as the hinge widens slightly and angle between 
the TM and the amphipathic helix (AP) increases, with a tilt allowing TatA to 
comfortably span the bilayer (Fig. 1.18A). Upon oligomerisation, TatA changes to a 
second conformation with the transmembrane helix pulled down into the membrane, at 
~90 degrees to the amphipathic helix, causing it to “pinch” the lipid bilayer (Fig. 1.18B). 
This orientation is thought to be shared by all the monomers within the oligomer, 
having a membrane thinning effect on the localised area within the TatA ring. Coarse 
grain molecular dynamic simulations shows that this membrane thinning allows water 
accessibility across the bilayer, thus facilitating substrate transport through the 
oligomer (Fig. 1.17C and 1.18C) (Hu et al., 2010, Rodriguez et al., 2013). Furthermore, 
Rodriguez and co-workers found that a T22P in the hinge region of TatA (note an 
alanine substitution here has already been shown to impair TatA oligomerisation, Hicks 
et. al., 2005) caused TatA to adopt the oligomer conformation when it was in a 
monomeric state.	 
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Figure 1.18) Diagram of proposed TatA orientations that cause membrane thinning and 
subsequent substrate translocation- A- Represents TatA in its monomeric form, spanning the entire 
bilayer, B- shows the proposed orientation of TatA in the oligomeric state, and the pulling downwards of 
the lipid bilayer that accompanies it, the substrate (green) is shown bound to the TatBC complex, a step 
which is thought  to regulated the oligomerisation of TatA, C- A pulling effect of the substrate forces it into 
the bilayer as the TatA subunits in the oligomer break apart. Adapted from Rodriguez et al. (2013). 
1.10.7 TatAC interactions 
TatA has been shown to directly interact with TatC through photo-crosslinking 
experiments that demonstrated the transmembrane helix (TM) of TatA is able to 
associate with TatC directly within E. coli inner membrane vesicles (INVs) (Frobel et 
al., 2011, Blummel et al., 2015). Additionally, plant Tha4 (TatA) was found to transiently 
interact with cpTatC and Hcf106 via chemical crosslinking in the presence of a 
functional precursor and a proton gradient (Mori and Cline 2002) 
To expand on the TatA-C photo-crosslinks in E. coli INVs, residues substituted with 
Bpa at positions in the TM5 and the P3 loop (including residues in TM3 and 4 that face 
the P3 loop) in TatC were shown to crosslink to both TatA and TatB, which would 
indicate an interaction with TatA in the vicinity of the TatB binding site (Fig. 1.19A and 
1.15A in Section 1.10.5) (Blummel et al., 2015). This is supported by disulphide 
crosslinking in the plants showing that Tha4 is able to interact at cpTatC TM5 and 
luminal loop L3 (analogous of E. coli periplasmic loop P3) (Aldridge et al., 2014). The 
latter study expanded these potential TatA sites by characterising them in the presence 
of overexpressed Tat substrate, and found that Tha4 interacted with cpTatC P3/TM5 
(near the proposed TatB binding site) in a manner that was unchanged with 
overexpressed substrate and therefore proposed to be constitutive (Aldridge et al., 
2014). Aldridge et al. (2014) also presented a model showing Hcf106 (analogous to E. 
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coli TatB) interacting at TatC TM5, with Tha4 interacting nearby with the L3 (P3) loop in 
a constitutive manner (Fig. 19B). Interestingly, photo-crosslinking in the E. coli P3 loop, 
identified a Bpa at TatC D211 as able to crosslink with TatA, but critically not with TatB, 
supporting the presence of a TatA/Tha4 binding site near the TatB site at TM5 but 
further towards the P3 loop region in both plant and bacterial models (Zoufaly et al. 
2012) 
Other interaction sites have been identified in the concave face of TatC in both plants 
and bacteria (Aldridge et al., 2014), Blummel et al., 2015) with plant studies identifying 
interactions at cpTatC TM4 being enhanced by substrate overexpression, as with the 
TM5 interaction (Aldridge et al., 2014). This may reflect TatA polymerisation in the 
concave face of TatC, triggered in response to substrate. Indeed when the crystal 
structure of A. aeolicus TatC was published, it was proposed that TatA may polymerise 
with its transmembrane helices arranging in the cup of TatC, around TM4/2 near the 
conserved E165 (E. coli E170) (Rollauer et al., 2012). 
 
 
 
 
 
 
 
 
 
 
Figure 1.19) Proposed TatA-TatC interactions in bacteria and plants- A- demonstrates E. coli TatC 
with residues shown as yellow spheres shown to photo-crosslink to TatA, E170, a residue which may be 
important for subsequent TatA interactions in the face of TatC is highlighted. B- Proposed Tat interactions 
in the plant homologous Tat system, with the constitutive arrangement having Hcf106 (analogous to E. coli 
TatB) at TM5, shown in cyan, along with nearby interacting Tha4 (analogous to E. coli TatA), with Tha4 
moving to the concave face of cpTatC during transport. Residues on cpTatC coloured orange are found to 
be important in signal peptide binding, with yellow residues mutated to Cys in the crosslinking to Hcf106 
and Tha4 and the Q234 (equivalent to E. coli E170) shown in magenta- adapted from Aldridge et al. 
(2013). 
B 
A 
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Aldridge et al. (2014) were also able to demonstrate a PMF dependence of some of the 
Tha4 binding sites on cpTatC, with crosslinks reduced at cpTatC TM5 and TM4 in 
response to dissipation of PMF with ionophore combination nigericin/valinomycin, 
which will be discussed in detail in section 1.11.  
1.11 The Role of PMF 
In plants, the twin arginine translocase was discovered as a ΔpH dependent system, 
distinguishing it from the ATP-dependent Sec system as outlined in detail in Section 
1.6. Specifically, it was found that the PMF was required for deep insertion of the Tat 
signal peptide (Gerard & Cline, 2007, Frobel et al., 2012) and also to promote large 
scale Tha4 self-interaction, as with TatA in E. coli, this was discussed extensively in 
Section 1.10. With regard to signal peptide binding, while substrate has been 
demonstrated to bind the Tat receptor complex in the absence of PMF in plants (Ma & 
Cline, 2013) and bacteria (Zoufaly et al. 2012), there is evidence to support a deeper 
binding site for the signal peptide in the TatBC complex, specifically in the concave 
face of TatC, which may require an intact PMF (Gerard & Cline, 2007, Blummel et al., 
2015, Ramasamy et al., 2013).  
Evidence using an in vitro Tat transport system with E. coli INV has suggested that the 
Δψ (electrical potential) of the PMF is more important than the proton gradient for 
driving Tat transport. From this study it was proposed that Tat transport needed two 
PMF dependent steps, one with a larger magnitude Δψ for a shorter time and a later 
step with a smaller Δψ for a longer time (Bageshwar & Musser, 2007). It should be 
noted in this context that PMF powered Tat transport in thylakoids has been 
demonstrated to require around 80,000 protons per substrate (Alder & Theg, 2003). 
With regard to TatA, there is evidence suggesting a PMF requirement for Tha4 (TatA) 
recruitment to the recognition complex in plants (Dabney-Smith et al., 2006, Mori & 
Cline, 2002) and bacteria (Rose et al., 2013, Alcock et al., 2013) along with data 
showing TatA crosslinking to substrate only in the presence of substrate (Frobel et al., 
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2012). However, with regard to specific amino acids in TatA, it has been suggested that 
the N-terminal region and hydrophilic acids in the transmembrane helix could facilitate 
proton movements from the periplasm during the oligomerisation step, based on 
molecular dynamics simulations (Rodriguez et al., 2013). It is should be noted here that 
plant studies have observed that Tha4 interactions at TM5 and TM4 of TatC were 
reduced in response to PMF dissipation with ionophores nigericin and valinomycin, 
suggesting the oligomerisation step may occur in the face of cpTatC (Aldridge et al., 
2014).  
The E165 residue in A. aeolicus TatC (equivalent to E170 in E. coli) has been identified 
as a candidate for a protonable amino acid which may play a role in an aqueous 
channel forming in the cavity of TatC (Rollauer et al., 2012, Ramasamy et al., 2013).  
1.12 The Tat Transport Cycle 
In the current model for Tat transport, 1) TatB and TatC for a recognition complex 
which is able to bind the signal peptide of a Tat substrate from the cytoplasmic side of 
the membrane. 2) TatA is then recruited to the recognition complex in a PMF-
dependent step whereby it forms an oligomer in the membrane which facilitates 
transport of the substrate across the membrane. 3) Once the substrate reached the 
periplasm the signal peptide is cleaved by peptidase, LepB. 4) The processed 
substrate is then released into the periplasm. 5) The Tat system goes back to its 
resting state (Fig. 1.20). 
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1.13 Aims of this Thesis: 
The overall aim of this work is to build upon the literature showing interactions between 
TatA and TatB with TatC, by focussing specifically on the role of TatA and identifying 
how it associates with TatC, and how these interactions change under various 
conditions of the Tat cycle (i.e. in the resting state, in the presence of overexpressed 
substrate, and in the absence of tatB). Co-purification data showing TatA/B interactions 
with TatC will be used to complement disulphide crosslinking, which can identify 
specific residues involved in interfaces between TatA and TatC. Specifically this thesis 
aims to: 
• Further decipher TatA, TatB and TatC subunit interactions using Ni-affinity co-
purification experiments with His-Tagged TatC 
Figure 1.20) Model of Tat transport- TatA (yellow), TatB (blue) and TatC (red) are shown in the 
membrane, with substrate (green) containing the twin arginine (RR) signal peptide.   
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• Characterise changes in co-purification of TatA/B with TatCHis from constructs 
expressing either TatA or TatB only with TatCHis  
• Map protein-protein interactions between TatA and TatC TM5, P3 and TM6 
through disulphide crosslinking a Cys scanning region in TatC in living E. coli 
cells 
• Identify sites occupied on TatC by TatA when TatB is absent 
• Identify sites occupied on TatC by TatA in the resting state of the Tat system, 
using uncouplers and TatC substitutions that prevent substrate binding 
• Monitor any changes in crosslinking patterns with overexpressed Tat substrates 
• Confirm observed crosslinks with expression of protein from low copy number 
vectors 
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Chapter 2: Materials and methods 
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2.1 Bacterial strains 
The E. coli strains used in this work are derived from strain K12. DH5α was used for all 
cloning applications, Experiments studying plasmid-borne tatABC operon were carried 
out in the chromosomal tat deletion strains DADE and DADE-P. A full list of strains is 
given in Table 2.1.  
 
 
2.2 Materials 
2.2.1 Growth Conditions 
Standard growth media was prepared by Central Technical Services at the School of 
Life Sciences, University of Dundee. Cultures were grown aerobically at 37oC with 
shaking at 200 rpm in Luria-Bertani (LB) broth, or on solid LB-Agar plates, both 
containing appropriate antibiotics (Table 2.3), unless otherwise stated. A 
comprehensive list of additives and media are shown in Table 2.2 and Table 2.4. 
2.2.2 Scoring Tat-dependent anaerobic growth on TMAO/glycerol media  
To identify whether cells harboured a functional Tat system, a stationary phase culture 
of the strain of interest was diluted in 1x M9 minimal medium salts (diluted from 10x 
stock with sterile water) to OD600 0.01 before spotting on M9 agar plates supplemented 
with TMAO and glycerol (Table 2.2). Plates were incubated in an anaerobic jar (BBL 
GasPak System) for three days at 37oC. AnaeroGen sachets were used to purge 
oxygen from the jar. Anaerobic test strips (Merck) were used to confirm anaerobic 
conditions within the anaerobic jar. 
Strain Genotype Resistance Reference 
DH5α 
F−, endA1, glnV44, thi-1, recA1, relA1, 
gyrA96, deoR, nupG, Φ80dlacZΔM15, 
Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ− 
None 
Promega; 
Grant et al. 
(1990)  
DADE MC4100,  ΔtatABCD,  ΔtatE None 
Wexler et al. 
(2000) 
DADE-
P 
MC4100,  ΔtatABCD,  ΔtatE, pcnB1 zad-
981::Tn10d 
KanR 
Lee et al. 
(2006b) 
Table 2.1) E. coli strains used in this work.  
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2.2.3 Scoring Tat-dependent growth on media containing 2% SDS 
 As a further test to identify whether cells harboured a functional Tat system, growth in 
the presence of SDS was assessed – this depends on the ability of the strain to export 
Tat-dependent amidases. A stationary phase culture of the strain of interest was diluted 
in LB to OD600 0.01 before spotting on LB agar containing 2% SDS (w/v) (Table 2.4) 
and incubating overnight at 37oC. 
		 	
Growth Media Components 
Luria-Bertani (LB) 1% (w/v) tryptone 
1% (w/v) NaCl, 
0.5% (w/v) yeast extract 
TSB Transformation buffer 1% (w/v) tryptone  
1% (w/v) NaCl 
0.5% (w/v) yeast extract  
10 mM MgSO4* 
5% (v/v) dimethyl sulfoxide 
10% (w/v) polyethylene glycol 6000 
10x M9 minimal medium salts 3% (w/v) KH2PO4 
6% (w/v) Na2HPO4 
1% (w/v) NH4Cl 
0.5% (w/v) NaCl 
MoSe salts 2 mM MgSO4 
1 mM K2SeO3  
1 mM (NH4)6Mo7O24.4H2O 
TMAO/glycerol agar  10% (v/v) 10x M9 minimal medium salts 
1.2% (w/v) Bacto agar 
0.1 mM CaCl2* 
0.5% (v/v) glycerol* 
2 mM MgSO4* 
0.1% (v/v) MoSe salts 
0.002% (w/v) thiamine* 
0.4% (v/v) Trimethylamine N-oxide (TMAO)* 
 
Table 2.2) Composition of growth media used in this work-Media was autoclaved at 121oC for 20 
mins prior to use, with the exception of those marked with an asterisk, which were filter sterilised before 
their addition. 
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Buffers and Solutions 
All buffers and solutions were prepared in distilled H2O, with a comprehensive list of is 
shown in Table 2.5, along with the components. 
 
Antibiotic Concentration in growth media 
Ampicillin 100 µg/ µL 
Chloramphenicol 25 µg/ µL 
Kanamycin  50 µg/ µL 
Supplement   Concentration in growth media 
Isopropyl β-D-1 thiogalactopyranoside 
(IPTG) 
1 mM 
L-arabinose Ranges between 0.001%-0.02% 
Sodium dodecyl sulfate (SDS) 2% (w/v) 
Solution Components 
2x Laemmli buffer, pH 6.8 (BioRad) 65.8 mM Tris-HCl 
2.1% SDS 
26.3% (v/v) glycerol 
0.01% (w/v) bromophenol blue 
Buffer 1, pH 7.5 50 mM Tris/HCl 
5 mM MgCl2 
10% (v/v) glycerol 
Elution Buffer 20 mM MOPS  
200 mM NaCl  
10 mM EDTA  
0.01% (w/v) digitonin/C12E9/Triton X-100 
HEPES/MgCl2 buffer, pH 6.8 50 mM HEPES 
5 mM MgCl2 
Resuspension buffer, pH 7.5 20 mM Tris/HCl 
200 mM NaCl 
SDS-PAGE running buffer 25 mM Tris 
192 mM glycine 
0.1% (w/v) SDS 
Sucrose Buffer 50 mM Tris.HCl pH 7.4 
1 mM EDTA,  
20% sucrose w/v 
TAE buffer 40 mM Tris 
1.142% (v/v) acetic acid 
1 mM EDTA 
Table 2.3) List of antibiotics used in this study- Ampicillin and kanamycin were dissolved in distilled 
H2O and chloramphenicol in 80% ethanol. All antibiotics were filter sterilised prior to use. 
Table 2.4) List of growth supplements used in this work- All chemicals were dissolved in distilled 
H2O and filter sterilised prior to use. 
Table 2.5) Composition of buffers and solutions utilised in this work  
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2.3 Molecular Biology Techniques 
2.3.1 Preparation of competant cells 
The host strain was grown overnight in 5 mL LB and from this, 100 µL was used to 
inoculate 10 mL of LB containing appropriate antibiotics as necessary, which was 
cultured until an OD600 of 0.3 was reached. Cells were then harvested by centrifugation 
at 3000 x g for 10 minutes and resuspended in 1 mL ice cold TBS transformation buffer 
(see Table 2.2). After incubation for 30 mins on ice, cells were competent and ready for 
use in transformation experiments directly, or were snap frozen in liquid nitrogen and 
stored at -80oC. 
2.3.2 Transformation of competent cells 
Competent cells of the strain of interest were thawed on ice, and 100 µL of cells per 
transformation were mixed with 1 µL (50 ng-1 µg) of plasmid DNA before incubation on 
ice for 30 mins. Cells were subsequently subjected to heat shock at 42oC for 90 
seconds before transferring onto ice for 2 mins. For the recovery step, 1 mL of LB was 
added to the cells before incubation at 37oC for 1 hour. The cells then harvested by 
centrifugation at 16000 x g for 1 minute and resuspended in 100 µL LB before 
spreading on LB agar plates containing appropriate antibiotics and incubating 
overnight. 
 
TBS, pH 7.5 20 mM Tris/HCl  
137 mM NaCl 
 
TBS Tween, pH 7.5 20 mM Tris/HCl  
137 mM NaCl 
0.1 % (v/v) Tween-20 
Transfer buffer 25 mM Tris 
192 mM glycine 
10% (v/v) methanol 
Wash Buffer, pH 7.2 20 mM MOPS 
200 mM NaCl 
50 mM imidazole 
0.01% (w/v) digitonin/C12E9/Triton X-100 
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2.3.4 Plasmid DNA preparation 
Cells harbouring the plasmid of interest was grown overnight in 5 mL LB and harvested 
by centrifugation at 3000 x g for 15 mins. Plasmid extraction was performed using a 
QIAprep spin miniprep kit (Qiagen), firstly resuspending the cell pellet in a buffer 
containing RNase before lysing the cells with NaOH and detergent. The reaction was 
quenched with sodium acetate before centrifugation at 16000 x g for 10 mins to remove 
cell debris. The supernatant was applied to a silica membrane before centrifugation at 
16000 x g to bind the DNA selectively to the column. The column was washed with a 
buffer containing guanidine hydrochloride and isopropanol, then with a buffer 
containing ethanol and a high salt concentration to remove contaminants from the 
DNA, using the centrifugation step as previously. The plasmid DNA was finally eluted 
using 50 µL of ultra-pure water. A list of all the plasmids used in this work is given in 
Table 2.6. 
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Construct Description Resistance Reference 
pQE60 Medium copy number expression vector with T5 promoter AmpR Qiagen 
pTH19KR Very low copy number expression vector with  Plac promoter KanR T. Hashimoto-
Gotoh 
pBAD33 High copy number vector with ParaBAD promoter ChlorR Guzman et al. 1995 
pQE80  Medium copy number expression vector with T5 promoter AmpR Qiagen 
pUNITATCC4 tatABC operon with cysteine-less tatC in pQE60 vector AmpR  Lee et al., 2006 
pQE60 AΔBCC-  tatABC operon with  cysteine-less tatC and a deletion of tatB AmpR G. Buchanan 
pTat101 Cysless tatABC operon with cysteine-less TatC in pTH19KR vector KanR Cleon et al.,l 2015 
pRep4 Encodes lacI repressor KanR Zamenhof and 
Villarejo (1972) 
pQE80 CueOH pQE80 encoding Tat substrate cueO with an C-terminal hexa-
histidine tag 
AmpR Alcock et al. 2013 
pTGS pBAD33 encoding gfp with a C-terminal ssrA tag fused to the TorA 
Tat signal sequence  
ChlorR DeLisa et al., 2002 
pUNITATCC4TatA L9C pUNITATCC4with tatA L9 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatA L10C pUNITATCC4with tatA L10 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatA I11C pUNITATCC4with tatA I11 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC M205C pUNITATCC4with tatC M205 substituted with cysteine AmpR Cleon et al 2015 
pUNITATCC4TatC L206C pUNITATCC4with tatC L206 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC L207C pUNITATCC4with tatC L207 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC T208C pUNITATCC4with tatC T208 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC P209C pUNITATCC4with tatC P209 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC P210C pUNITATCC4with tatC P210 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC D211C pUNITATCC4with tatC D211 substituted with cysteine AmpR F. Cleon 
Table 2.6) Plasmids used and constructed in this study 
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pUNITATCC4TatC V212C pUNITATCC4with tatC V212 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC F213C pUNITATCC4with tatC F213 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC S214C pUNITATCC4with tatC S214 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC Q215C pUNITATCC4with tatC Q215 substituted with cysteine AmpR F. Cleon 
pUNITATCC4TatC T216C pUNITATCC4with tatC T216 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC M205C pQE60 AΔBCC- with tatC M205 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC L206C pQE60 AΔBCC- with tatC L206 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC L207C pQE60 AΔBCC- with tatC L207 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC T208C pQE60 AΔBCC- with tatC T208 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC P209C pQE60 AΔBCC- with tatC P209 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC P210C pQE60 AΔBCC- with tatC P210 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC D211C pQE60 AΔBCC- with tatC D211 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC V212C pQE60 AΔBCC- with tatC V212 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC F213C pQE60 AΔBCC- with tatC F213 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC S214C pQE60 AΔBCC- with tatC S214 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC Q215C pQE60 AΔBCC- with tatC Q215 substituted with cysteine AmpR F. Cleon 
pQE60 AΔBCC- TatC T216C pQE60 AΔBCC- with tatC T216 substituted with cysteine AmpR F. Cleon 
pTAT101 ABCC- TatC M205C pTAT101 ABCC- with tatC M205 substituted with cysteine KanR F. Cleon 
pTAT101 ABCC- TatC L206C pTAT101 ABCC- with tatC L206 substituted with cysteine KanR F. Cleon 
pTAT101 ABCC- TatC P209C pTAT101 ABCC- with tatC P209 substituted with cysteine KanR F. Cleon 
pTAT101 ABCC- TatC P210C pTAT101 ABCC- with tatC P210 substituted with cysteine KanR F. Cleon 
pTAT101 ABCC- TatC D211C pTAT101 ABCC- with tatC D211 substituted with cysteine KanR F. Cleon 
pTAT101 ABCC- TatC V212C pTAT101 ABCC- with tatC V212 substituted with cysteine KanR F. Cleon 
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pTAT101 ABCC- TatC F213C pTAT101 ABCC- with tatC F213 substituted with cysteine KanR F. Cleon 
pTAT101 ABCC- TatA L9C pTAT101 ABCC- with tatA L9 substituted with cysteine KanR This work 
pTAT101 ABCC- TatA L10C pTAT101 ABCC- with tatA L10 substituted with cysteine KanR This work 
pTAT101 ABCC- TatA L11C pTAT101 ABCC- with tatA I11 substituted with cysteine KanR This work 
pUNITATCC4TatA L9C, TatC 
M205C 
pUNITATCC4with tatA L9 and tatC M205 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
L206C 
pUNITATCC4with tatA L9 and tatC L206 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
L207C 
pUNITATCC4with tatA L9 and tatC L207 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
T208C 
pUNITATCC4with tatA L9 and tatC T208 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
P209C 
pUNITATCC4with tatA L9 and tatC P209 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
P210C 
pUNITATCC4with tatA L9 and tatC P210 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
D211C 
pUNITATCC4with tatA L9 and tatC D211 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
V212C 
pUNITATCC4with tatA L9 and tatC V212 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
F213C 
pUNITATCC4with tatA L9 and tatC F213 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
S214C 
pUNITATCC4with tatA L9 and tatC S214 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
Q215C 
pUNITATCC4with tatA L9 and tatC Q215 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
T216C 
pUNITATCC4with tatA L9 and tatC T216 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
M205C 
pUNITATCC4with tatA L10 and tatC M205 substituted with cysteine AmpR This work 
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pUNITATCC4TatA L10C, TatC 
L206C 
pUNITATCC4with tatA L10 and tatC L206C substituted with 
cysteine 
AmpR This work 
pUNITATCC4TatA L10C, TatC 
L207C 
pUNITATCC4with tatA L10 and tatC L207 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
T208C 
pUNITATCC4with tatA L10 and tatC T208 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
P209C 
pUNITATCC4with tatA L10 and tatC P209 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
P210C 
pUNITATCC4with tatA L10 and tatC P210 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
D211C 
pUNITATCC4with tatA L10 and tatC D211 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
V212C 
pUNITATCC4with tatA L10 and tatC V212 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
F213C 
pUNITATCC4with tatA I11 and tatC F213 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
S214C 
pUNITATCC4with tatA I11 and tatC S214 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
Q215C 
pUNITATCC4with tatA I11 and tatC Q215 substituted with cysteine AmpR This work 
pUNITATCC4TatA L10C, TatC 
T216C 
pUNITATCC4with tatA I11 and tatC T216 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
M205C 
pUNITATCC4with tatA I11 and tatC M205 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
L206C 
pUNITATCC4with tatA I11 and tatC L206 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
L207C 
pUNITATCC4with tatA I11 and tatC L207 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
T208C 
pUNITATCC4with tatA I11 and tatC T208 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
P209C 
pUNITATCC4with tatA I11 and tatC P209 substituted with cysteine AmpR This work 
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pUNITATCC4TatA I11C, TatC 
P210C 
pUNITATCC4with tatA I11 and tatC P210 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
D211C 
pUNITATCC4with tatA I11 and tatC D211 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
V212C 
pUNITATCC4with tatA I11 and tatC V212 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
F213C 
pUNITATCC4with tatA I11 and tatC F213 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
S214C 
pUNITATCC4with tatA I11 and tatC S214 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
Q215C 
pUNITATCC4with tatA I11 and tatC Q215 substituted with cysteine AmpR This work 
pUNITATCC4TatA I11C, TatC 
T216C 
pUNITATCC4with tatA I11 and tatC T216 substituted with cysteine AmpR This work 
pUNITATCC4TatA L9C, TatC 
V167C 
pUNITATCC4with tatA L9 and tatC V167 substituted with cysteine AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
M205C 
pQE60 AΔBCC- with tatA L9 and tatC M205 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
L206C 
pQE60 AΔBCC- with tatA L9 and tatC L206 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
L207C 
pQE60 AΔBCC- with tatA L9 and tatC L207 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
T208C 
pQE60 AΔBCC- with tatA L9 and tatC T208 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
P209C 
pQE60 AΔBCC- with tatA L9 and tatC P209 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
P210C 
pQE60 AΔBCC- with tatA L9 and tatC P210 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
D211C 
pQE60 AΔBCC- with tatA L9 and tatC D211 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
V212C 
pQE60 AΔBCC- with tatA L9 and tatC V212 substituted with 
cysteine 
AmpR This work 
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pQE60 AΔBCC- TatA L9C, TatC 
F213C 
pQE60 AΔBCC- with tatA L9 and tatC F213 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
S214C 
pQE60 AΔBCC- with tatA L9 and tatC S214 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
Q215C 
pQE60 AΔBCC- with tatA L9 and tatC Q215 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
T216C 
pQE60 AΔBCC- with tatA L9 and tatC T216 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
M205C 
pQE60 AΔBCC- with tatA L10 and tatC M205 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
L206C 
pQE60 AΔBCC- with tatA L10 and tatC L206 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
L207C 
pQE60 AΔBCC- with tatA L10 and tatC L207 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
T208C 
pQE60 AΔBCC- with tatA L10 and tatC T208 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
P209C 
pQE60 AΔBCC- with tatA L10 and tatC P209 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
P210C 
pQE60 AΔBCC- with tatA L10 and tatC P210 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
D211C 
pQE60 AΔBCC- with tatA L10 and tatC D211 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
V212C 
pQE60 AΔBCC- with tatA L10 and tatC V212 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
F213C 
pQE60 AΔBCC- with tatA I11 and tatC F213 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
S214C 
pQE60 AΔBCC- with tatA I11 and tatC S214 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
Q215C 
pQE60 AΔBCC- with tatA I11 and tatC Q215 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L10C, TatC 
T216C 
pQE60 AΔBCC- with tatA I11 and tatC T216 substituted with 
cysteine 
AmpR This work 
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pQE60 AΔBCC- TatA I11C, TatC 
M205C 
pQE60 AΔBCC- with tatA I11 and tatC M205 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
L206C 
pQE60 AΔBCC- with tatA I11 and tatC L206 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
L207C 
pQE60 AΔBCC- with tatA I11 and tatC L207 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
T208C 
pQE60 AΔBCC- with tatA I11 and tatC T208 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
P209C 
pQE60 AΔBCC- with tatA I11 and tatC P209 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
P210C 
pQE60 AΔBCC- with tatA I11 and tatC P210 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
D211C 
pQE60 AΔBCC- with tatA I11 and tatC D211 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
V212C 
pQE60 AΔBCC- with tatA I11 and tatC V212 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
F213C 
pQE60 AΔBCC- with tatA I11 and tatC F213 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
S214C 
pQE60 AΔBCC- with tatA I11 and tatC S214 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
Q215C 
pQE60 AΔBCC- with tatA I11 and tatC Q215 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA I11C, TatC 
T216C 
pQE60 AΔBCC- with tatA I11 and tatC T216 substituted with 
cysteine 
AmpR This work 
pQE60 AΔBCC- TatA L9C, TatC 
V167C 
pQE60 AΔBCC- with tatA L9 and tatC V167 substituted with 
cysteine 
AmpR This work 
pTAT101 ABCC- TatA L9C, TatC 
M205C 
pTAT101 ABCC- with tatA L9 and tatC M205 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA L9C, TatC 
L206C 
pTAT101 ABCC- with tatA L9 and tatC L206 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA L9C, TatC 
V212C 
pTAT101 ABCC- with tatA L9 and tatC V212 substituted with 
cysteine 
KanR This work 
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pTAT101 ABCC- TatA L9C, TatC 
F213C 
pTAT101 ABCC- with tatA L9 and tatC F213 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA L10C, TatC 
M205C 
pTAT101 ABCC- with tatA L10 and tatC M205 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA L10C, TatC 
L206C 
pTAT101 ABCC- with tatA L10 and tatC L206 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA L10C, TatC 
V212C 
pTAT101 ABCC- with tatA L10 and tatC V212 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA L10C, TatC 
F213C 
pTAT101 ABCC- with tatA L10 and tatC F213 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA I11C, TatC 
M205C 
pTAT101 ABCC- with tatA I11 and tatC M205 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA I11C, TatC 
L206C 
pTAT101 ABCC- with tatA I11 and tatC L206 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA I11C, TatC 
V212C 
pTAT101 ABCC- with tatA I11 and tatC V212 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA I11C, TatC 
F213C 
pTAT101 ABCC- with tatA I11 and tatC F213 substituted with 
cysteine 
KanR This work 
pTAT101 ABCC- TatA L9C, TatC 
V167C 
pTAT101 ABCC- with tatA L9 and tatC V167 substituted with 
cysteine 
KanR This work 
pQE60 TatABCHis tatABC operon with His6-tagged tatC in pQE60 vector AmpR Buchanan et al., 
2002 
pQE60 TatACHis tatAC operon with tatB deleted and His6-tagged tatC in pQE60 
vector 
AmpR Fritsch et al., 2012 
pQE60 TatBCHis (pFAT75ΔA) tatBC operon with tatA deleted and His6-tagged tatC in pQE60 
vector 
AmpR G. Buchanan 
Tarry et al., 2009 
pQE60 TatABCHisD211A tatABC operon with His6-tagged tatC containing the D211A 
subsitution in pQE60 vector 
AmpR Buchanan et al., 
2002 
pTat101 TatABCHis tatABC operon with His6-tagged tatC in pTh19KR vector KanR This work 
pHASoxYZ pSU20 with tat promoter controlling production of N-terminally HA-
tagged SoxY and SoxZ, both from Paracoccus panthotrophus. 
ChlorR Koch et al., 2012 
DeLisa et al (2002)
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2.3.5 DNA Quantification 
A nanodrop ND-1000 system (Thermo Scientific) spectrophotometer was used to 
calculate the concentration of DNA by measuring absorbance at 260 nm, with 1.5 µL of 
DNA solution pipetted onto the pedestal for quantification. Using the extinction 
coefficient of 0.020 ng µL-1 cm-1 for double stranded DNA and of 0.030 ng µL-1 cm-1 for 
single stranded, a nucleic acid concentration in ng µL-1 was calculated. 
2.3.6 DNA amplification using Polymerase Chain Reaction (PCR) 
DNA sequences of interest from plasmids were amplified using PCR. Herculase II DNA 
polymerase (Agilent) was used as to amplify the DNA in a thermocycler (Eppendorf 
Mastercycler personal). Forward and reverse primers flanking the DNA to be amplified 
were added to the reaction mixture, along with HercII reaction buffer (Agilent), dNTPs, 
dimethylsulfoxide (DMSO) and template DNA, according to Table 2.7. The 
thermocycler programme used to amplify the tat operon from plasmids is outlined in 
Table 2.8.  
 
 
 
 
 
 
 
 
 
Table 2.7) The steps programmed in the PCR cycle during the QuikChange experiment.  
Table 2.8)  -The composition of the QuikChange PCR mix used- with the volume of each reagent and 
the final concentration noted  
66	
	 	 	
2.3.7 QuikChange site directed mutagenesis 
To construct plasmids encoding single amino acid codon substitutions in tatA, tatB and 
tatC, primers were designed that included an altered codon flanked either side by 15 
nucleotides directly complementary to the template strand (a comprehensive list of 
primers is given in Table 2.9). A polymerase chain reaction (PCR) was then performed, 
identical to that in Table 2.7 but with an elongation time of 15 mins, to yield the mutated 
plasmid product, and the methylated template DNA was removed by adding 1 unit of 
DpnI (Roche) before incubating for 1 hour at 37oC. The PCR mix was used to transform 
competent DH5 α cells (or DH5α pRep4 for pQE60-based plasmids). A single colony 
following transformation was grown overnight at 37oC with agitation at 200 rpm, before 
isolating plasmid DNA using a Qiagen miniprep plasmid preparation kit and 
confirmation of the presence of the introduced mutation by DNA sequence analysis  
(DNA Sequencing Service, University of Dundee). 
2.3.8 Agarose gel electrophoresis of DNA	
Plasmids and DNA products from PCR were analysed using gel electrophoresis to 
check the mobility, and therefore get an approximation of size in base pairs (bp). The 
sample DNA was mixed with loading dye (ratio of 1:4) and loaded onto a 1% (w/v) 
agarose gel containing GelRed stain (Biotem). The gel was placed in a tank containing 
TAE buffer and 200V was applied to drive migration of the DNA. Once complete, the 
gel was imaged using UV light at 302 nm in a Gel Doc XR+ camera (BioRad). A ladder 
corresponding to DNA bp sizes was used to estimate side of the product DNA.
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2.3.9 DNA Digestion 
DNA was digested or fragmented using restriction endonucleases, which cleave DNA 
at specific sequences of base pairs. Restriction with endonucleases (NEB or Roche) 
was performed according to manufacturer’s instructions. Reactions were performed in 
a 50 µL volume with 4 U of enzyme at 37oC for between 1-3 hours depending on the 
enzyme. After restriction of plasmid DNA, it was treated with rAPID alkaline 
phosphatase (AP) (Roche), according to manufacturer’s instructions, to prevent self-
ligation. Linearised vectors and DNA fragments were purified using a QIAgen PCR 
Purification Kit according to manufacturer’s instructions. 
 
Primer 5’-3’ sequence 
TatA L9C For AATTTGGCAGTTATTGTGTATTGCCGTCATGTT 
TatA L9C Rev AACATGACGGCAATACACAATAACTGCCAAATT 
TatA L10C For AGTATTTGGCAGTTATGCATTATTGCCGTCATC 
TatA L10C Rev  GATGACGGCAATAATGCATAACTGCCAAATACT 
TatA I11C For AACGATGACGGCAATACACAATAACTGCCAAAT 
TatA I11C Rev AATTTGGCAGTTATTGTGTATTGCCGTCATGTT 
TatB L9C For ATCGGTTTTAGCGAATGTCTATTGGTGTTCATC 
TatB L9C Rev GATGAACACCAATAGACATTCGCTAAAACCGAT 
TatB L10C For GGTTTTAGCGAACTGTGTTTGGTGTTCATCATC 
TatB L10C Rev GATGATGAACACCAAACACAGTTCGCTAAAAC 
TatB L11C For TTTAGCGAACTGCTATGCGTGTTCATCATCGGC 
TatB L11C Rev GCCGATGATGAACACGCATAGCAGTTCGCTAAA 
TatC M205C For GCATTCGTTGTCGGGTGTTTGCTGACGCCGCCG 
TatC M205C Rev CGGCGGCGTCAGCAAACACCCGACAACGAATGC 
TatC F94A For TATCAGGTGTGGGCAGCTATCGCCCCAGCGCTG 
TatC F94A Rev CAGCGCTGGGGCGATAGCTGCCCACACCTGATA 
TatC E103A For TGTATAAGCATGCGCGTCGCCTGGTG 
TatC E103A Rev CCACCAGGCGACGCGCATGCTTATAC 
TatC V167C For TTTATGGCGTTTGGTGTCTCCTTTGAAGTGCCG 
TatC V167B Rev CGGCACTTCAAAGGAGACACCAAACGCCATAAA 
TatC E170C For TTTGGTGTCTCCTTTGAAGTGCCGGTAGCAATT 
TatC E170C Rev AATTGCTACCGGCACTTCAAAGGAGACACCAAA 
TatC M163C For GTTATGGCGCTGTTTATGGCGTTTGGTGTCTCC 
TatC M163C Rev GGAGACACCAAACGCCATAAACAGCGCCATAAC 
Table 2.9) Primers used in this work,-noted forward and reverse.  
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2.3.10 DNA ligation 
Ligation was performed using T4 DNA ligase (Roche) to ligate insert (amplified form 
PCR or purified following digestion from another vector) into the linearised vector 
(which was AP treated as in Section 2.3.9). The reaction was performed in 10 µL with 
50 ng of linearised vector and insert at a ratio of 1:3 with 1 U of T4 DNA ligase for three 
hours at room temperature. Of the reaction mix, 5 µL was used to transform DH5α 
competent cells as in Section 2.3.2. Clones from the subsequent transformation were 
screened for presence of the insert by PCR (Section 2.3.6), with primers flanking the 
insert and agarose gel electrophoresis was utilised (Section 2.3.8) to check the 
presence of a DNA fragment corresponding to the insert. Vectors which harboured the 
insert were confirmed by DNA sequencing. 
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2.4 Protein methods 
2.4.1 SDS PAGE 
Proteins were separated according to their molecular weight using SDS polyacrylamide 
gel electrophoresis (SDS PAGE). SDS PAGE gels were prepared using the Mini-
PROTEAN II System (BioRad) according to instructions. Resolving gel (see Table 
2.10) was poured until it was ~2 cm from the top of the glass plate and absolute 
ethanol layered on top, before the acrylamide was left to polymerise. Once the 
resolving gel was set, the ethanol was removed and stacking gel (see Table 2.10) was 
added to the top of the glass plate, a comb was then inserted and the gel allowed to set 
providing wells for the samples.  
Components of resolving gel 
12.5% (v/v) of 30% (w/v) acrylamide 
0.375 M Tris.HCl pH 8.8 
0.1% (w/v) SDS 
0.1% (w/v) Ammonium persulfate (APS) 
0.1% (w/v) Tetramethylethylenediamine (TEMED) 
Components of stacking gel 
4% (v/v) of 30% (w/v) acrylamide 
0.125 M Tris.HCl pH 6.8 
0.1% (w/v) SDS 
0.1% (w/v) Ammonium persulfate (APS) 
0.1% (w/v) Tetramethylethylenediamine (TEMED) 
 
A gel tank filled with SDS PAGE running buffer was used. Samples were mixed with an 
appropriate amount of 2x Laemmli buffer (with or without β-mercaptoethanol depending 
on whether it was desirable to maintain disulphide bonds) and mixed thoroughly before 
being loaded into the gel. Prestained protein marker (Precision plus, BioRad) was used 
as a protein standard on each gel after which 100 V was applied to the gel to separate 
the proteins in the stacking gel, before the voltage was increased to 200 V for migration 
through the resolving gel. Once complete, the gel was either used for Western blot or 
stained with Coomassie blue dye.  
 
 
Table 2.10) Components of the resolving and stacking gel used to produce polyacrylamide gels for 
SDS-PAGE 
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2.4.2 Western Blotting 
Electroblotting was achieved by either dry or semi-dry transfer. Dry transfer was 
performed using an iBlot 2 device (Life Technologies) according to manufacturer’s 
instructions. For semi-dry transfer gels following SDS PAGE were soaked in transfer 
buffer for 15 minutes, with a gel-sized piece of nitrocellulose membrane (Amersham 
Hybond, GE Healthcare) and four similarly sized blotting papers soaking separately. 
The transfer was performed using a transfer cell (Trans-Blot SD Semi-Dry Transfer 
Cell, BioRad) with 2 sheets of soaked filter paper placed on the positive electrode and 
the membrane placed on top, followed by the SDS PAGE gel. Two more filter papers 
were added and a roller was used to ensure the gel was fully in contact with the 
membrane, the transfer cell was then fully assembled, with the negative electrode in 
contact the surface of the top blotting paper. The transfer was performed at 10 V for 1 
hour.   
After the transfer, the nitrocellulose membrane was blocked by immediately placing it in 
TBS solution with 5% milk for 1 hour at room temperature, or 5oC overnight, with gentle 
agitation. For the primary antibody incubation, the milk was removed and replaced with 
the primary antibody raised against the protein of interest, diluted suitably in TBS-
Tween, before agitation at room temperature for 1 hour. The membrane was then 
washed twice for 15 minutes with TBS-Tween before the secondary antibody, that 
cross-reacted with the primary antibody, was diluted in TBS-Tween and applied for the 
secondary incubation. After a further hour with gentle agitation, the membrane was 
washed again twice for 15 minutes in TBS-Tween before detection. Antibodies used in 
this thesis are listed in Table 2.11. 
The detection method utilised the catalytic activity of horse radish peroxidase (HRP) 
enzyme conjugated to the secondary antibody. When a chemiluminescent substrate 
containing luminol and H2O2 was applied to the membrane (chemiluminescent HRP 
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Table 2.11) List of antibodies in this study used for Western blots 
substrate, Millipore) HRP catalyses the oxidation of luminol, causing it to emit light and 
highlight bands on the membrane where the primary antibody has bound.   
The light detection method used either X-ray film (Konica Minolta) developed in a SRX-
101A film processor (Konoca Minolta) or a CCD camera in chemiluminescent detection 
system (GeneGnome, Syngene). 
 
	
 
 
 
 
 
 
2.4.3 Cell fractionation and isolation of membranes  
50 mL of LB was inoculated with a single colony of the strain of interest and grown 
overnight before cells were harvest and washed in 25 mL resuspension buffer. Cells 
were resuspended in 1 mL resuspension buffer after the washing step, and 
supplemented with 100 µL protease inhibitor cocktail (one Roche EDTA- free tablet in 
500 uL resuspension buffer). Cells were then lysed by sonication for 5 sec with 5 sec 
breaks, 10 cycles, amplitude 20%, before pelleting the cell debris at 16000 x g for 5 
mins and retaining the supernatant. The supernatant was centrifuged at 292500 x g  for 
30 mins at 4oC in an Optima MAX-E benchtop ultracentrifuge (Beckman) with rotor TLA 
120.2. The subsequent pellet, containing the membrane fraction, was resuspended in 
100 µL buffer 1 and retained as the membrane fraction. This was used directly for 
further experiments or snap frozen in liquid nitrogen and stored at -80oC 
Antibody Organism Dilution Reference 
E. coli anti-TatC 
antiserum 
(polyclonal) 
Rabbit 1:10,000 Alami et al., 2002 
E. coli anti-TatA 
antiserum 
(polyclonal) 
Rabbit 1:10,000 Sargent et al., 
2001 
E. coli anti-TatB 
antiserum 
(polyclonal) 
Rabbit 1:10,000 Sargent et al., 
2001 
Tetra-His 
(monoclonal) 
Mouse 1:20,000 Qiagen cat. 
34670 
GFP 
(monoclonal) 
Mouse 1:5000 Roche cat. 
11814460001 
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2.4.4 Periplasmic preparation of E. coli 
5 mL of cells at OD600 0.3 were harvested by centrifugation at 4000 x g for 10 min and 
resuspended in 200 µL ice cold sucrose buffer before incubation on ice for 10 min 
mixing at 1 min intervals. Cells were then harvested by centrifugation at 16000 x g for 1 
min before resuspension in 100 µL ice cold 5 mM MgCl2 with incubation on ice for 10 
min, as previously. The sample was then centrifuged at 16000 x g for 10 min at 5oC 
and the supernatant retained as the osmotic shock fluid containing periplasmic 
proteins.  
2.4.5 Determining protein concentration of membrane fractions 
Protein concentration of membrane fractions was obtained using a DC protein assay kit 
(BioRad) based around the Lowry assay. This involves the oxidation of amino acids in 
the protein and the subsequent reaction of amino acids (primarily tryptophan, tyrosine 
and cysteine) with Cu+ to form molybdenum/tungsten blue. The amount 
molybdenum/tungsten blue product, and therefore the amount of protein, can be 
detected in a spectrophotometer set at 750 nm. 
In a 96-well plate, a standard curve was produced with triplicate samples of BSA 
(Sigma Aldrich), from 2-10 µg in 5 µL ultrapure water, along with a blank containing 
water only. Protein samples were diluted 1:10 and 1:100 in 5 µL ultrapure water. 
According the manufacturer’s instructions, 25 µL of reagent A was added to each 
sample and incubated at room temperature for 5 mins, 200 µL of reagent B was then 
added before further incubation at room temperature for 15 minutes. Absorbance at 
750 nM was obtained using an ELx808 absorbance microplate reader (BioTek).  
2.4.6 Detergent solubilisation of membrane fractions  
A single colony of the strain of interest was used to inoculate 5mL of LD medium and 
cultured overnight with shaking. This was used, at a 1:100 dilution, to inoculate a 1 L 
culture, which was grown overnight. Subsequently cells were harvested at 3000 x g for 
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20 mins before resuspension in 10 mL 20 mM MOPS/200 mM NaCl, pH 7.2 
supplemented with 100 µL protease inhibitor cocktail (Roche) (1 tablet in 500 µL 20 
mM MOPS/200 mM NaCl, pH 7.2) and lysed by sonication (as described in Section 
2.4.1) Folowing ultracentrifugation, the final membrane pellet was resuspended in 4 mL 
20 mM MOPS, 200 mM NaCl pH 7.4. 
Protein concentration of the suspended membrane fraction was determined using a DC 
protein assay kit (BioRad) as in Section 2.4.4. For purification, resuspended 
membranes were diluted with wash buffer to a final concentration of 5 mg/mL and 
supplemented with either 1% digitonin/1% C12E9/1% Triton X-100 before the sample 
incubated on a rotating wheel (20 rpm) at 4oC for 1 hour. After the incubation step, 
insoluble material was pelleted by centrifugation at 150000 x g for 1 hour at 4oC with 
the supernatant retained as the solublised membrane protein. 
2.4.7 Nickel affinity co-purification assay 
Co-purification assays involved isolation of plasmid-encoded His6-tagged TatC from 
solubilised membranes. During purification the His6-tagged TatC should bind to the Ni-
affinity resin, allowing unbound material to be washed away. Subsequently the tagged 
TatCHis will be eluted and the eluent analysed using Western blotting with anti-TatA, 
TatB and TatC to identify proteins which co-elute with TatCHis. 
Two 1 mL washes with ice- cold wash buffer was used to equilibrate 100 µL of IMAC 
Ni-charged resin (BioRad), pelleting the beads with centrifugation at 400 x g for 1 min 
after each wash and finally resuspending the resin using 1 mL solubilised membrane 
protein from Section 2.4.5. This was incubated at 4oC with rotation on a wheel at 20 
rpm for 1 hour before the resin was pelleted at 400 x g for 1 min with the supernatant 
removed and retained as the unbound fraction. The resin was then washed four times 
with 1 mL ice-cold wash buffer, pelleting as previously, and retaining the supernatant 
from the final wash as the wash fraction. The resin was then suspended in 100 µL 
elution buffer and incubated at 4oC with rotation on a wheel at 20 rpm for 1 hour. A final 
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centrifugation was performed and the supernatant retained as the elution fraction. The 
retained samples were mixed with an appropriate amount of Laemmli buffer (BioRad) 
and analysed by SDS-PAGE and Western blotting.  
2.4.8 In vivo disulphide crosslinking of proteins from a medium copy number 
construct 
E. coli strain, DADE, harbouring the lacI-encoding plasmid, pRep4 (Qiagen) and 
pUNITATCC4/pQE60AΔBCCC- derivative was grown overnight and this was used at a 
1:100 dilution to inoculate fresh LB which was cultured until an OD600 of 0.3 was 
reached. Three 2.5 mL aliquots were then withdrawn and made up to 5 mL with fresh 
LB. A control sample was left untreated, an oxidised sample had copper 
phenanthroline (360 mg phenanthroline monohydrate in 5 mL 50% ethanol freshly 
added to 150 mg CuSO4 in 5 mL dH2O) added to a final concentration of 1.8 mM and a 
reduced sample had 10 mM dithiothreitol added. After incubation at 37oC for 1 minute 
with agitation at 200 rpm, the cells were harvested before resuspending in 100 µL 
resuspension buffer with 12 mM EDTA and 8 mM N-ethylmaleimide added and 
incubated at 37oC for 10 mins. Cells were pelleted at 16000 x g for 1 minute before 
solubilising in 1 x Laemmli buffer (BioRad) for analysis by SDS-PAGE and Western 
blotting.  
2.4.9 In vivo disulphide crosslinking from a medium copy number construct with 
overexpressed substrate 
E. coli strain, DADE, harbouring the lacI-encoding plasmid, pRep4 (Qiagen) along with 
pUNITATCC4expressing tatA and tatC Cys substitutions and pTGS was grown 
overnight. This culture was used at a 1:100 dilution to inoculate fresh LB which was 
grown until an OD600 of 0.25 was reached, at which point L-arabinose at concentrations 
of 0.001-0.2% (v/v) was added to each sample as required before growth was 
continued for a further 20 minutes. The OD600 of each sample was normalised, if 
necessary, and made up to 5 mL with fresh LB. The crosslink and analysis stage was 
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identical to the normal crosslinking experiments in vivo at medium copy number in 
Section 2.4.8 from then onwards.  
2.4.10 In vivo disulphide crosslinking at very low copy number with and without 
overexpressed substrate 
E. coli strain, DADE, harbouring plasmid pTat101 ABCC- and in cases where substrate 
was required, pQE80 CueOH, was grown overnight. This culture was used at a 1:100 
dilution to inoculate fresh LB and supplemented with 1 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) to induce expression of plasmid-encoded His-tagged 
CueO, as required. The culture was grown until an OD600 of 0.3, at which point three 25 
mL aliquots were withdrawn and made up to 50 mL with fresh LB. A control sample 
was left untreated, an oxidised sample had copper phenanthroline added to a final 
concentration of 1.8 mM and a reduced sample had 10 mM dithiothreitol added. After 
incubation at 37oC for 1 minute with agitation at 200 rpm, the cells were harvested and 
resuspended in 1 mL resuspension buffer with 12 mM EDTA and 8 mM N-
ethylmaleimide added.  The cells were incubated at room temperature for 10 minutes 
before 100 µL protease inhibitor was added (one Roche cOmplete protease inhibitor 
cocktail tablet dissolved in 500 µL of resuspension buffer). Cells were then fractionated 
into soluble fraction and membrane fractions as in Section 2.4.3 with the membrane 
fraction resuspended in 50 µL Laemmli Buffer (BioRad) for analysis by SDS-PAGE and 
Western blotting.  
2.4.11 In vivo disulphide crosslinking with indole as an uncoupler 
In order to elucidate the role of PMF in TatA-TatC interactions, an uncoupler was used. 
Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) has been used previously to 
examine the role of PMF in vivo (Alcock et al., 2013). During the oxidation step of 
crosslinking, however, CCCP precipitated out as a bright yellow solid. From this it was 
deduced that CCCP would not be an appropriate ionophore to use, and indole was 
identified as a viable alternative. Indole has been characterised extensively as an 
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uncoupler in bacteria and was found to have fewer precipitation problems than CCCP 
in this work (Chimerel et al., 2013, Ismail et al., 2015).  
Cells were grown to OD600 0.3 as with previous in vivo crosslinking protocols before 
indole (stock 1 M in ethanol) was introduced by adding cells directly onto the 
appropriate amount of 1 M indole to give a final concentration of 5 mM in the reaction 
vessel and mixing quickly by inversion to prevent precipitation. Samples not incubated 
with indole had the equivalent amount of ethanol added at this stage.  Incubation took 
place at room temperature for 5 minutes. To the oxidised samples, 3.6 mM copper 
phenanthroline was added directly before mixing the cells.  
To show that the indole only dissipated the PMF and did not cause cell lysis, a control 
sample was washed twice in its volume with LB after indole incubation, centrifuging at 
3000x g for 15 minutes to pellet the cells before crosslinking as above. This sample 
should be identical to cells not incubated at all with indole. 
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Chapter 3: TatA is loosely associated with the 
TatBC recognition complex 
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3.1 Introduction 
 
3.1.1 Proposed interactions between TatA and TatBC 
Several models for Tat transport assume a TatBC substrate recognition complex, 
initially devoid of TatA, which binds substrate and triggers TatA recruitment to the 
complex in a protonmotive force (PMF) dependent step (e.g. Palmer & Berks 2012) 
(see Chapter 1, Section 1.12). Past studies examining the purification of TatC-
containing complexes yielded contradictory findings, with some supporting the 
presence of a low level of TatA in the recognition complex whilst others did not (Section 
3.1.2). As mentioned in Chapter 1, Section 1.10.5 when TatA is found to co-purify with 
TatBC it is only present in very low amounts. However, crosslinking studies have 
observed a constitutively-bound Tha4 (the plant TatA equivalent) present on the TatBC 
complex in a manner unperturbed by PMF dissipation or substrate overexpression 
(Aldridge et al., 2014). Further to this, crosslinking experiments using E. coli inside-out 
inner membrane vesicles (INVs) observed that TatA can crosslink to TatC when a 
photoreactive amino acid was introduced into various positions in TatC, including the 
P3 loop and TM5 (Zoufaly et al., 2012, Blummel et al., 2015) (Chapter 1, Section 
1.10.6), suggesting that TatA may be present as a regular component of the TatBC 
complex.  
3.1.2 Previous purification of Tat complexes 
One of the earliest studies examining the kinds of complexes formed by E. coli Tat 
subunits was undertaken by Bolhuis and co-workers (2001), who undertook affinity 
chromatography of overproduced strep-tagged TatC that had been solubilised from the 
membrane with digitonin. Subsequent gel filtration of the TatC-containing fractions 
identified a ~600 kDa complex in which, TatB and TatCStrep were both present, with a 
small amount of TatA also detected. Radio-labelling experiments confirmed the 
presence of all three Tat subunits in the purified complex, although it was noted that 
there was a gradual loss of TatA during the purification steps (Bolhuis et al, 2001).  
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Later studies found that digitonin-solubilised TatB and TatCStrep purified as a single 
complex during affinity purification trials, with a very small amount of associated TatA. 
This complex had a molecular mass of ~600 kDa, in accordance with calibrated gel 
chromatography (Oates et al., 2003). An additional study using membranes solubilised 
with the same detergent found a TatBC complex of ~440 kDa from cells overproducing 
Tat components with a small amount of associated TatA (Behrendt et al., 2007). 
Using the alternative technique of blue native polyacrylamide gel electrophoresis (BN-
PAGE), the E. coli TatABC complex purified in digitonin was shown to migrate with a 
mass of ~370 kDa. Later it was shown by direct BN-PAGE analysis of digitonin-
solubilised membrane fractions that bulk of TatB and essentially all of the TatC is found 
in this single 370kDa TatABC complex (Oates et al., 2005). In the same study it was 
seen that the vast majority of TatA was not present in this complex but was present as 
a separate series of complexes ranging in size from 100-500 kDa (Oates et al., 2005).  
However, one criticism of these early studies is that they worked with Tat proteins that 
were heavily overproduced from plasmid vectors. A subsequent study analysing the 
Tat proteins at native level using immunoprecipitation found that while TatB and TatC 
could be isolated together, no TatA purified with TatC (McDevitt et al., 2006). Indeed, 
further purification trials found that digitonin-solubilised TatBCHis migrated at ~430 kDa 
on BN-PAGE whether or not TatA was present in the cells (Orriss et al., 2007). Further 
to this, Tarry et al. (2009) were able to purify a stable complex of TatBC associated 
with the SufI substrate precursor, using affinity chromatography with a His-tag on either 
SufI or TatC itself, from strains lacking both TatA and TatE. The TatBC-SufI complex 
migrated as two discrete bands with estimated molecular weights of 540 and 580 kDa 
on BN-PAGE, with subsequent negative stain electron microscopy suggesting that the 
complexes had different numbers of SufI molecules bound. 
More recently, co-purification trials have been performed using His-tagged TatC 
produced from a very low copy number plasmid construct (approximately four times 
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above native level). Here it was seen that a low level of TatA co-eluted with TatB and 
TatC during Ni affinity purification (Cleon et al., 2015).   
Early studies on TatA-containing complexes were performed by Sargent and co-
workers (2001), where untagged TatA was purified from membranes solubilised in the 
detergent CHAPS. Following anion exchange, gel filtration of TatA-containing fractions 
identified a TatA-containing complex at ~600 kDa (Sargent et al., 2001). This complex 
was found to contain mostly TatA, with a small amount of associated TatB. Another 
study by Porcelli and co-workers found that when using digitonin in the solubilisation 
step, a TatA complex, separate to TatB and TatC, could be purified and was 
approximately 460 kDa in size (Porcelli et al., 2002). Indeed further studies observed 
TatA oligomers purified in detergents C12E9 or digitonin that varied in size from ~100 
kDa to over 700 kDa, and that migrating as a distinct ladder of bands on BN-PAGE 
(Gohlke et al., 2005, Oates et al., 2005).  
Finally, it should be noted that when TatA was overproduced with TatCHis in the 
absence of TatB, a heterogeneous mix of complexes containing TatA and TatC were 
observed, unlike the homogeneous complex formed between TatB and TatC (Fritsch et 
al., 2012).  
From these findings it is unclear whether TatA is always associated with the TatBC 
complex, or whether it transiently associates with the complex only during Tat 
transport, and can be detected during purification as an artefact due to overexpression 
of Tat proteins. The work described in this chapter seeks to build on prior affinity 
purification trials performed to decipher the effect of protein overexpression and 
detergent choice on the association of TatA with TatC.  
3.1.3 Detergents used in this work 
Digitonin is a steroidal saponin (Fig 3.1) which has detergent properties and has been 
utilised to purify Tat components throughout most of the prior literature due to its ability 
to maintain the integrity of TatB-TatC interactions (Oates et al., 2003, Richter et al., 
81	
	 	 	
2007). Outside the Tat field, digitonin has successfully been used to purify higher-order 
oligomers of ATP synthase from mitochondrial membranes (noted for their similarity to 
bacterial membranes) (Schagger & Pfeiffer, 2000).  
C12E9 (nonaethylene glycol monododecyl ether) is a non-ionic polyethylene detergent 
(Fig 3.1), which has been harnessed previously in the purification	 of TatA oligomers of 
various sizes (Porcelli et al., 2002, Gohlke et al., 2005). In addition, McDevitt et al., 
(2005) observed a TatBC complex purified in C12E9 using sedimentation equilibrium 
trials, which in this case was void of detectable TatA, as observed again subsequently 
in McDevitt et al., (2006) where Tat proteins purified at native level in C12E9 yielded a 
stable TatBC complex with no associated TatA. DeLeeuw et al., (2002) on the other 
hand observed small amounts of TatA associated with TatBCHis using C12E9 when the 
Tat proteins were overproduced. Outside the Tat field C12E9 has been used to 
successfully isolate complex II from phototrophic Rhodoferax fermentans, where it was 
demonstrated to have a superior ability to preserve the catalytic activity over several 
other non-ionic detergents tested.  
Apart from these two detergents, several other detergents have been used in Tat 
studies. Triton X-100 (Fig 3.1) has been utilised previously in the purification of TatCHis 
whereby TatB and TatC were found to co-elute in Ni affinity purification trials, though in 
this instance the elution of TatA was not examined (Buchanan et al., 2002). It should 
also be noted that 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS) (Fig 3.1) has also been utilised successfully in Sargent et al. (2001) and 
DeLeeuw et al. (2001) to purify TatA(B) complexes. In addition to this, detergent Lauryl 
Maltose Neopentyl Glycol (LMNG) (Fig 3.1) was used to purify TatC from A. aeolicus 
prior to crystallisation (Rollauer et al., 2012). 
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3.2 Aims: 
The work described in this Chapter aims to build on previous co-purification studies by 
using a Ni-affinity based approach to determine if there is co-elution of TatA and TatB 
with TatCHis. Potential artefactual TatA-TatC interactions caused by a result of protein 
overexpression will be explored by studying these components at high copy number 
and at close to native levels, and the role of selected detergents in TatA-TatC 
interactions, along with any potential effect of the presence of TatB will be investigated.   
	
	 	
Fig. 3.1 Detergents used in this work- Chemical structures of digitonin, Triton X-100, C12E9 
(Nonaethylene glycol monododecyl ether), LMNG (2,2-didecylpropane-1,3-bis-β-D-maltopyranoside), 
CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) obtained from the  Sigma Aldrich 
website. 
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Figure 3.2) Western blot analysis of Ni2+ affinity-purified TatABCHis. Following solubilisation of 
membranes in 1 % digitonin, the solubilised material was incubated with Ni2+-affinity resin, the unbound 
fraction (U) was retained, the resin was washed (W) and bound material eluted with imidazole (E). Each 
fraction was analysed via Western blotting for the presence of TatA, TatB or TatC, as indicated, with 5µL of 
sample loaded into each well. Top- Membranes from E. coli strain DADE expressing TatABCHis Bottom- 
Membranes from strain DADE expressing TatABC as a negative control.  
3.3 Results 
3.3.1 A Tat(A)BCHis complex can be purified after solubilisation in 1% digitonin,  
E. coli strain DADE, which lacks chromosomally-encoded Tat components, 
overproducing TatA, TatB and TatCHis from pQE60ABCHis was used as an initial 
starting point for this study. Following solubilisation of membranes from this strain in 
1% digitonin and purification of TatCHis via Ni affinity chromatography, TatB was shown 
to co-purify, consistent with these proteins forming a stable complex, (Fig 3.2 Top). No 
TatB or TatC bound to the resin when TatC was produced without a His-tag, indicating 
that the interaction with the affinity matrix was specific to tagged TatC (Fig 3.2 Bottom). 
Some TatA was associated with the TatBCHis complex as a faint band which cross-
reacts with the TatA antibodies, detected in the elution fraction (Fig. 3.2 Top). However, 
this appeared to be only a very small fraction of the total amount of TatA present in the 
solubilised membranes (compare the unbound with the elution fractions in Fig 3.2). 
Some TatCHis and TatB was also detected in the unbound fraction, however under 
these conditions it is clear that the majority of each has bound to the Ni2+ resin.  
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3.3.2 TatA-TatCHis interactions are potentially enhanced in the absence of TatB 
when analysed using digitonin as detergent 
To explore the types of TatCHis-containing complexes that might be present in the 
absence of either TatA or TatB, similar experiments were undertaken using digitonin-
solubilised membranes of strain DADE expressing either pQE60A(ΔB)CHis (i.e. TatACHis 
without TatB) or pFAT75ΔA (a pQE60-based vector encoding TatBCHis, i.e. lacking 
TatA). 
As expected, in the absence of TatA, a TatBCHis complex could be isolated (Fig 3.3 
Top), in accord with the previous findings of Orriss et al. (2007). In the absence of 
TatB, TatA clearly co-eluted with TatC (Fig 3.3 Bottom), confirming the prior 
observations of Fritsch et al. (2012) and indicating that the likely binding site for TatA 
on the TatBC complex is the TatC rather than the TatB protein. Interestingly, it 
appeared qualitatively that more TatA may co-elute with TatCHis in the absence of TatB 
than in its presence (compare anti-TatA in Fig. 3.2 and 3.3) suggesting that in the 
absence of TatB, TatA-C interactions are promoted. This could potentially be explained 
by additional TatA molecules moving in to occupy the now vacant TatB site on TatCHis 
perhaps representing a step in the Tat cycle which TatB modulates. 	
	
	
	
	
	
	
	
	
 
Figure 3.3) Western blot analysis of Ni2+ affinity-purified TatACHis and TatBCHis. Following 
solubilisation of membranes in 1 % digitonin, the solubilised material was incubated with Ni2+-affinity 
resin, the unbound fraction (U) was retained, the resin was washed (W) and bound material eluted with 
imidazole (E). Each fraction was analysed via Western blotting for the presence of TatA, TatB or TatC, 
as indicated, with 5µL of sample loaded into each well. Top- Membranes from E. coli strain DADE 
expressing TatBCHis Bottom- Membranes from strain DADE expressing TatACHis  
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3.3.3 A TatB and TatCHis complex can be purified after solubilisation in 1% C12E9, 
with no associated TatA 
When TatCHis-containing complexes were purified from membranes of E. coli strain 
DADE harbouring pQE60ABCHis using 1% C12E9 as detergent, a different elution 
pattern was observed (Fig 3.4 Top). Most notable was the lack of any detectable TatA 
in the elution fraction, suggesting that, unlike digitonin, solubilisation in C12E9 causes 
TatA to dissociate from the TatBCHis complex. TatB and TatCHis still appeared to form a 
stable complex in C12E9 (Fig. 3.4 Top) consistent with prior observations (DeLeeuw et 
al., 2002, McDevitt et al., 2005, McDevitt et al., 2006, Behrendt & Bruser, 2014). Again 
control experiments using untagged Tat proteins showed that there was no non-
specific binding of TatA, B or C to the Ni resin.  
This discrepancy between detergents may reflect differences between the chemistry of 
digitonin and C12E9 with the latter perhaps having an ability to dissociate the more 
weakly bound TatA (this is expanded on in detail in Section 3.4.1). Interestingly, the 
conditions used to purify native levels of TatCHis in McDevitt et al. (2006), where TatA 
was found not to co-elute with TatC, utilised C12E9 in the solubilisation step, suggesting 
that the choice of detergent rather than the copy number of Tat components may be 
the reason for the lack of co-purifying TatA.  
 
	
	
	
	
	
	
 
Figure 3.4) Western blot analysis of Ni2+ affinity-purified TatABCHis. Following solubilisation of 
membranes in 1 % C12E9, the solubilised material was incubated with Ni2+-affinity resin, the unbound 
fraction (U) was retained, the resin was washed (W) and bound material eluted with imidazole (E). Each 
fraction was analysed via Western blotting for the presence of TatA, TatB or TatC, as indicated, with 5µL 
of sample loaded into each well. Top- Membranes from E. coli strain DADE expressing TatABCHis 
Bottom- Membranes from strain DADE expressing TatABC as a negative control. 
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Figure 3.5) Western blot analysis of Ni2+ affinity-purified TatACHis and TatBCHis. Following 
solubilisation of membranes in 1 % C12E9, the solubilised material was incubated with Ni2+-affinity resin, 
the unbound fraction (U) was retained, the resin was washed (W) and bound material eluted with imidazole 
(E). Each fraction was analysed via Western blotting for the presence of TatA, TatB or TatC, as indicated, 
with 5µL of sample loaded into each well. Top- Membranes from E. coli strain DADE expressing TatBCHis 
Bottom- Membranes from strain DADE expressing TatACHis 
3.3.4 Trace amounts of TatA can be co-purified with TatCHis after C12E9 
solubilisation when TatB is absent 
Although TatA could not be purified with TatCHis after solubilisation with C12E9 when 
TatB was present (Section 3.3.3), it was hypothesised that the absence of TatB may 
modify TatA-TatC interactions, as was observed above after solubilisation with 
digitonin.  
It can be seen that the use of C12E9 as detergent instead of digitonin made little 
difference to the elution of TatB with TatCHis from TatBCHis expressing constructs, as 
expected (Fig. 3.5 Top). In the absence of TatB, a very low level of TatA was found to 
co-elute with TatCHis (Fig 3.5 Bottom), suggesting that there may potentially be some 
modulation of TatA-TatC interaction in the absence of TatB. However, the 
enhancement of TatA-TatCHis interactions was much more notable when using 
digitonin, whereby a weak TatA-TatCHis association in the presence of TatB became 
much stronger in its absence (compare Fig. 3.2 and 3.3). It therefore appears that 
TatA-TatC interactions are destabilised when C12E9 is used as detergent. 
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3.3.5 Using the TatC D211A substitution as a tool to examine TatA-TatC 
interactions  
The D211 residue in the short periplasmic loop 3 of TatC is highly conserved and has 
been hypothesised to have an important role in Tat transport. Buchanan et al. (2002) 
found that substitution of D211 with alanine could not be tolerated, shown by 
subsequent analysis of Tat activity, while Kneuper et al. (2012) and Cleon et al. (2015) 
both found that the D211R substitution abolished Tat transport (the position of D211 is 
shown in Fig. 3.6A). 
In addition to data showing the negative impact of D211 TatC substitutions on Tat 
activity, Buchanan et al. (2002) is the only study to have observed the effect of D211A 
on subunit interactions where it was reported that the substitution caused an 
abolishment of TatB co-elution with TatCHis. This was shown through Ni2+-affinity 
purification experiments using the detergent Triton X-100, the only report for which this 
detergent has been used for the study of Tat components (Buchanan et al., 2002). 
Currently this observation has yet to be confirmed using any other detergents, and the 
effect of the TatC D211A substitution on TatA-TatC interactions has not been 
examined. It was hypothesised in this work that if TatB-TatC interactions are impaired, 
this may promote TatA-TatC interactions as was observed in the absence of TatB seen 
in Sections 3.3.2 and 3.3.4. In support of this proposal, crosslinks to TatA have been 
observed through residues in the TatC P3 loop in E. coli (Zoufaly et al., 2012) and 
plants (Aldridge et al., 2014). Indeed, performing co-purification experiments using 
TatCHis D211A would allow the investigation of TatA-TatCHis interactions when TatB is 
present but presumably not tightly associated with TatC and in turn reveal whether 
D211 may also modulate TatA interactions.   
3.3.6 The TatCHis D211A substitution impairs Tat transport  
To test the Tat transport activity of TatC containing the D211A substitution (Fig. 3.6A), 
the export of Tat substrates was analysed by growth assays on two types of selective 
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media, (i) screening for growth in the presence of 2% SDS assesses whether two Tat-
dependent cell wall amidases, AmiA and AmiC, have been exported to the periplasm 
(Stanley et al., 2001, Ize et al., 2003), whereas (ii) screening for growth on minimal 
media containing TMAO/glycerol under anaerobic conditions would identify cells able to 
export Tat-dependent TMAO and DMSO reductases that collectively support anaerobic 
respiration using TMAO as the final electron acceptor (Santini et al., 1998) (Fig 3.6B).  
It can be seen, as expected, that the strain harbouring pQE60ABCHis could grow on 
both types of selective media. However, cells harbouring pQEABCHisD211A showed no 
detectable anaerobic growth on minimal TMAO medium, although the strain was able 
to grow in the presence of 2% SDS (Fig. 3.6B). This is consistent with the findings of 
Buchanan et al. (2002) who also observed growth of TatABC D211A expressing strains 
on SDS but not M9/TMAO/glycerol.  Further to this, the latter work observed negligible 
periplasmic TorA activity in strains expressing TatABCHisD211A. While the discrepancy 
in the export of substrates is curious, it is clear that the D211A substitution in TatC 
severely impairs Tat function.  
	
Figure 3.6) Growth assays to test for the presence of an active Tat system with the TatC 
substitution D211A- A- shows the position of the D211A substitution in TatC, B- DADE (a ΔtatABCDE 
strain) was transformed with medium copy number pQE60 based vectors encoding tatABCHis/tatABC 
and spotted onto media to test standard anaerobic growth on LB, with detergent stress (2% SDS) and 
anaerobically on minimal media containing glycerol with TMAO as the final electron acceptor. Proteins 
expressed are noted with the top denoting the conditions of growth. 
	
A B 
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3.3.7 The TatCHis D211A substitution causes detergent-dependent dissociation of 
TatB and stabilisation of TatA-TatC interactions  
It was reported by Buchanan et al. (2002) that the TatB-TatC interaction was disrupted 
when TatC harboured the D211A substitution, using Triton X-100 as detergent. 
However, as discussed above, Triton X-100 has not been used routinely as a detergent 
for the purification of Tat complexes. Therefore, it was essential to first determine the 
amount of TatA that co-purifies with TatCHis (without the D211A substitution) when 
membranes were solubilised in Triton X-100. Fig. 3.7 demonstrates that, while TatB 
and TatC form a stable complex in this detergent, no detectable TatA is found in the 
elution fraction. Thus, the Tat(A)BC complex appears to behave the same way in Triton 
X-100 as it does in C12E9, with a loss of TatA from the complex. 
Next, to confirm the prior findings of Buchanan et al. (2002), membranes of strain 
DADE expressing pQE60ABCHisD211A were solubilised using 1% Triton X-100 as 
detergent. Subsequent Ni-affinity purification demonstrated that while TatCHis was 
clearly present in the elution fraction, all of the TatB remained unbound (Fig. 3.8 Top 
panel). This, taken together with the small amount of TatA present in the elution 
fraction, indicates that TatB is no longer able to form a stable complex with TatCHis and 
in its absence TatA-TatCHis interactions are increased. This could be explained by TatA 
moving to occupy the vacated TatB site, as may also be the case when cells express 
TatA and TatC only (Sections 3.3.4 and 3.3.2).  
Figure 3.7) Western blot analysis of Ni2+ affinity-purified TatABCHis. Following solubilisation of 
membranes in 1 % Triton X-100 the solubilised material was incubated with Ni2+-affinity resin, the unbound 
fraction (U) was retained, the resin was washed (W) and bound material eluted with imidazole (E). Each 
fraction was analysed via Western blotting for the presence of TatA, TatB or TatC, as indicated, with 5µL 
of sample loaded into each well.  
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Interestingly, when C12E9 was used as detergent to solubilise TatABCHisD211A 
proteins, the Tat proteins behaved essentially the same on Ni-affinity purification as 
they did in Triton X-100, i.e. the TatB-TatC interactions were disrupted and TatB was 
found solely in the unbound fraction (Fig 3.8, Middle panel). Again, a low level of TatA 
was seen to co-purify with TatCHis in this experiment. By contrast, when 
TatABCHisD211A proteins were solubilised using digitonin, a stable TatBC complex was 
still observed in the presence of the TatC D211A substitution, and no TatB was 
detected in the unbound fraction (Fig. 3.8, Bottom panel). The most plausible 
explanation for these findings is that the nature of the TatBC interaction is altered in the 
presence of the TatC D211A substitution and that this altered or more loosely bound 
TatB can be selectively stripped from its TatC binding site by some types of detergents. 
Since the co-elution of TatA with TatC seems unaffected by the TatC D211A 
substitution (for example compare Figs. 3.7 and 3.1), it would suggest that either the 
binding of TatA is remote from the TatC P3 loop and the D211 residue, or that it binds 
to the site in a different conformation to that of TatB. 
	
 
B 
Figure 3.8) Western blot analysis of Ni2+ affinity-purified TatABCHisD211A. Following solubilisation of 
membranes in 1 % Triton X-100, 1% C12E9 or 1 % digitonin the solubilised material was incubated with 
Ni2+-affinity resin, the unbound fraction (U) was retained, the resin was washed (W) and bound material 
eluted with imidazole (E). Each fraction was analysed via Western blotting for the presence of TatA, TatB 
or TatC, as indicated, with 5µL of sample loaded into each well.  
1% Triton X-100 
1% C12E9 
1% digitonin 
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3.3.8 Tat(A)BCHis can be purified using 1% digitonin but not 1% C12E9 when 
proteins are expressed from a low copy number vector 
To determine whether any of the co-purification results seen for the wild type Tat 
complexes in Figs 3.2 and 3.4 arose due to the relative overexpression of Tat 
components, similar experiments were repeated for Tat proteins produced at close to 
native copy number from plasmid pTat101 (estimated to be approximately four times 
native level; Kneuper et al., 2012). Figure 3.9 (Top panel) demonstrates that when 
membranes are solubilised with digitonin, TatA can still be co-purified with TatBCHis 
when the subunits are present at low copy number. As expected, control experiments 
indicated that binding to the resin was specific to the His-tag present on TatC as Tat 
proteins expressed at a very low copy number without a His-tag did not bind to the Ni 
resin (Fig 3.9, Bottom panel). 
When 1% C12E9 was used to solubilise Tat proteins from the membrane, TatB and 
TatCHis could still co-elute from the Ni-charged resin, however TatA was not associated 
with the complex, which was also seen at medium copy number in this detergent (Fig. 
3.4). Thus it appears that it is the nature of the detergent used for the purification 
experiments rather than the copy number of the Tat proteins that is critical for the types 
of TatC-containing complexes isolated.   
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Figure 3.9) Western blot analysis of Ni2+i affinity-purified TatABCHis produced at a very low copy 
number. Following solubilisation of membranes in 1 % C12E9 or digitonin, as indicated, the solubilised 
material was incubated with Ni2+-affinity resin, the unbound fraction (U) was retained, the resin was washed 
(W) and bound material eluted with imidazole (E). Each fraction was analysed via Western blotting for the 
presence of TatA, TatB or TatC, as indicated, with 5µL of sample loaded into each well. A- Membranes from 
E. coli strain DADE expressing TatABCHis B- Membranes from strain DADE expressing TatABC as a 
negative control. 
 
B 
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3.4 Discussion	
3.4.1 TatA is weakly associated with TatC in the Tat(A)BC complex 
The work presented in this Chapter, in combination with prior literature, makes a very 
strong case for the presence of at least a small amount of TatA in the TatBC 
recognition complex. As the experiments here were performed using isolated 
membranes, the complexes should be in the resting state, and any protonmotive force-
dependent intermediate complexes (for example translocation intermediates where 
large assemblies of TatA are recruited to the TatBC complex) should not be present. 
Moreover, this work has clearly demonstrated that there is co-elution of TatB with TatC 
when either digitonin or C12E9 are used to solubilise the Tat components and at two 
different protein expression levels. This indicates a stable interaction	 between these 
two proteins. When using digitonin a low level of TatA is also clearly found associated 
with TatCHis, which is not seen when the C12E9 detergent is used   
3.4.2 Choice of detergent is important: A Tat(A)BC complex can be purified with 
digitonin but not C12E9 
Given that TatA has been found consistently to co-elute with affinity tagged TatC in the 
presence of digitonin, it may be the case that TatA is always associated with the TatBC 
complex, but the interaction is weak or transient, and therefore easily disrupted by 
harsher detergents (for example C12E9), or other buffer constituents (since Bolhuis et 
al. (2001) noticed successive loss of TatA associated with the TatBC complex during 
purification steps). The results presented here neatly account for the findings of 
McDevitt et al. (2006), who failed to co-purify TatA with TatBCHis at native levels of 
protein production when membranes were solubilised in C12E9. An alternative 
explanation is that digitonin may somehow promote interactions that would not be 
observed in native membranes (for example by causing conformational change in the 
TatBC complex and driving TatA association). However, given that TatA association is 
still observed when protein is expressed from low copy number constructs, and 
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previous studies in plants have observed interactions between Tha4-cpTatC (TatA-
TatC) interactions in thylakoid membranes which do not change in response to 
substrate (i.e. constitutive interactions; Aldridge et al., 2014) this seems less likely.  
Interestingly, previous studies purifying ATP synthase from mitochondrial membranes 
(which have notable similarity to bacterial inner membranes) found that digitonin could 
stabilise higher order oligomers which could not be seen with other detergents 
(Schagger & Pfeiffer, 2000). Indeed, it could be the case that digitonin has properties 
that can facilitate extraction of membrane protein complexes in a more intact manner 
than with detergents that can more readily strip native membrane lipids away from or 
dissociate interactions between membrane proteins.  
3.4.3 A potential step in the Tat cycle: TatB dissociation from TatC promotes 
TatA-TatC interactions 
When TatCHis purification was undertaken in the absence of TatB, it was seen that a 
low level of TatA could now co-elute with TatCHis in C12E9 detergent, or that interaction 
was enhanced (for membranes solubilised with digitonin). There are a number of 
possible explanations that may account for this finding. It may be that TatB normally 
partly occludes TatA interaction with TatC, and its removal allows TatA to bind more 
tightly to its binding site. Alternatively, TatA could in addition be occupying the vacated 
TatB site on TatC TM5, given the homology between the two proteins, and the 
suggestion from crosslinking studies that both TatA and TatB can interact at TM5 
(Blummel et al., 2015). In this context it is interesting to note that studies of the 
thylakoid Tat system suggest that TatA occupies a site at the P3 near TM5 loop 
constitutively (Aldridge et al., 2014) and this is supported by crosslinking studies in E. 
coli where crosslinks to TatA from TatC P3 residues 209 and 211 were observed 
(Zoufaly et al., 2012, Blummel et al., 2015). Importantly, Blummel et al. (2015) also 
observed that when TatB was absent TatA crosslinked to the TatC P3 loop, which may 
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account for the increased co-purification of TatA observed in this work in the absence 
of TatB. 
Finally it is possible that TatA may be able to interact with the concave face of TatC in 
a step modulated by the presence of TatB. Indeed, crosslinks have been observed 
between TatA and this region of TatC in the thylakoid Tat system (Aldridge et al., 
2014), and Rollauer et al. (2012) proposed that TatA may interact at this region of TatC 
based on in silico models. Removal of TatB could allow TatA to interact with this site on 
TatC in a step that would normally only occur when TatB is triggered to move. Indeed, 
Blummel et al., (2015) also observed increased TatA crosslinks across TatC TM3 and 
TM4 in the absence of TatB.		
3.4.4 The D211A substitution in TatC destabilises TatB-TatC interactions but still 
supports TatA-TatC interactions 
Buchanan et al. (2002) concluded that the TatC D211A substitution impaired 
interactions with TatB based on the loss of TatB-TatCHis co-elution after Ni affinity 
purification in Triton X-100 detergent solution. Here, the prior findings were confirmed 
and built upon showing that the TatC D211A mutation does not prevent interaction of 
TatC with TatA, on the contrary, in C12E9 and Triton X-100 solution TatA-TatCHis 
interaction appeared to be enhanced. This is consistent with co-elution of TatA with 
TatCHis observed when TatB was removed and is in support of the proposition that 
removal of TatB promotes TatA-TatC interactions. 
By contrast, in digitonin solution all of the TatB remained bound to TatCHisD211A, a 
markedly different finding to the results when C12E9 and Triton X-100 were used as 
detergents. Taken at face value, the Triton X-100 and C12E9 purification results would 
suggest that the toxicity of the TatC D211A substitution is caused by dissociation of 
TatB from TatC, however in light of digitonin purification results, it seems more likely 
that TatB and TatC are still associated in the native E. coli membrane, but the 
interaction between the two is severely weakened.	 If this were the case it would be 
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reasonable to suggest that TatC D211 interacts with TatB and therefore crosslinks to 
TatB may be observed through residues in the TatC P3 loop. However of those P3 
residues that were selected for photocrosslinking, residues 209 and 211 itself, neither 
formed a crosslink with TatB when substituted with Bpa (Zoufaly et al., 2012, Blummel 
et al., 2015). Those residues could, however, crosslink to TatA (and in plants Tha4, 
equivalent to TatA, was shown to interact at the P3 loop (Aldridge et al., 2014). 
However, when Zoufaly et al. (2012) performed crosslinking using a D211-Bpa TatC 
variant, it was noted that Tat activity was severely impaired, perhaps consistent with a 
destabilisation of TatB-TatC interactions similar to those observed with D211A, which 
may lead to a loss of crosslinking to TatB. Indeed an alternative explanation could be a 
global effect on the Tat complex, whereby the D211A substitution causes an allosteric 
effect which favours TatA interaction over TatB. For example, perhaps D211 is 
responsible for the successful dissociation of TatA from the Tat complex, and its 
replacement causes aberrantTatA interactions which adversely affect TatB interactions.   
In conclusion, the work in this Chapter strongly suggests that TatA is usually 
associated with the TatBC complex, and this complex will henceforth be called the 
Tat(A)BC complex.  
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Chapter 4: TatA interacts with TatC at the 
periplasmic facing region of TM6 in vivo 
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4.1 Introduction 
4.1.1 Utilising crosslinking to dissect protein interactions in the Tat system 
When deciphering protein-protein interactions, crosslinking-based methods provide an 
excellent indicator as to whether proteins are in proximity to each other. Interacting 
proteins can be identified from a reaction mixture as a covalently linked dimer, giving a 
change in molecular weight corresponding to the two proteins combined, and being 
responsive to antibodies raised to each protein. This covalent linkage is derived by 
chemical means, by adding crosslinking reagents to the reaction mixture containing 
proteins of interest, such as DSS (disuccinimidyl suberate), which can link proteins 
through lysine residues via an amine-reactive N-hydroxysuccinimide (NHS) ester. DSS 
itself consists of two NHS groups at either end of an eight carbon spacer, and therefore 
the amine groups on two proteins may be relatively far apart (Fig.4.1B).  
The ability of DSS to traverse lipid bilayers means it lends itself well to analysing 
interactions between membrane proteins. Indeed, this method was used by Hicks et al. 
(2003) where TatA homo-oligomers were crosslinked together and in DeLeeuw et al. 
(2001) where TatA was also self-crosslinked. Dabney-Smith et al. (2006) also 
crosslinked Tha4 (the thylakoid TatA analogue) using DSS showing that it forms homo-
oligomers in a similar manner to E. coli TatA.  
Similarly, crosslinking can be performed with sulfhydryl-reactive groups separated by a 
spacer arm, as with DSS, however, instead of the amino-reactive NHS group, a 
maleimide can be used to couple with cysteine (Fig. 4.1A). To study interactions in the 
Tat system, Blummel et al. (2015) successfully utilised bismaleimidohexane (BMH), a 
compound with two maleimide groups separated by a 12 Å spacer arm, to link together 
two TatC proteins in the TatBC complex via cysteine residues incorporated into the 
periplasmic facing region of TatC. While in this instance, membrane-soluble BMH was 
used, a similar principle can also be used to label protein regions accessible to the 
periplasm by utilising molecules which cannot cross the lipid bilayer. For example, 
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Koch et al. (2012) utilised membrane-insoluble methoxypolyethylene glycol maleimide 
(MAL-PEG) to label cysteine groups accessible to the periplasm in TatA and TatB, 
identifying their N-out, C-in topology in cells.  
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Formaldehyde can also be added to a reaction mixture to covalently link two proteins 
together. In water, formaldehyde reacts to form glycol, which is able to link a lysine 
Fig. 4.1) Mechanisms behind maleimide, DSS and formaldehyde crosslinking- A- shows crosslinker 
molecule with two reactive maleimide groups, which is linked by a carbon chain of a variable length. The 
maleimide group reacts with free Cys residues on proteins, B- shows DSS crosslinking with an 8 carbon 
chain and two NHS groups at either side. These groups react with primary amines in lysine side chains to 
link two proteins together, C- shows formaldehyde crosslinking, whereby formaldehyde reacts with water 
to form glycol, which reacts with primary amines in proteins to link them to the backbone of another 
protein (protein backbone shown as black wavy line).  
A B 
C 
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residue on one protein to the peptide backbone of an interacting partner (Fig. 4.1C). 
Unlike DSS/maleimide crosslinking, this only requires the functional group (a primary 
amine) to be present in one protein if the interacting partners are different, however, 
this slight convenience is offset by the fact the that no data can be derived about where 
on the interacting protein the primary amine is crosslinking, again allowing only the 
proximity of two proteins to be determined. Formaldehyde crosslinking was used by 
DeLeeuw et al. (2001) to identify TatA homo-oligomers.  
Alternatively, crosslinking can be performed directly through residues incorporated into 
the protein without adding a crosslinking molecule to the reaction mixture, for example 
through Cys residues in disulphide crosslinking, or through a photo-reactive amino acid 
analogue in photo-crosslinking. 
Disulphide crosslinking has been demonstrated to be a useful tool in dissecting Tat 
protein interactions. Essentially, this method can be used to elucidate protein 
interactions by engineering Cys-less variants of two proteins and re-engineering Cys 
residues back into them at sites which may be in contact. If these Cys residues are 
close to each other in the protein complex, a disulphide bond will form under oxidising 
conditions, linking the two proteins together covalently (Fig. 4.2) as a heterodimer (or 
homodimer if the proteins are the same). The subsequent molecular weight, 
corresponding to the combined weight of both proteins, can be analysed by Western 
blotting, whereby the heterodimer will respond to antibodies raised to both proteins in 
the dimer. Disadvantages to this method include the need for a protein which can 
function without native Cys residues, and in turn tolerate non-native Cys substitutions 
(for example, important residues may be involved in interaction sites, but sites may be 
disrupted by trying to analyse them with Cys substitutions). Interactions that are 
observed, however, are relatively reliable as Cys is a small amino acid, which requires 
close proximity to another Cys to form a disulphide bond, to an extent precluding non-
specific crosslinks unless the proteins are interacting aberrantly. 
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Similarly, photo-crosslinking can be used to analyse protein interactions, for example 
using a benzoylphenylalanine (Bpa) photo-reactive amino acid analogue incorporated 
by genetic means into the protein of interest. Upon exposure to UV, the Bpa photo-
reactive group, a benzophenone, is activated, causing it to couple covalently with 
nearby interacting proteins via the production of free radicals (Fig. 4.2). This allows 
crosslinking to be performed without the need for both removal of native Cys residues 
from proteins or exposure to oxidising agents. However, given that Bpa is significantly 
larger than Cys, issues around disrupting interaction faces caused by its incorporation 
into proteins may be exacerbated. In addition to this, photo-crosslinks require UV 
exposure, which may damage living cells, and furthermore this approach does not 
immediately reveal where on the interacting protein the Bpa group is crosslinking.	
Photo-crosslinking and disulphide crosslinking are the most commonly used 
crosslinking approaches to study Tat complexes (Chapter 1, Sections 1.10.5 and 
Fig. 4.2) Mechanisms behind disulphide and photo-crosslinking- Top- shows the mechanism behind 
photo-crosslinking with the radical formed via UV light in the first step, Bottom- shows a disulphide 
crosslink forming between to Cys residues under oxidising conditions, (wavy lines represent protein 
backbone)  
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1.10.7) and this thesis uses disulphide crosslinking to analyse interactions between 
TatA and TatC. A Cys scanning region in TatC encompassing part of TM5, the P3 loop 
and part of TM6 was chosen to crosslink to the TatA transmembrane helix (the 
rationale for this choice and specific residues is detailed in Section 4.1.3). Given the 
small size of Cys, disulphide crosslinking lends itself well to performing Cys scanning 
mutagenesis with minimal disruption to Tat activity, while Cys substitutions in the TatA 
transmembrane helix (TM) and TatC TM5 have been previously demonstrated to be 
well tolerated (Rollauer et al., 2012, Kneuper et al., 2012, Greene et al., 2007, Cleon et 
al., 2015). In addition, a disulphide crosslinking approach will also allow specific 
residues in both TatA and TatC to be directly identified as in close proximity.  
4.1.2 Crosslinking the E. coli Tat subunits in vitro and in vivo  
In the E. coli Tat system, in vitro disulphide crosslinking, whereby experiments are 
performed on isolated membrane fractions, has been used to identify a site at TM5 of 
TatC where TatB is proposed to bind constitutively (Rollauer et al., 2012, Kneuper et al. 
2012), while TatC self-interaction has been identified across all transmembrane helices 
of TatC using the same method (Punginelli et al., 2007). In addition to this, a proposed 
arrangement of the TatBC complex has been put forward based on photo-crosslinking 
in E. coli inside-out inner membrane vesicles (INVs) (discussed in detail in Chapter 1, 
Section 1.10.5) with TatB occupying sites at TatC TM5 and TM2/4 (Blummel et al., 
2015). With regard to TatA, photo-crosslinking in E. coli INVs has shown interactions at 
TatC TM5/P3/P2 (Zoufaly et al., 2012, Blummel et al., 2015) and found that TatE, a 
functional homologue of TatA is associated with TatC in INVs (Eimer et al., 2015). 
In vivo disulphide crosslinking in living E. coli cells would allow an examination of 
protein-protein interactions in the presence of a PMF, delivering information as to the 
behaviour of membrane proteins in their native environment. Indeed, Cleon et al. 
(2015) published data showing that in vivo, the TatC homodimer that was Cys-linked 
through TM5 could not be observed unless overexpressed substrate was present, 
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apparently in disagreement with results using isolated E. coli membrane fractions in 
Rollauer et al. (2012) and Kneuper et al. (2012) which demonstrated TatC 
homodimerisation through M205C without the need for overexpressed substrate. From 
this, it is conceivable that crosslinking patterns observed between Tat subunits in vitro 
may not reflect those seen in vivo. Indeed, the role of PMF, which is not present in 
vitro, in modulating Tat subunit interactions has been explored extensively (Chapter 1, 
Section 1.10.5 and 1.10.7), which could feasibly translate to differential interactions 
detectable using disulphide crosslinking studies. 
The work in this Chapter characterises TatA-TatC interactions further using in vivo 
disulphide crosslinking. This approach allows interactions to be mapped between the 
two subunits in the presence of the PMF and native lipid environment.  
4.1.3 TatA and TatC Cys substitutions chosen in this work  
Previous work has already identified TatC TM5 as a likely candidate for the TatB 
binding site (Chapter 1, Section 1.10.5), while other studies in plants and E. coli have 
identified both TatC TM5 and the P3 loop (or equivalent in chloroplast TatC) as a 
candidate for TatA interactions. Specifically, residue M205 in TatC TM5, when 
substituted with Bpa, was found to photo-crosslink to both TatA and TatB in E. coli 
INVs (Blummel et al., 2015) and when substituted with Cys was found to crosslink to 
Cys residues introduced at TatB L9, L10 I11 and I12 in isolated E. coli membrane 
fractions (Rollauer et al., 2012, Kneuper et al., 2012), The TM of the chloroplast TatA 
orthologue, Tha4, was also found to bind to the cpTatC TM5 (at the equivalent of TatC 
M205) in a manner enhanced by overexpression of Tat substrate, while a second Tha4 
binding site at the equivalent of the TatC P3 loop, was found to be unaffected by both 
substrate overexpression and PMF dissipation and was proposed to be a constitutive 
binding site for Tha4 (Aldridge et al., 2014). The Tha4 interaction with the P3 loop is in 
agreement with data showing that an E. coli TatC D211 Bpa substitution resulted in  
photo-crosslinking with TatA, suggesting a potential TatA interaction site at TatC P3 
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(Zoufaly et al., 2012). This Chapter explores this region further, thoroughly scanning 
the TatC TM5/P3/TM6 region for interactions with TatA using disulphide crosslinking	
experiments.  
A scanning region on TatC covered the periplasmic facing part of TM5, including the 
residues found to crosslink TatB (TatC M205 and L206) (Rollauer et al., 2012, Kneuper 
et al., 2012, Blummel et al., 2015), the P3 loop and the periplasmic side of TM6 was 
selected for introduction of single Cys substitutions. The three residues chosen in TatA 
to mutate to Cys were L9, L10 and I11 – this region of TatA is most homologous to 
TatB, which has three leucines at these positions. The positions of the Cys mutations 
introduced into TatA and TatC shown in Fig. 4.3.		
	
	
 
	
	
	
	
	
	
If Cys residues, engineered into TatA and TatC, are close to each other in the final 
complex (~5Å or less) they will form a disulphide bond under oxidising conditions. This 
will generate a covalent linkage between the two proteins, meaning that on subsequent 
SDS-PAGE they will migrate at the apparent molecular weight of both proteins 
combined. This heterodimer between TatA and TatC will also be responsive to both 
Figure 4.3) Residues substituted to Cys in TatA and TatC - Cys substitutions are shown as sticks in 
TatC (red) and TatA (yellow). Residues in the transmembrane helix of TatA are shown along with residues 
in the TM5 of TatC (orange M205-L207), the P3 loop (brown T208-V212) and TM6 (yellow F213-T216), 
images generated in PyMol using NMR structure of TatA (Rodriguez et al., 2013) and a homology model 
of E. coli TatC (Cleon et al., 2015). TM- transmembrane helix, AP- amphipathic helix.. 
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anti-TatA and anti-TatC antibodies using Western blotting, and will disappear upon 
reduction. Homodimers, may also be detected based on previous data showing these 
proteins self-associate (See Sections 1.10.5 and 1.10.7). 
4.2 Aims 
The work described in this Chaper intends to elucidate TatA-TatC interactions occuring 
in living E. coli cells to potential identify Tat protein associations. This will include 
performing Cys scanning and crosslinking between the TatC region encompassing 
TM5/P3/TM6 to identify residues able to crosslink residues in the TatA transmembrane 
helix. 
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4.3 Results: 
4.3.1 The in vivo disulphide cross-linking protocol used in this study is not lethal 
to E. coli cells 
To induce Cys crosslinking it is necessary to expose E. coli cells to a membrane 
permeable oxidising reagent. In this work, copper phenanthroline was used. Work 
undertaken in collaboration with Johann Habersetzer resulted in development of a 
protocol whereby cells were treated with 1.8 mM copper phenanthroline for 1 minute, 
after which the reaction was quenched and the samples analysed. To analyse whether 
the copper phenanthroline concentration and incubation time used had any detrimental 
effect to E. coli cells, cell suspensions were treated with either 1.8mM copper 
phenanthroline for 1 minute, or mock treated with buffer, after which serial dilution and 
colony counting was performed. A comparison between the numbers of colony forming 
units (CFU) following copper phenanthroline treatment compared to the control showed 
that similar numbers of cells were recovered in both cases (Fig. 4.4). It can therefore 
be concluded that the 1 minute copper phenanthroline treatment of cells is not lethal. 
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Figure 4.4) Colony forming units of E. coli recovered with and without copper phenanthroline 
exposure. E. coli strain DADE (ΔtatABCD, ΔtatE) was incubated with 1.8 mM copper phenanthroline or 
buffer only for one minute, after which dilution series were prepares and plated on LB-agar and scaling 
counts to give mean CFU/mL. The error bars represent standard error of the mean, n = 3. 
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4.3.2 Cys substitutions used in this work do not abolish Tat activity 
As stated in Section 4.1.1, Cys substitutions of TatA and TatC could conceivably 
disrupt any potential interaction face/s between the proteins, preventing the Tat system 
from functioning. To determine whether any of the Cys substitutions abolished activity 
of the Tat system, Tat-dependent growth phenotypes were assessed for E. coli strain 
DADE (ΔtatABCD, ΔtatE) producing each of the Cys substitutions from the medium 
copy number pQE60 based vector, pUNITATCC4. Plasmid pRep4, which encodes 
lacIq, was also present in the strain to reduce protein expression from the lac promoter 
on pUNITATCC4. Table 4.1 shows the results following screening for Tat transport 
activity  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1) Cys substitutions in TatA and TatC do not abolish Tat activity. E. coli strain DADE 
(ΔtatABCD, ΔtatE) harbouring pRep4 and pQE60-based vector, pUNITATCC4 encoding wild type TatB 
along with the indicated Cys substitutions in TatA and TatC was scored for growth by spotting 5 µL cells 
at OD600 0.01 onto LB-agar containing 2% SDS or M9-glycerol-TMAO. The LB-SDS plates were 
incubated aerobically and the M9-glycerol-TMAO plates anaerobically for 24 hours before analysis.  “+” 
denotes positive growth, “-“ denotes no growth. DADE harbouring either pQE60 only or pQE60 encoding 
wild type TatABC was used as negative and positive controls, respectively. 
TatA TatC 2% SDS M9/TMAO/Glycerol TatA TatC 2% SDS
M9/TMAO/
Glycerol
+ + L10C P210C + +
- - L10C D211C + +
L9C M205C + + L10C V212C + +
L9C L206C + + L10C F213C + +
L9C L207C + + L10C S214C + +
L9C T208C + + L10C Q215C + +
L9C P209C + + L10C T216C + +
L9C P210C + + I11C M205C + +
L9C D211C + + I11C L206C + +
L9C V212C + + I11C L207C + +
L9C F213C + + I11C T208C + +
L9C S214C + + I11C P209C + +
L9C Q215C + + I11C P210C + +
L9C T216C + + I11C D211C + +
L10C M205C + + I11C V212C + +
L10C L206C + + I11C F213C + +
L10C L207C + + I11C S214C + +
L10C T208C + + I11C Q215C + +
L10C P209C + + I11C T216C + +
Cys substitution Cys substitution
Wild	type	
Empty	pQE60	vector
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by (i) testing for Tat-dependent export of cell wall amidases that confer resistance to 
2% SDS added to the growth media (Stanley et al., 2001, Ize et al., 2003) and (ii) 
testing for anaerobic growth on M9 minimal medium with TMAO as sole electron 
acceptor, to identify the ability to export Tat-dependent TMAO and DMSO reductases 
(Santini et al., 1998; Chapter 2, Section 3.3.6).  
The results clearly indicate that all of the Cys constructs used in this work yield 
functional TatA and TatC proteins.	
4.3.3 TatA-TatC disulphide crosslinking in vivo 
Next, disulphide crosslinking was performed using suspensions of strain DADE 
(ΔtatABCD, ΔtatE) producing Cys-substituted TatA and TatC alongside wild type TatB 
from plasmid pUNITATCC4. The strain also routinely contained plasmid pRep4, in 
order to reduce protein expression from the lac promoter on pUNITATCC4. 
Cells were grown until OD600 0.3 was reached, whereupon three separate aliquots were 
withdrawn and diluted by addition of an equivalent volume of fresh LB. Oxidised 
samples had 1.8 mM copper phenanthroline added and incubated for 1 minute, while 
control cells were left untreated and reduced cells had 10 mM dithiothreitol (DTT) 
added before incubation for 1 minute. Subsequently all three samples were treated with 
N-ethylmaleimide to cap all remaining free disulphides and cells were lysed with 
Laemmli buffer and loaded onto SDS-PAGE for Western blotting. 
4.3.3.1 TatA L9C crosslinks TatC F213C at TM6 in vivo 
Fig. 4.5A presents an anti-TatC Western blot showing oxidised whole cell samples of 
strain DADE producing TatA L9C, wild type TatB and successive TatC Cys 
substitutions in the scanning region encompassing TatC M205C-T216C. It is apparent 
that for the TatA L9C - TatC M205C oxidised sample, no TatA-TatC heterodimer was 
detected, which would be expected to migrate at ~37 kDa (the combined SDS-PAGE 
molecular weight of TatA and TatC; monomeric TatC migrating just below 25 kDa on 
109	
	 	 	
the same blot in Fig. 4.5A). This implies that TatA L9C is not near to TatC M205C in 
vivo, despite studies showing that a position equivalent to TatA L9C in chloroplast Tha4 
could crosslink to the cpTatC residue equivalent to TatC M205C (Aldridge et al., 2014). 
It is also notable that no TatC M205C homodimer, expected to migrate just below 50 
kDa, was detected under oxidising conditions. This lack of homodimer contrasts to 
previous crosslinking results with the same Cys-substituted TatC in isolated 
membranes (Rollauer et al., 2012, Kneuper et al., 2012, Punginelli et al., 2007) and E. 
coli INVs (Blummel et al., 2015). This seems to suggest that, in vivo, TatC 
homodimerisation is prevented at this position in E. coli. This conclusion is supported 
by results presented by Cleon et al. (2015), who also reported that there was no TatC-
TatC dimerisation through M205C in vivo unless a Tat substrate was overexpressed.  
Again, for position L206C in TatC (Fig. 4.5A), it can be seen that no TatA-TatC 
heterodimer or TatC-TatC homodimer can be detected under oxidising conditions. 
Rollauer et al. (2012) observed a prominent TatC homodimer linked through L206C in 
isolated membranes, again suggesting that in vivo TatC dimerisation may be prevented 
in this part of TatC. In contrast, Fig 4.5A shows that TatC L207C formed a weak 
homodimer after oxidation, but again there was a lack of any detectable TatA-TatC 
heterodimer formation. It should be noted that TatC homodimer, linked through L207C, 
was seen in vitro by Rollauer et al. (2012).   
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Figure. 4.5) TatA L9C interacts with TatC F213C in vivo. A-C Anti-TatC Western blots performed on 
whole cell samples of E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pREP4 and pUNITATCC4 
producing wild type TatB along with the indicated Cys substitutions in TatA and TatC. A Cells were 
oxidised with 1.8 mM copper phenanthroline for 1 min, B Cells were left untreated, C cells were treated 
with 10 mM of the reductant DTT for 1 min. In each case the loading volume was 5 µL. The positions of 
the TatC monomer, TatC dimer and TatAC heterodimer are indicated. D Anti-TatA Western blots of 
selected samples from A-C to detect a corresponding TatA-TatC heterodimer band at ~37 kDa. “C”, 
corresponds to control, untreated samples from B, “O” to oxidised samples from A and “R” to reduced 
samples from C. The positions of the TatA-TatC heterodimer and TatA homodimer are indicated and the 
overexposed TatA monomer band has been cropped for clarity. E denotes positions of Cys substitutions 
in TatC examined in this experiment. 
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Taken together, these results suggest that TatA does not interact through L9C with the 
periplasmic facing region of TatC TM5. Moreover, the distinct TatC homodimerisation 
through TM5 observed in vitro in previous studies is either completely absent or 
apparently greatly diminished in vivo.  
Upon inspection of the crosslinking results between TatA L9C and Cys substitutions in 
the TatC P3 loop under oxidising conditions (Fig. 4.5A), again no TatAC heterodimer 
can be detected for any of the positions tested, from TatC T208C through to V212C. 
This conflicts with results from the thylakoid Tat system, where an interaction between 
the equivalent position of TatA L9C in the plant orthologue, Tha4 and a position at the 
centre of the L3 loop of cpTatC (analogous to the P3 loop of TatC) was found (Aldridge 
et al., 2014). Furthermore in E. coli INVs a Bpa incorporated into TatC position 211 (at 
the centre of the P3 loop) was able to crosslink to TatA. However in this latter case it is 
not known which region of TatA was crosslinked, and could potentially be the flexible 
N-terminal region (Zoufaly et al., 2012).  
The results presented here would suggest that in E. coli cells, TatA is not interacting 
through L9C in the TatC P3 loop. It can clearly be seen that there is strong TatC 
homodimerisation for cysteines within the P3 loop, this is particularly pronounced for 
positions T208C, P209C, P210C and D211C but not present for V212C. Existing data 
on TatC homodimer formation via residues in the P3 loop is conflicting, with Blummel et 
al. (2015) and Zoufaly et al. (2012) both reporting no self-crosslinks through Bpa 
residues incorporated into positions 211 and 209 in P3 (in the presence of TatB), 
whereas Aldridge et al. (2014) reported distinct cpTatC homodimers forming through 
Cys substitutions at the centre of the equivalent of the P3 loop in chloroplast TatC.  
Finally, moving along to look at crosslinks between TatA L9C and residues in the TM6 
region of TatC, strikingly, a clear TatA-TatC heterodimer band linked via TatA L9C and 
TatC F213C is apparent under oxidising conditions. This band appears to be notably 
stronger than the TatC F213C-linked homodimer that is also observed under oxidising 
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conditions migrating just below 50 kDa, suggesting TatA is more favourably interacting 
at this position in vivo. With the exception of weak TatC self-interactions through 
T216C (relative to the intensity of TatC homodimer bands formed through the P3 loop), 
no other homodimeric or heterodimeric crosslinks were detected for any of the other 
Cys substitutions tested in TatC TM6.  
Interestingly, residues 213 and 216 are on the same face of TatC TM6, and this may 
represent a self-interaction face. Indeed, Punginelli et al. (2007) and Aldridge et al. 
(2014) both observed TM6-TM6 crosslinks in membrane fractions of E. coli and intact 
plant thylakoids, respectively, through residues at the centre of the fifth transmembrane 
helix.  
Figs 4.5B and C are critical control experiments that serve to demonstrate that the 
TatA-TatC heterodimer formed through TatA L9C and TatC F213C under oxidising 
conditions in Fig 4.5A is not present under either untreated or reduced conditions 
indicating that it arises from a disulphide crosslink. Compared to the formation of TatC 
homodimers under oxidising conditions, relatively weak TatC homodimer bands can 
still be seen in the P3 loop at positions T208C, P209C and D211C along with a 
homodimer at T216C at TM6 under untreated conditions (Fig.4.5B). Upon reduction 
with DTT, interactions through T216C disappear while interactions in the P3 loop are 
still maintained (Fig. 4.5C). This suggests that associations through the P3 loop are 
very favourable in the absence of an oxidising agent to initiate the reaction and is likely 
due to the proximity of the loop to the oxidising periplasm. It may be that the 
periplasmic DsbAB system is responsible for some of this disulphide bond formation in 
the absence of externally-added oxidant as was suggested for TatA homodimerisation 
through Cys residues in TatA that are proximal to the periplasm (Greene et al., 2007).  
The TatA-TatC homodimer between TatA L9C and TatC F213C, detected under 
oxidising conditions, should also be responsive to anti-TatA antibodies. Fig. 4.5D 
shows that, indeed, a similar band at ~37 kDa can also be identified when probed with 
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an anti-TatA antibody. This indicates that the dimer is composed of both TatA and TatC 
proteins, and given its absence under control and reduced conditions, is demonstrated 
to be disulphide-linked. Furthermore the absence of such a band between TatA L9C 
and TatC D211C, V212C or S214C (Fig 4.5D) adds further support to the identification 
of this band in the TatA blot (Fig. 4.5A).  
It should be noted that, in the native Tat system, TatA is produced at levels vastly in 
excess of TatC (Chapter 1, Section 1.10) and this native stoichiometry is very likely 
preserved for the plasmid-encoded proteins. As such, the population of TatA 
associated with TatC will be more difficult to detect on Western blots using anti-TatA 
antibodys as opposed to anti-TatC antibody, due to the large amount of unreacted TatA 
also present on the Western blot. This explains the relative weakness of the TatA-TatC 
heterodimer bands in Fig. 4.5D. It should be noted that the highly overexposed TatA 
monomer was cropped from anti-TatA Western blots in Fig 4.5D for clarity, with the full 
Western blots presented in the Supplementary Section.  
Fig. 4.5D also demonstrates that TatA L9C itself can strongly self-associate, with 
intense TatA homodimer bands observed at around 30 kDa, in agreement with 
crosslinks observed for the same position of E. coli TatA in vitro (Greene et al., 2007). 
Remarkably, a higher molecular weight band is also observed in the oxidised samples 
on the anti-TatA blots, which may correspond to higher order oligomers of TatA which 
are somehow promoted through the creation of a Cys-linked dimer. Indeed, a band 
corresponding to a similar molecular weight was observed on some anti-TatA Western 
blots by Greene et al. (2007) after disulphide crosslinking of the same position in vitro.  
4.3.3.2 TatA L10C crosslinks TatC V212C in vivo 
Fig. 4.6A presents an anti-TatC Western blot showing oxidised whole cell samples of 
strain DADE producing TatA L10C, wild type TatB and successive TatC Cys 
substitutions in the scanning region encompassing TatC M205C-T216C. It can be seen 
that no TatA-TatC or TatC-TatC dimers form through TatC M205C, similar to what was  
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Figure. 4.6) TatA L10C interacts with TatC V212C in vivo. A-C Anti-TatC Western blots performed on 
whole cell samples of E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pREP4 and pUNITATCC4 
producing wild type TatB along with the indicated Cys substitutions in TatA and TatC. A Cells were 
oxidised with 1.8 mM copper phenanthroline for 1 min, B Cells were left untreated, C cells were treated 
with 10 mM of the reductant DTT for 1 min. In each case the loading volume was 5 µL. The positions of 
the TatC monomer, TatC dimer and TatAC heterodimer are indicated. D Anti-TatA Western blots of 
selected samples from A-C to detect a corresponding TatA-TatC heterodimer band at ~37 kDa. Below 
each panel, “C”, corresponds to control, untreated samples from B, “O” to oxidised samples from A and 
“R” to reduced samples from C. The positions of the TatA-TatC heterodimer and TatA homodimer are 
indicated and the overexposed TatA monomer band has been cropped for clarity. E denotes positions of 
Cys substitutions in TatC examined in this experiment. 
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seen for TatA L9C in Section 4.3.3.1. Again a similar result was seen for TatA 
L10C/TatC L206C, with no TatC homodimer or TatAC heterodimer detected. A faint 
TatC homodimer through TatC L207C, again identical to observations in Section 
4.3.3.1 with the Cys substitution TatA L9C, was observed, but no detectable TatAC 
heterodimer was apparent.  
Moving on to examine interactions between TatA L10C and cysteine substitutions in 
the P3 loop, a TatA-TatC heterodimer band was detected between TatA L10C and 
TatC V212C, which appears to be much fainter than that observed for TatA L9C and 
TatC F213C (compare the intensity of monomer and dimer forms of TatC relative to the 
TatA-TatC heterodimer in Section 4.3.3.1 Fig 4.5A), however, the placement of TatA 
L9C near F213C would allow TatA L10C on the same TatA to be near V212C, so this 
interaction is plausible. TatC self-interactions were also detected for Cys substitutions 
in the TatC P3 loop under oxidising conditions (Fig. 4.6A) and not surprisingly appear 
very similar to those observed for the TatA L9C crosslinking results in Fig 4.5A, for 
example with prominent TatC homodimer bands seen through positions T208C-V212C. 
It should be noted that homodimerisation through V212C was not observed in Section 
4.3.3.1 with constructs expressing TatA L9C under oxidising conditions, although 
whether this is direct result of the different Cys substitution in TatA is not clear.  
Crosslinks through TatA L10C to Cys residues in TatC TM6 are not present under 
oxidising conditions as shown in Fig. 4.6A, with TatC homodimers forming only through 
TatC F213C and S214C. With constructs expressing TatA L9C, TatC homodimers 
were observed through T216C, but not S214C, under oxidising conditions (Section 
4.3.3.1, Fig. 4.5A). The reason for these differences is not clear. 	
Fig. 4.6B and 4.6C show that the weak TatA-TatC heterodimer band between TatA 
L10C and TatC V212C under oxidising conditions is not observed on anti-TatC 
Western blots under untreated or reducing conditions, suggesting it results from a 
disulphide linkage. As with constructs expressing TatA L9C, TatC homodimers under 
116	
	 	 	
oxidising conditions are still present under control conditions, though they seem more 
prominent in the P3 loop at positions P210 and D211 and in TM6 at F213C and T216C 
(Fig. 4.6B). Weaker TatC homodimer bands are present at all other positions tested, 
though these disappear, or are greatly diminished, under reducing conditions, with the 
exception of relatively faint TatC homodimer bands through P209C, P210C and D211C 
(Fig. 4.6C). As with constructs expressing TatA L9C alongside the TatC Cys 
substitutions, it indicates a propensity for TatC to form homodimers through the P3 
loop.  
TatC homodimer formation is seen through Q215C and T216C in TM6 under untreated 
conditions from TatA L10C expressing constructs (Fig. 4.6B) suggesting that TatC 
homodimerisation through TM6 residues in these experiments is favourable. This 
potential homodimerisation through TatC TM6 is supported by crosslinked homodimers 
that have have been observed through several positions in TatC TM6 (Punginelli et al., 
2007), along with cpTatC self-interactions at TM6 (Aldridge et al., 2014), these 
interactions may be present but occurring at a lower level under in vivo conditions.  
Fig. 4.6D demonstrates that the TatA L10C crosslink to TatC V212C seen on the anti-
TatC western blot under oxidising conditions (Fig. 4.6A), cannot be detected using the 
anti-TatA antibody. It is likely that the relatively small population of TatA associated 
with TatC is greatly outnumbered by free monomers or multimers of TatA in the 
membrane, making it more difficult to detect the TatA subpopulation associated with 
TatC. With regard to TatA homodimer formation, TatA L10C seems to self-crosslink 
less favourably than TatA L9C (Compare Fig. 4.5D and 4.6D), with less homodimer 
present in the control and reduced lanes than for TatA L9C. This is in agreement with 
the in vitro observations of Greene et al. (2007) who reported a reduced level of 
homodimer formation through TatA L10C than L9C.  
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4.3.3.3 TatA I11C crosslinks with TatC V212C and F213C in vivo 
Fig. 4.7A shows an anti-TatC Western blot of oxidised whole cell samples of strain 
DADE producing TatA I11C, wild type TatB and successive TatC Cys substitutions in 
the scanning region encompassing TatC M205C-T216C. It can be seen that there is an 
absence of any TatA-TatC interaction through TatA I11C to Cys residues in TM5. 
Taken together with the absence of any interactions through TatA L9C and L10C with 
TatC M205C, L206C or L207C (Section 4.3.3.1, Fig 4.5A and Section 4.3.3.2, Fig 
4.6A), this would suggest that TatA is unlikely to be associated with TatC TM5 in vivo. 
Though Blummel et al. (2015) observed that a Bpa substitution at position 205 in TatC 
could photo-crosslink TatA in INVs; this was much less favourable than the TatB-TatC 
heterodimer population that was able to form under identical conditions. Furthermore 
Kneuper et al. (2012) and Rollauer at al. (2012) both found residues in TatB (equivalent 
to those in homologous TatA) that formed disulphide crosslinks to TatC M205C in vitro. 
It is likely that TatB is occupying TatC TM5 in vivo, which probably prevents TatA 
association.  
Notably, a clear TatC homodimer can be observed linked through position M205C 
under oxidising conditions (Fig. 4.7A). Though this was not seen under oxidising 
conditions with constructs expressing TatA L9C or L10C (Section 4.3.3.1, Fig. 4.5A and 
Section 4.3.3.2, Fig. 4.6A), it was seen in untreated conditions for L10C (Section 
4.3.3.2, Fig. 4.6B). It should be noted that Cleon et al. (2015) reported this M205C 
homodimeric crosslink only formed in vivo after substrate binding, suggesting that there 
is some low level of interaction with native substrates during some of the experiments 
undertaken here. Comparatively weaker TatC homodimer bands through TatC L206C 
and L207C can also be seen (Fig 4.7A). 
Moving to the P3 loop interactions under oxidising conditions in Fig 4.7A, no TatA-TatC 
interactions were detected except for a faint crosslink between TatA I11C and TatC  
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Figure. 4.7) TatA I11C interacts with TatC V212C and F213C in vivo. A-C Anti-TatC Western blots 
performed on whole cell samples of E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pREP4 and 
pUNITATCC4 producing wild type TatB along with the indicated Cys substitutions in TatA and TatC. A 
Cells were oxidised with 1.8 mM copper phenanthroline for 1 min, B Cells were left untreated, C cells 
were treated with 10 mM of the reductant DTT for 1 min. In each case the loading volume was 5 µL. The 
positions of the TatC monomer, TatC dimer and TatAC heterodimer are indicated. D Anti-TatA Western 
blots of selected samples from A-C to detect a corresponding TatA-TatC heterodimer band at ~37 kDa. 
Below each panel, “C”, corresponds to control, untreated samples from B, “O” to oxidised samples from A 
and “R” to reduced samples from C. The positions of the TatA-TatC heterodimer and TatA homodimer are 
indicated and the overexposed TatA monomer band has been cropped for clarity. E denotes positions of 
Cys substitutions in TatC examined in this experiment. 
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V212C, that appeared to be much lower relative to the population of TatA L9C-TatC 
F213C linked heterodimer (Section 4.2.2.1, Fig 4.5A). It should be noted that TatA 
L10C crosslinking to TatC V212C was detected previously (Section 4.3.3.2, Fig 4.6A) 
which implies TatA L10C and I11C are close to TatC V212C, though it is not clear if 
these interactions are occurring on the same TatC protein through which F213C is able 
to crosslink TatC (Section 4.3.3.1, Fig 4.5) or whether the TatA transmembrane helix is 
simultaneously interacting with a separate TatC proteins through these residues. As 
expected, prominent TatC homodimer bands are detected through Cys substitutions in 
the P3 loop (T208C-V212C) under oxidising conditions (Fig. 4.7A), as was seen in 
Section 4.3.3.1 and 4.3.3.2.  
Crosslinking TatA I11C to Cys substitutions in TatC TM6 reveals a TatA-TatC 
heterodimer band with F213C, which is of a similar intensity to that seen for V212C in 
the P3 loop. Indeed, the presence of TatA L9C interactions with F213C, TatA L10C 
interactions with V212C and TatA I11C interactions with both F213C and V212C would 
indicate that all three faces of the TatA transmembrane helix are able to interact with 
TatC at this site. Of these interactions, TatA L9C crosslinks to F213C appeared to be 
the strongest, and this could indicate either transient reactions through TatA L10C and 
I11C being detected relative to a much stronger TatA L9C crosslink to TatC F213C, or 
perhaps multiple TatC monomers interacting with one TatA, as is discussed further in 
Section 4.4.2. While no other TatA-TatC heterodimers are observed linked through 
TatA I11C at positions tested in the TatC TM6, fainter TatC homodimer bands appear 
at all positions under oxidising conditions, relative to Cys substitutions tested in the P3 
loop (Fig. 4.7A). Fig. 4.7B and 4.7C demonstrate that no TatA I11C-mediated TatA-
TatC heterodimers were detected under untreated or reducing conditions, while TatC 
homodimerisation can be seen strongly through all residues in the P3 loop relative to 
weaker interactions in the TM5, specifically at M205C (seen also under control 
conditions with TatA L10C in Section 4.3.3.2, Fig. 4.6B). TatC homodimerisation also 
occurs in TM6 through residues F213C, S214C and Q215C, with a relatively less 
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intense band found at T216C. Under reducing conditions TatC homodimer bands for 
Cys residues outside of the P3 loop are not detected (Fig. 4.7C). 
Fig. 4.7D shows a band of ~37 kDa cross-reacts with anti-TatA antibodies and 
corresponds to positions where TatA I11C was crosslinked to TatC V212C and F213C 
(seen in Fig. 4.7A). The fact that this band was not detected under reducing and 
untreated conditions demonstrates this band is very likely to be a disulphide-linked 
TatAC heterodimer. TatA homodimerisation may be stronger through TatA I11C than 
L10C based on the intensity of bands around 30 kDa in Fig 4.6D compared to Fig. 
4.7D. Greene et al. (2007) observed similar levels of homodimer formation for both of 
these substitutions, although as stated previously these experiments were performed in 
vitro, while this study analyses interactions in vivo, which may account for this noted 
difference as was discussed at length in Section 4.3.3.2.  
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4.4 Discussion 
4.4.1 TatA interacts with TatC TM6 and the extreme N-terminus of the P3 loop in 
vivo 
Disulphide crosslinking between TatA and TatC in Sections 4.3.3.1-4.3.3.3 suggests 
that residues tested in the transmembrane helix of TatA can interact with both F213C in 
the TM6 of TatC and V212C at the extreme N-terminal end of the P3 loop in vivo. 
Comparing crosslink intensity through TatA-TatC, it appears that the TatA L9C 
crosslink to F213C (Section 4.3.3.1, Fig 4.5A) is stronger than that of TatA L10C with 
TatC V212C (Section 4.3.3.2, Fig 4.6A) and TatA I11C with TatC V212C and F213C 
(Section 4.3.3.3, Fig 4.7A). This may indicate that the TatA-TatC interaction at this 
region of TatC is based around the association of TatA L9C with TatC F213C, with 
other crosslinks seen through TatA L10C and I11C forming at a lower level due to 
proximity. A diagram showing these crosslinks is presented in Fig. 4.8. Due to the 
strong association with TatC F213, this site will be hereby referred to as the TatA 
interaction site at TatC TM6. 
Interactions between TatA and TatC TM6 have not been characterised previously - 
indeed the plant TatA homologue, Tha4, was found to interact with the cpTatC P3 loop  
 
 
 
 
 
 
 
Figure 4.8) Diagram showing crosslinks between TatA and TatC in this work, along with the 
proposed placement of TatB from previous studies. TatA (yellow) is shown with near the TatC TM6 
according to crosslinking data from Sections 4.3.3.1-4.3.3.3, with crosslinking residues shown as 
spheres. TatB is placed at TM5 with residues highlighted shown to interact with disulphide crosslinking in 
vitro (Rollauer et al. 2012, Kneuper et al., 2012) 
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through an equivalent residue in the transmembrane helix (P9C), however, at a more 
central position in the loop (Aldridge et al., 2014). Indeed the subsequent model 
presented in Aldridge et al. (2014) showed TatA at a position nearer the TatC TM5 than 
TM6. Crosslinks between TatA and TatC in this work are supported, however, by 
photo-crosslinks presented in Blummel et al. (2015) where residues at the periplasmic 
end of TatC TM3, which face TM6, could crosslink to TatA in E. coli inside-out inner 
membrane vesicles (INVs) suggesting a proximity of TatA in this region of TatC (See 
Chapter 1, Section 1.10.7. Blummel et al. (2015) did however find that photo-reactive 
residues incorporated at position 205 in the TM5 of TatC could crosslink to TatA in 
INVs, which was not seen with disulphide crosslinking in this work, and in addition 
Aldridge et al. (2014) found that residues in the TM5 cpTatC would interact with 
chloroplast TatA (Tha4). TatC TM5 has been proposed as a constitutive binding site for 
TatB (Rollauer et al., 2012, Kneuper et al., 2012) but given the homology between TatA 
and TatB (Chapter 1, Section 1.10.1) it is conceivable that both TatA and TatB are able 
to differently occupy the same site at TatC TM5 at difference stages of the Tat cycle. It 
appears however that in vivo in E. coli this is not occurring and as such PMF may play 
a role in modulating these interactions.   
Alcock et al. (2013) and Rose et al. (2013) both observed oligomerisation of 
fluorescently labelled TatA in vivo however this was only when Tat substrate was 
overexpressed. With endogenous substrate levels, as with crosslinking trials in this 
chapter, the TatA fluorescent clusters indicative of TatA oligomerisation were much 
less abundant. This would suggest that the interaction seen between TatA and TatC 
TM6 is not due to the presence of endogenous substrate in vivo, unless a low level of 
activation would promote this TatA-TatC association to the extent which it can be seen 
with crosslinking but not fluorescence microscopy. This seems unlikely however, given 
the amount of TatA-TatC heterodimer band on Western blots in Section 4.3.3.1, 4.5A 
relative to the amount of unreacted TatC monomer, would suggest this is a favourable 
interaction, coupled to fact that the Tat translocases expressed in these crosslinking 
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experiments are largely in excess of the native amount, and as such the effect of 
endogenous substrate would be mitigated.  
Chapter 3 saw TatA association with TatC in affinity purification trials, where low levels 
of TatA were able to co-purify with His-tagged TatC in detergent-solubilised membrane 
fractions, and this is supported by in vivo observations in this Chapter where TatA 
crosslinked to TatC TM6. It is not known at this stage if this TatA association is 
constitutive or represents a transient interaction occurring at one or more stages of the 
Tat transport cycle. Chapter 5 will examine this in further detail.  
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Chapter 5: TatA occupies a constitutive binding 
site at TatC TM6, moving to occupy TatC TM5 in 
response to substrate overexpression  
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5.1 Introduction 
5.1.1 Identifying further TatA interaction sites on TatC 
The results presented in Chapter 4 identified a potential interaction site for TatA at the 
sixth transmembrane helix of TatC (TM6) and the extreme C-terminal part of the third 
periplasmic loop (P3), with in vivo disulphide crosslinking detected through Cys 
substitutions in the TatA transmembrane helix with TatC V212C and in particular 
F213C. As discussed in Chapter 4, other interactions between TatA and TatC within 
the TatC Cys scanning regions tested in this thesis (from M205C in TM5, through the 
P3 loop to TatC T216C at TM6), have been reported in the prior literature, including 
Cys crosslinks between P9C in Tha4 (the plant homologue of TatA) with the centre of 
the P3 loop of cpTatC (Aldridge et al., 2014), and photo-crosslinks to TatA when a 
photoreactive Bpa was introduced at position 211 at the TatC P3 loop (Zoufaly et al., 
2012) or at position 205 in TM5 (Blummel et al., 2015). The conditions used for 
crosslinking analysis in Chapter 4, i.e. in living cells and in the presence of endogenous 
Tat substrates, could plausibly lead to differences in TatA-TatC interactions relative to 
the largely in vitro earlier studies. The work in this Chapter aims to explore these 
potential differences in greater detail. 
5.1.2 Potential changes in TatA-TatC interactions in the absence of TatB 
While the results described in Chapter 4 strongly indicate the presence of TatA near 
TatC TM6 in vivo, no TatA was found interacting at TM5, the presumed TatB 
constitutive binding site (Rollauer et al., 2012, Kneuper et al., 2012). This conflicts with 
previous studies suggesting that TatA has the ability to bind here in the thylakoid Tat 
system (Aldridge et al., 2014) and in E. coli INVs (Blummel et al., 2015). Given the 
noted homology between the TMs of TatA and TatB, coupled to observations in 
Chapter 3 that the absence of TatB led to increased TatA-TatC associations in affinity-
purification experiments, it seems likely TatA could occupy the TatB binding site. 
Indeed, it has been reported that in the absence of TatB, TatA association with TatC is 
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increased, as seen by enhanced photo-crosslinking with TatA through the TatC P3 loop 
and periplasmic facing regions of TM3 (Blummel et al., 2015). Therefore, is it 
conceivable that crosslinks between TatA and TatC TM5 may be present when TatB is 
absent. 
5.1.3 The influence of substrate expression and PMF on TatA-TatC interactions 
Aldridge et al. (2014) proposed that the Tha4 (TatA) interaction site at the equivalent of 
the P3 loop in cpTatC was constitutive, based on the finding that the intensity of the 
Tha4-cpTatC heterodimer did not change with either substrate overexpression or PMF 
dissipation. The work presented in Chapter 4 found no interaction of TatA with the TatC 
P3 loop in the presence of TatB in vivo, where the PMF was present, but instead, it 
was found that TatA occupied a site near TatC TM6. However, the experiments in 
Chapter 4 were carried out in the presence of native Tat substrates and it is unclear to 
what extent this influences the results obtained. Currently no E. coli strain exists where 
all of the genes encoding Tat substrates have been deleted. However, a substrate-free 
Tat system can be achieved in vivo by the combined introduction of F94A and E103A 
substitutions into TatC. Previously these substitutions have been shown to prevent Tat 
substrate binding, and the subsequent oligomerisation of TatA (Holzapfel et al., 2007, 
Alcock et al., 2013). Undertaking disulphide crosslinking in the presence of these 
substitutions will allow the determination of sites occupied by TatA in a resting, 
substrate-free state.  
Aldridge et al. (2014) observed that although substrate overexpression did not alter 
interaction of Tha4 with the cpTatC P3 loop, it did result in increased association of 
Tha4 with cpTatC TM4 and TM5. It was proposed that this represented substrate gated 
Tha4 docking on cpTatC. Microscopy-based studies in living cells of E. coli have also 
observed recruitment of fluorescently labelled TatA to the TatBC complex in response 
to substrate overexpression (Alcock et al., 2013, Rose et al., 2013). While the in vivo 
conditions, through which disulphide crosslinking is performed in Chapter 4, allows 
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endogenous levels of substrate to bind the translocase, it is conceivable that 
overexpressed substrate could lead to a change in TatA-TatC interactions which would 
be reflected by a change in Cys crosslinking patterns. 
Tat transport is powered by the PMF and Chapter 1, Section 1.11 has outlined in detail 
the known effect of PMF dissipation on the Tat system. Previous work examining the 
reliance of Tat subunit interactions on PMF found that it is required for TatA recruitment 
and oligomerisation in E. coli (Alcock et al., 2013, Rose et al., 2012) and plant 
thylakoids (Dabney-Smith et al., 2006, Mori & Cline, 2002). Undertaking disulphide 
crosslinking in a background where the PMF has been dissipated will report on whether 
any of the crosslinks observed in Chapter 4 are dependent on membrane energisation.   
5.2 Aims 
The work presented in this chapter aims to identify any potential sites on TatC which 
may be occupied by TatA when TatB is absent, using in vivo disulphide crosslinking. 
Potential constitutive TatA-TatC interactions will be analysed using disulphide 
crosslinking in a background where the Tat system cannot bind substrates. The effect 
of substrate overexpression will also be analysed in living cells by examining any 
potential change in TatA-TatC crosslinking. Finally, any potential change in TatA-TatC 
crosslinking will examined in response to PMF dissipation by performing crosslinking 
experiments on cells incubated with chemical ionophores. 
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5.3 Results 
5.3.1 TatA L9C crosslinks both TatC TM5 and TM6 in vivo in the absence of TatB, 
with weaker interactions at P210C in the P3 loop.  
To explore potential interactions between TatA and TatC when TatB was absent, 
disulphide crosslinking experiments were performed exactly as in Chapter 4, using 
pQE60-based constructs expressing Cys substituted TatA and TatC only.   
Fig. 5.1A shows an anti-TatC Western blot of oxidised whole cell samples of strain 
DADE producing TatA L9C, and successive TatC Cys substitutions in the scanning 
region encompassing TatC M205C-T216C, in the absence of TatB. It can clearly be 
seen for TatA L9C and TatC M205C, a TatA-TatC heterodimer band has appeared 
which was not present when TatB was co-expressed (compare Chapter 4, Fig 4.5A 
with Fig 5.1A). TatC homodimer formation through M205C also appeared more 
prominent in the absence of TatB. A similar, but less pronounced effect was observed 
for crosslinking of TatA L9C to TatC L206C under the same conditions, with fainter 
hetero- and homodimer bands observed on anti-TatC blots (Fig. 5.1A). This 
crosslinking pattern between TatA and TatC is remarkably similar to that observed 
previously between TatB L9C and TatC M205C and L206C in vitro (Rollauer et al., 
2012, Kneuper et al., 2012) suggesting that the homology between TatA and TatB 
could translate into the ability to differently occupy an interaction site on TatC. 
Crosslinking with TatA L9C and TatC L207C showed no notable difference in the 
absence of TatB, with a faint TatC homodimer detected and no TatA-TatC heterodimer. 
Taken together these results strongly imply that TatA is able to occupy the TatB 
constitutive site when TatB is absent.  
Interestingly, when observing TatA-TatC interactions in the TatC P3 loop, a 
heterodimer band has appeared linking TatA L9C to TatC P210C when TatB is absent 
(Fig 5.1A). Crosslinking data from Zoufaly et al. (2012) observed an interaction with 
TatA through a Bpa substitution at TatC D211 and Aldridge et al. (2014) showed 
disulphide crosslinks between the equivalent of the TatA L9C residue (Tha4 P9C) and  
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Figure 5.1) TatA L9C interacts with TatC TM5/TM6 and weakly at P3 in the absence of TatB in vivo- 
A-C Anti-TatC Western blots performed on whole cell samples of E. coli strain DADE (ΔtatABCD, ΔtatE) 
harbouring pREP4 and pQEA(ΔB)C producing the indicated Cys substitutions in TatA and TatC. A Cells 
were oxidised with 1.8 mM copper phenanthroline for 1 min, B Cells were left untreated, C cells were 
treated with 10 mM of the reductant DTT for 1 min. In each case the loading volume was 5 µL. The 
positions of the TatC monomer, TatC dimer and TatAC heterodimer are indicated. D- denotes positions of 
Cys substitutions in TatC examined in this experiment. 
D 
C 
B 
A 
Oxidised, TatA L9C, ΔtatB 
Untreated, TatA L9C, ΔtatB 
Reduced, TatA L9C, ΔtatB 
α-TatC 
α-TatC 
α-TatC 
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the cpTatC L3  (third luminal) loop (P3 loop in E. coli). Both of these studies were 
performed in the presence of TatB or the plant orthologue Hcf-106. 
TatA-TatC crosslinks also appeared through TatC V212C in the absence of TatB, with 
a similar crosslink maintained at F213C at a weaker level (compare Chapter 4, Fig. 
4.5A with Fig 5.1A). This implies that while the interactions between TatA and TatC 
through TM6 and the extreme N-terminal part of the P3 loop are preserved in the 
absence of TatB, the appearance of a new nearby crosslink between TatA L9C and 
V212C potentially suggests a greater degree of freedom experienced by the TatA TM, 
or perhaps another TatA monomer interacting nearby. 
In Fig. 5.1A at the TatC P3 loop the intensity of the TatC homodimers linked through 
P209C-V212C seems stronger in the absence of TatB (compare Chapter 4, Fig. 4.5A 
and Fig. 5.1A). It appears that when TatB is not present, TatC monomers may 
rearrange or move closer to each other to facilitate further interactions in the P3 loop. It 
is of note that the residues nearer the centre of the P3 loop (P209C, P210C and 
D211C) all showed greater homodimer formation than other positions in the P3 loop. 
Increased TatC homodimerisation when TatB was absent was also observed with 
photo-crosslinking experiments in Blummel et al. (2012) where TatC self-crosslinks 
through T208C and P209C were increased when TatB was lacking.  
Crosslinks between TatA L9C and TatC F213C in the TM6 have already been 
discussed above, however under oxidising conditions no further TatA L9C crosslinks to 
TatC were observed for TatC TM6, as in the presence of TatB (compare Chapter 4, 
Fig. 4.5A and Fig. 5.1A). Also no TatC homodimer interactions were seen in TatC TM6, 
comparable to the presence of TatB where only very faint homodimers were observed 
(Fig.5.1A). 
Fig. 5.1B and 5.1C show that, as was the case in the presence of TatB, no TatA-TatC 
heterodimers were observed in untreated and reducing conditions, demonstrating the 
new heterodimer interactions through TatA L9C at TatC TM5 and V212C are 
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disulphide-linked. Under untreated conditions, all homodimer formation was confined to 
the P3 loop, in particular residues P210C and V212C (Fig. 5.1B) and in the presence of 
reductant, all TatC homodimers were greatly reduced (Fig. 5.1C).  
Anti-TatA Western blots were performed to confirm whether the bands migrating at ~37 
kDa in Chapter 4, Fig. 4.9A are responsive to anti-TatA antibodies. In Fig. 5.2, the 
characteristic band at ~37 kDa, was detected at corresponding positions, specifically 
between TatA L9C and TatC M205C/L206C, with no heterodimer through L207C and 
T208C as expected. Likewise, the TatA-TatC heterodimer band was detected in anti-
TatA Western blots through TatC V212C and F213C. Because the ~37 kDa band was 
consistently detected with both anti-TatC and anti-TatA antibodies, and was not 
detected after untreated or reducing conditions, it can be concluded that it is a TatA-
TatC disulphide-bonded heterodimer. No TatA-TatC heterodimer band between TatA 
L9C and TatC P210C was observed on Western blots using anti-TatA antibodies,  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2) TatA-TatC heterodimer through TatA L9C and TatC TM5/TM6 can be detected on anti-
TatA Western blots in the absence of TatB - Western blots performed on whole cell samples of E. coli 
strain DADE (ΔtatABCD, ΔtatE) harbouring pREP4 and pQE60AΔBC expressing Cys substituted TatA 
and TatC as noted. Cells were O- oxidised with 1.8 mM copper phenanthroline, C- cells were untreated, 
R- cells were treated with 10 mM of the reductant DTT for 1 min. In each case the loading volume was 5 
µL. The positions of the TatA-TatC heterodimer and TatA homodimer are indicated and the overexposed 
TatA monomer band has been cropped for clarity. 
TatA L9C, ΔtatB 
TatA L9C, ΔtatB 
α-TatA 
α-TatA 
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suggesting that the population was very low, as expected given the low intensity seen 
on anti-TatC Western blots (Fig.5.1A). With regard to TatA homodimerisation through 
L9C in the absence of TatB, there seems to be little difference in the intensity, with an 
apparently strong interaction seen even under reducing or untreated conditions 
(Compare Chapter 4, Section 4.3.3.1, Fig. 4.5D and this Section, Fig. 5.2). The higher 
molecular weight band seen in the oxidised fractions in Chapter 4, Section 4.3.3.1-
4.3.3.3 was also still present. 
5.3.2 TatA L10C interacts with TatC TM5 in the absence of TatB 
Fig. 5.3A shows an anti-TatC Western blot of oxidised whole cell samples of strain 
DADE producing TatA L10C, and successive TatC Cys substitutions in the scanning 
region encompassing TatC M205C-T216C, in the absence of TatB. No TatA-TatC 
heterodimer was detected between TatA L10C and TatC M205C, however, a 
heterodimer was detected with TatC L206C. This suggests that TatA L9C may interact 
with TatC M205C (shown in Chapter 4, Fig. 4.5A), while TatA L10C interacts with the 
adjacent L206C, as TatA occupies the TatB constitutive site. Interestingly, a similar 
result was observed for Cys crosslinking between TatB with TatC at equivalent 
positions in vitro, where the intensity of the TatB-TatC heterodimer linking TatB L10C to 
TatC L206C was higher than TatB L10C to TatC L205C and similarly the amount of 
TatB-TatC heterodimer linked through TatB L9C and TatC M205C was higher than that 
seen when crosslinking TatB L10C to the same TatC position (Rollauer et al., 2012).  
As in Chapter 4, Sections 4.3.3.1-4.3.3.3, TatC homodimerisation appeared to be 
higher through TatC M205C and L206C in the absence of TatB (compare Chapter 4, 
Fig. 4.5A and Fig. 5.3A). No TatA-TatC homodimerisation was observed at L207C, with 
a faint TatC homodimer band relative to M205C and L206C seen in the absence of 
TatB (Fig. 5.3A).  
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Figure 5.3) TatA L10C interacts with TatC TM5 and weakly at P3 in the absence of TatB in vivo- A-C 
Anti-TatC Western blots performed on whole cell samples of E. coli strain DADE (ΔtatABCD, ΔtatE) 
harbouring pREP4 and pQEA(ΔB)C producing the indicated Cys substitutions in TatA and TatC. A Cells 
were oxidised with 1.8 mM copper phenanthroline for 1 min, B Cells were left untreated, C cells were 
treated with 10 mM of the reductant DTT for 1 min. In each case the loading volume was 5 µL. The 
positions of the TatC monomer, TatC dimer and TatAC heterodimer are indicated. D- denotes positions of 
Cys substitutions in TatC examined in this experiment. 
D 
C 
B 
A 
Oxidised, TatA L10C, ΔtatB 
Reduced, TatA L10C, ΔtatB 
Untreated, TatA L10C, ΔtatB 
α-TatC 
α-TatC 
α-TatC 
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Moving on to examine interactions with the TatC P3 loop under oxidising conditions in 
the absence of TatB through TatA L10C, no TatA-TatC heterodimers were detected 
except for a faint  interaction through TatC P210C at ~37 kDa (Fig. 5.3A). A similar 
interaction was observed through TatA L9C in Fig 4.5A, indicating interactions in the 
P3 loop occurring through both TatA L9C and L10C in the absence of TatB, which are 
not detected when TatB is present (Chapter 4, Sections 4.3.3.1-4.3.3.2). Interestingly, 
the interaction through TatA L10C and TatC V212C, seen in the presence of TatB in 
Chapter 4, was no longer detected when TatB was absent. This seems to support 
observations in Chapter 4, Section 4.3.4.2 whereby TatA L9C did not interact with TatC 
V212C in the presence of TatB but seemingly shifted to facilitate interactions with 
V212C in the absence of TatB seen in Fig. 5.3, in this case presumably moving TatA 
L10C away from V212C. Through all positions in the P3 loop, TatC homodimerisation 
was more pronounced in the absence of TatB, suggesting that TatC monomers are 
able to move into closer proximity through the P3 loops (compare Chapter 4, Fig. 4.6A 
and Fig. 5.3A). Fig. 5.3A also shows that, at positions tested in TatC TM6, no TatA-
TatC heterodimers were detected under oxidising conditions, with an increased TatC 
homodimer band seen through F213C (relative to that in the presence of TatB) and a 
fainter TatC homodimer band through T216C (relative to interactions in the P3 loop on 
the same Western blot). An absence of TatA L10C interactions at this region of TatC is 
not surprising, as they were not present in the presence of TatB (Chapter 4, Fig. 4.6A).  
As expected, no TatA-TatC homodimers were detected on anti-TatC Western blots 
under untreated and reducing conditions (Fig. 5.3B and 5.3C), while TatC 
homodimerisation was seen across all positions in TatC under untreated conditions 
with the exception of L206C in the TM5 and T216C in the TM6 (Fig. 5.3B). This may be 
due to the apparently increased favourability of TatC homodimerisation when TatB is 
absent. All homodimer interactions were diminished under reducing conditions, as 
expected (Fig. 5.3C).  
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On anti-TatA Western blots in Fig. 5.4, the TatA-TatC heterodimer formed through TatA 
L10C and TatC L206C in Fig. 5.3A was not detected, suggesting the crosslink itself is 
relatively weak, despite its presence on anti-TatC Western blots (Fig. 5.3A). Similarly, 
the fainter interaction in the P3 loop at P210C was not detectable on anti-TatA Western 
blots and TatA homodimerisation through TatA L10C in the absence of TatB, does not 
seem notably different (compare Fig. 4.6D and Fig. 5.4).  
 
 
 
 
 
 
 
 
 
 
 
 
This seems to suggest that interactions seen through TatA L10C with the scanning 
region of TatC are more difficult to detect, and as such may be weaker proximal 
interactions, with TatA L9C playing a more prominent role in the interface between 
TatA and TatC.  
 
Fig. 5.4) TatA-TatC heterodimer formed through TatA L10C and TatC TM5 cannot be detected on 
anti-TatA Western blots in the absence of TatB- Western blots performed on whole cell samples of E. 
coli strain DADE (ΔtatABCD, ΔtatE) harbouring pREP4 and pQE60AΔBC expressing Cys substituted 
TatA and TatC as noted. Cells were O- oxidised with 1.8 mM copper phenanthroline, C- cells were 
untreated or R cells were treated with 10 mM of the reductant DTT for 1 min. In each case the loading 
volume was 5 µL. The positions of the TatA-TatC heterodimer and TatA homodimer are indicated and 
the overexposed TatA monomer band has been cropped for clarity. 
α-TatA 
α-TatA 
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5.3.3 TatA I11C crosslinks TatC TM5, V213C and F213C in the absence of TatB in 
vivo 
Fig. 5.5A shows an anti-TatC Western blot of oxidised whole cell samples of strain 
DADE producing TatA I11C, and successive TatC Cys substitutions in the scanning 
region encompassing TatC M205C-T216C, in the absence of TatB. TatA I11C 
crosslinked to both TatC M205C and L206C, in each case showing heterodimer bands 
migrating at ~37 kDa, indicating a similar interaction to that observed through TatA L9C 
(Fig. 5.1A), and demonstrating that all three faces of the TatA TM can interact at TatC 
TM5. A similar result was observed for the TatB TM (Rollauer et al., 2012), whereby 
TatB L9C, L10C and L11C could each crosslink TatC M205C in vitro, further indicating 
that these two proteins are both able to bind to this site on TatC.  
TatC homodimers formed strongly through TatC M205C compared to the apparently 
weaker association through L206C and L207C. As with TatA L9C and L10C (Sections 
5.3.1, Fig. 5.1A and 5.3.2, Fig. 5.3A), a TatA-TatC heterodimer appeared for Cys 
substitutions in the middle of the TatC P3 loop under oxidising conditions in the 
absence of TatB, however here it is at position P209C as opposed to P210C and as 
with TatA L9C and L10C, appears notably weaker than interactions seen with TM5 and 
TM6 (Fig. 5.5A). From the combination of crosslinks observing TatA L9C, L10C and 
I11C with the TatC P3 loop in the presence (Chapter 4, Sections 4.3.3.1-4.3.3.3) and 
absence (Sections 5.3.1-5.3.3) of TatB, it appears that low level interactions are 
present between the TM of TatA and the centre of the P3 loop when TatB is absent, 
and it may be that in the absence of TatB, the arrangement of the Tat subunits may be 
different from that observed in the native state. At the extreme C-terminal part of the P3 
loop, V212C seems to more favourably associate with TatA I11C than P209C (Fig. 
5.5A). Indeed, the interaction between TatA I11C and TatC V212C was also observed 
in the presence of TatB (Chapter 4, Section 4.3.3.3). As expected, prominent TatC 
homodimerisation was present through every position in the P3 loop and appears to be 
stronger than that observed in the absence of TatB (compare Fig. 4.7A with Fig. 5.5A.).  
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Figure 5.5) TatA I11C interacts with TatC TM5/TM6 and weakly at P3 in the absence of TatB in 
vivo- A-C Anti-TatC Western blots performed on whole cell samples of E. coli strain DADE (ΔtatABCD, 
ΔtatE) harbouring pREP4 and pQEA(ΔB)C producing the indicated Cys substitutions in TatA and TatC. A 
Cells were oxidised with 1.8 mM copper phenanthroline for 1 min, B Cells were left untreated, C cells 
were treated with 10 mM of the reductant DTT for 1 min. In each case the loading volume was 5 µL. The 
positions of the TatC monomer, TatC dimer and TatAC heterodimer are indicated. D- denotes positions 
of Cys substitutions in TatC examined in this experiment. 
D 
C 
B 
A 
Oxidised, TatA I11C, ΔtatB 
Untreated, TatA I11C, ΔtatB 
Reduced ,TatA I11C, ΔtatB 
α-TatC 
α-TatC 
α-TatC 
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TatA-TatC interactions were also present through TatA I11C at the start of TM6, with a 
TatA-TatC heterodimer band forming though TatC F213C. Interestingly, the 
combination of an interaction at TatC V212C and F213C is shared by TatA L9C 
(Section 5.3.1) however they seem weaker through TatA I11C perhaps indicating that 
the L9C/I11C face of the TatA TM is in this vicinity on TatC, and TatA I11C can form 
transient interactions, while TatA L9C is interacting directly. TatC homodimerisation 
through TM6 under oxidising conditions was not detected, which is similar to 
observations made for TatA L9C and L10C under oxidising conditions (with the sole 
exception of a TatC T216C homodimer in the TatA L10C dataset; Section 5.3.1 and 
5.3.2). 
Fig. 5.5B and 5.5C shows that for untreated and reducing conditions, no TatA-TatC 
crosslinks were detected when constructs were expressing TatA I11C, and in addition 
the TatC homodimersation seen with oxidation was preserved in untreated conditions, 
with prominent TatC-TatC homodimers forming through M205C in the TM5 and all 
positions in the P3 loop, particularly P210C, D211C and V212C. Fainter interactions 
compared to those seen in the P3 loop were seen through residues in TM6, which were 
not present under oxidising conditions. The intensity of TatC homodimer bands through 
TatC P210C, D211C and V212C was notably decreased upon reduction (Fig. 5.5C), 
while still present at all positions observed under untreated conditions (Fig. 5.5B). 
Clearly based on this and control blots from all crosslinks performed thus far, TatC 
homodimerisation is very favourable, more so in the absence of TatB (compare all anti-
TatC blots in Chapter 4, Section 4.3.3.1-4.3.3.3 with Sections, 5.3.1-5.3.3). 
Corresponding anti-TatA blots demonstrate clearly the presence of a TatA-TatC 
heterodimer through TatA I11C and TatC M205C and L206C at ~37 kDa, which was 
absent in untreated or reducing conditions (Fig. 5.6). The weaker TatA I11C - TatC 
P209C heterodimer band (relative to those observed in TatC TM6; Fig. 5.5A) cannot be 
detected with anti-TatA antibodies, which was also the case for the TatA P3 loop 
interactions with TatA L9C and L10C, suggesting the interaction is weaker. In addition 
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to this, the interactions observed through TatA I11C and TatC V212C or F213C 
detected on anti-TatC blots under oxidising conditions cannot be seen with anti-TatA 
antibodies, again alluding to the weakness of this interaction in the absence of TatB, as 
they could be detected in Chapter 4, Section 4.3.3.3 (compare Chapter 4, Fig.4.7D and 
Fig. 5.5.) where TatB was present. TatA homodimerisation itself seems unchanged in 
the presence and absence of TatB (compare Chapter 4, Fig.4.7D and Fig. 5.5D). 
Indeed, based on this observation, it may be the case that lack of TatB decreased the 
intensity of TatA-TatC crosslinks through TatA I11C and V212C and F213C, as 
occurred through TatA L9C and F213C (Chapter 4, Section 4.3.3.1, Fig 4.5A compared 
to Section 5.3.1, Fig. 5.1).	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.6) TatA-TatC heterodimer through TatA I11C and TatC TM5 can be detected on anti-TatA 
Western blots in the absence of TatB- Western blots performed on whole cell samples of E. coli strain 
DADE (ΔtatABCD, ΔtatE) harbouring pREP4 and pQE60AΔBC expressing Cys substituted TatA and TatC 
as noted. Cells were O- oxidised with 1.8 mM copper phenanthroline, C- cells were untreated or R- cells 
were treated with 10 mM of the reductant DTT for 1 min. In each case the loading volume was 5 µL. The 
positions of the TatA-TatC heterodimer and TatA homodimer are indicated and the overexposed TatA 
monomer band has been cropped for clarity. 
TatA I11C, ΔtatB 
TatA I11C, ΔtatB 
α-TatA 
α-TatA 
140	
	 	 	
5.3.4 Mapping TatA-TatC interactions in the absence of TatB in vivo 
The TatA-TatC crosslinking experiments in Chapter 4 demonstrated that TatA is able to 
interact at TatC TM6 when TatB is present. Here it was assumed that TatB was 
occupying its site at TM5 (Rollauer et al., 2012 and Kneuper et al., 2012), blocking any 
potential TatA-TatC interactions. Performing the same crosslinks between TatA and 
TatC in vivo in the absence of TatB found that while TatA could still occupy the site 
near TatC TM6, it could also crosslink to TM5 in a manner similar to TatB. Fig. 5.7 
shows TatA TM interactions with TatC proposed to be present in vivo when TatB is 
absent. It should be noted that interactions between TatA and TatC TM6 may be 
slightly different in the presence and absence of TatB, as the TatA L9C and TatC 
V212C crosslink appeared in the absence of TatB, while the TatA L10C and V212C 
disappeared, but this may also be accounted for by further TatA monomers associating 
with TatC (only two are shown in Fig. 5.7). Indeed, as fluorescently labelled TatB has 
been demonstrated not to leave the TatBC complex (Alcock et al., 2013) it may 
relocate within the complex, therefore its removal may cause aberrant shifts within the 
whole complex.	
 
 
 
	
	
	
	
	
	
Figure 5.7) Diagram showing crosslinks between TatA and TatC in the absence of TatB- TatA 
(yellow) is shown with near the TatC TM6 and TM5 according to crosslinking data from Sections 
4.3.4.1- to.3.4.3. With crosslinking residues shown as spheres. Residues selected to be further tested to 
examine both of the TatA sites on TatC shown with black boxes.  
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To further analyse these sites on TatC, found to be occupied by TatA in the presence 
and absence of TatB, the most prominent crosslinks for each of the proposed TatA 
interaction sites were taken forward for further study. Specifically, this included TatA 
L9C crosslinking to TatC F213C to study the proposed site at TatC TM6 and TatA L9C 
crosslinking to TatC M205C to analyse TatA occupying the TatB constitutive site at 
TM5.  
5.3.5 The TatA interaction site at TatC TM6 in vivo is occupied in the absence of 
substrate binding 
TatA has been found to interact at TatC TM6 when TatB is present (Chapter 4, Section 
4.3.3.1), and is a candidate for a constitutive TatA-TatC interaction site. To determine 
whether TatA occupies this site in the absence of substrate binding, the crosslinking 
analysis described in Chapter 4, in the presence of TatB, was undertaken, in this case 
using TatC that harboured the combined F94A/E103A substitutions at the signal 
peptide binding site.  
It can be seen that a clear heterodimer band at ~37 kDa, formed by TatA L9C 
crosslinking TatC F213C (TM6), was detected under oxidising conditions, that was 
responsive to both anti-TatA and TatC antibodies (Fig. 5.8A). The presence of this 
crosslink strongly suggests that TatA occupies this site in the absence of substrate 
interaction (i.e. the resting state) and is therefore constitutively bound. Furthermore, the 
homodimer formation between TatC F213C, which would usually migrate just below 50 
kDa on anti-TatC Western blots, was not present in the resting state, supporting the 
inference of Cleon et al. (2015) that TatC dimerisation is a step in an activated Tat 
cycle. It should be noted that TatC homodimers were clearly observed in crosslinking 
experiments where endogenous substrate was able to bind (Chapter 4, Sections 
4.3.3.1-4.3.3.3).  
To examine whether the TatB constitutive site at TatC TM5, where TatA was found to 
bind in the absence of TatB (seen in Sections 5.3.1-5.3.3), could be occupied by TatA 
in the presence of TatB but the absence of substrate binding, crosslinking experiments 
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were performed between TatA L9C and TatC M205C in the presence of the TatC 
F94A/E103A substitutions. Fig. 5.8B demonstrates no bands migrating at a higher  
 
 
	
	
	
	
	
	
	
	
	
	
 
molecular weight than the TatC monomer appeared on the anti-TatC Western blot 
under oxidising conditions, suggesting, as expected, that in the resting state there is no 
TatC dimerisation and that TatA does not interact at TatC TM5. It is likely that TM5 is 
occupied by TatB as outlined in Section 5.3.5.  
The anti-TatA Western blots of the TatA L9C and TatC M205C crosslinking samples 
(Fig. 5.8B) are very similar to blots after crosslinking TatA L9C with TatC F213 (Fig. 
5.8A), but as expected, no TatA-TatC heterodimer band was observed at ~37 kDa. 
Periplasm 
Cytoplasm 
TatA L9C X TatC F213C (F94A, E103A) 
TatA L9C X TatC M205C (F94A, E103A) 
C     O     R 
A 
B 
Figure 5.8) TatA L9C interacts with TatC F213C in the absence of substrate binding- A and B show 
anti-TatC/anti-TatA Western blots (as indicated) of whole cell samples of E. coli strain DADE (ΔtatABCD, 
ΔtatE) harbouring pRep4 and pUNITATCC4 expressing wild type TatB, TatA L9C and A TatC F213C with 
the F94A and E103A substitutions or B TatC M205C with the F94A and E103A substitutions. Cells were 
O- oxidised with 1.8 mM copper phenanthroline, C- untreated or R- treated with 10 mM of the reductant 
DTT for 1 min. Loading volume in each case was 5 µL. Diagramme of TatC (red) and the TatA 
transmembrane helix (yellow) is shown on the right with the positions of the Cys substitutions tested. The 
positions of F94 and E103 that were mutated to prevent signal peptide binding are shown in light blue. 
C     O     R C     O     R 
C     O     R 
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Observing both anti-TatA Western blots in Fig. 5.8, TatA homodimers linked through 
TatA L9C seem somewhat diminished in the resting state, comparing homodimer 
formation when co-expressed with TatC F94A/E103A in Fig 5.8 and or without the 
F94A/E103A substitutions in Fig 4.7D, with less homodimer present in the untreated or 
reduced conditions. A possible explanation for this is the lack of TatA oligomerisation 
due to the system being in the resting state (Alcock et al., 2013, Rose et al., 2013), 
causing a decrease in TatA homodimers, though it should be acknowledged that 
without comparing amounts of homodimer directly this is somewhat speculative. In 
addition to this, the higher molecular weight bands above 37 kDa still appeared on anti-
TatA blots under oxidising conditions, as discussed in Section 4.3.3.1. 
Given the strength of the TatA-TatC heterodimer formed through TatA L9C and TatC 
F213C in the resting state compared with the amount of unreacted TatC monomer (Fig 
5.8A), it would suggest that a significant amount of TatA is associated with TatC under 
resting conditions in vivo. In light of this, henceforth this thesis will now refer to the TatA 
binding site at TM6 as the constitutive site. 
5.3.6 TatA-TatC interactions during substrate binding/translocation 
The effect of substrate overexpression on Tat subunit interactions has been explored 
previously in E. coli through fluorescence microscopy experiments in living E. coli cells, 
where it was found that disperse fluorescently-labelled TatA in the membrane formed 
clusters, presumed to correspond to TatA multimers, in response to overexpressed 
substrate (Rose et al., 2013, Alcock et al., 2013). It was proposed that this represents a 
step whereby TatA is recruited to the TatBC recognition complex and forms an 
oligomer which facilitates substrate translocation. Work examining specific crosslinking 
between Tat subunits in the presence of overexpressed substrate has been performed 
in E. coli where TatC M205C was found to self-crosslink only in the presence of 
overexpressed CueOHis (Cleon et al., 2015) and plant thylakoids, whereby Tha4 (TatA) 
was found to more favourably associate with cpTatC TM5 and TM4, while interactions 
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at the proposed constitutive site in the equivalent of the P3 loop were unchanged 
(Aldridge et al., 2014). The plant studies utilised a modified OE17 precursor protein as 
the Tat substrate, which bound to the Tat complex but did not dissociate and was not 
translocated, in order to increase the lifetime of the complex.  
It is conceivable that as Tat substrates are overexpressed in E. coli, TatA interactions 
on TatC may change, and that this could be detected using disulphide crosslinking. 
Thus, in the next Section, potential change/s in interactions through the TatA 
constitutive site at TatC TM6 and any potential TatA interactions at the TatB 
constitutive site at TM5 in the presence of overexpressed substrate were explored.   
5.3.7 TatA moves from its constitutive site at TM6 to the TatB constitutive site at 
TM5 in response to overexpressed substrate 
To identify whether TatA changed its crosslinking pattern to TatC in response to 
overexpressed substrate, crosslinking was performed in a background with an induced 
artificial Tat substrate, comprising green fluorescent protein fused to the signal 
sequence of the Tat substrate TorA and also harbouring a C-terminal SsrA tag, which 
targets the non-transported fusion protein for degradation by proteolytic ClpXP 
machinery in the cytoplasm. This construct, which is encoded on a pBAD33-based 
vector under the control of the arabinose-inducible ParaBAD promoter is named pTGS 
and was used previously by DeLisa et al. (2002) and was shown to be exported in a 
Tat-dependent manner.  
It should be noted that the strain used for these experiments was DADE-P, which has 
the chromosomal pcnB1 allele that substantially lowers the copy number of leaky 
ColE1-type plasmids such as pQE60 to 1-2 per cell (Lee et al., 2006). This was 
necessary because pRep4, was previously used to repress expression from T4 
promoter on pQE60, shares the same origin of replication with pTGS, and therefore 
would compete if co-transformed. It is not known whether the expression of the Tat 
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proteins from pQE60-based plasmids in strain DADE-P is higher or lower than in strain 
DADE/pREP4.   
5.3.7.1 Induction of substrate expression with L-arabinose does not impair cell 
growth during 20 min incubation phase 
As noted above, the substrate to be used was encoded on a pBAD33 based vector, 
pTGS, which requires induction with L-arabinose. L-arabinose is toxic to strains which 
contain the araD gene, such as DADE-P (Englesberg et al., 1969) so a relatively short 
incubation time with this inducer was used to attempt to mitigate any potential 
damaging effect. Growth assays were performed to determine whether growth was 
impaired over the 20 minute incubation of the experiment (Fig. 5.9).	The results show 
that over this time period, the propagation of the cells does not seem to be adversely 
affected by the presence of L-arabinose. 
 
 
 
 
 
 
 
 
 
 
Figure 5.9) Growth of DADE-P is not affected during incubation with L-arabinose – DADE-P 
(ΔtatABCD, ΔtatE, pcnB1 zad-981::Tn10d) cells at  OD600 of ~0.25 were either inoculated with L-
arabinose (0.01% final concentration; red squares) for 20 mins, or mock inoculated (blue diamonds). 
Error bars show standard error of the mean, n=3. 
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5.3.7.2 TatA L9C crosslinks to TatC F213C at the proposed constitutive 
interactions site for TatA decrease with substrate overexpression 
In order to elucidate the effect of substrate binding on TatA-TatC interactions, the 
artificial Tat substrate protein TorAss-GFP-ssrA was used. Plasmid pTGS was co-
introduced along with the pUNITATCC4 vector encoding TatB along with Cys 
substituted TatA and TatC proteins, into DADE-P. To analyse any change in 
crosslinking pattern at the TatA constitutive site, the construct producing TatA L9C and 
TatC F213C alongside TatB was used. From Fig. 5.10 it can be seen that as the 
amount of L-arabinose was increased, and therefore the amount of translocated 
substrate, the intensity of the TatA-TatC heterodimer at ~37 kDa, linked through TatA 
L9C and TatC F213, appeared to decrease. This would indicate that TatA is vacating 
its constitutive site, or changing its association with TatC as the flux of substrate is 
increased through the Tat pathway. This observation is at odds with observations in  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10) The TatA-TatC heterodimer intensity at TatC TM6 decreases as Tat substrate level is 
increased- Anti-TatC Western blot performed on whole cell samples of E. coli strain DADE-P (ΔtatABCD, 
ΔtatE, pcnB1 zad-981::Tn10d) harbouring plasmid pUNITATCC4 expressing wild type TatB and Cys-
substituted TatA L9C and TatC F213C along with pTGS, which encodes the artificial Tat substrate TorAss-
GFP-ssrA. These are shown with “C” untreated conditions, or after oxidation with 1.8 mM copper 
phenanthroline following induction of TorAss-GFP-ssrA production with the indicated concentration of L-
arabinose. DADE-P harbouring pUNITATCC4 alongside empty pBAD33 was also oxidised, noted by 
“empty pBAD33”. Bottom panel shows an anti-GFP Western blot performed on the periplasmic fraction of 
an aliquot of cells taken from each sample after incubation with L-arabinose but before oxidation.  
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plant thylakoids where Tha4 (TatA) interactions at the constitutive site at the P3 loop in 
cpTatC appeared unaffected by substrate overexpression (Aldridge et al., 2014). It is 
important to note, however, that Aldridge et al. (2014) utilised a substrate which binds 
irreversibly to the TatC complex, and is not transported, therefore steps involving the 
movement of TatA may be missed.   
The intensity of the TatC homodimer crosslinked through F213C increased in response 
to substrate, suggesting that dimerisation is induced by substrate overexpression (Fig. 
5.10), as was observed previously through M205C (Cleon et al., 2015). A possible 
explanation for this is that as TatA vacates TatC TM6, F213C of one TatC becomes 
free to interact with another F213C.  
As a control to confirm that TorAss-GFP-ssrA was being produced and translocated in 
these experiments, aliquots of cells were withdrawn separately after incubation with 
each concentration of L-arabinose but prior to the crosslinking step, and the level of 
GFP assessed by Western blotting of periplasmic fractions (Fig. 5.10, lower panel). It 
can be seen that periplasmic substrate protein was clearly detectable, and increased 
with increasing arabinose concentrations. 
5.3.7.3 TatA L9C crosslinks to TatC M205C at the TatB constitutive interactions 
site at TatC TM5 increase with substrate overexpression 
Since TatA can occupy the TatB constitutive site on TatC (TM5) when TatB is absent 
(Section 5.3.1, Fig 5.1), it was hypothesised that during substrate overexpression TatA 
may be able to occupy the TatB site at TM5 even when TatB is present in cells, 
perhaps related to the apparent movement of TatA from its constitutive site. To analyse 
this, cells producing TatA L9C and TatC M205C alongside wild type TatB were 
oxidised in the presence of overexpressed substrate. It can clearly be seen that the 
intensity of the TatA L9C-TatC M205C heterodimer band increased as substrate level 
was increased by induction with L-arabinose (Fig. 5.11). Taken together with the 
decreased crosslinks seen at F213C, these findings suggest that TatA moves from its 
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constitutive site at TM6, to the TatB constitutive site at TM5 in response to substrate, 
and presumably after TatB has vacated TM5. As residues TatC M205C and F213C are 
~15 Å apart the results cannot be explained by one TatA accounting for both 
interactions. Whether this movement of TatA is from one TatC to another, or occurs on 
the same TatC is unclear at this stage. Again, it should be noted that TatC 
homodimerisation through M205C increased with overexpressed substrate, in 
agreement with the findings of Cleon et al. (2015).  
 
 
 
 
 
 
 
 
 
5.3.7.4 TatA homodimerisation through TatA L9C increases in response to 
overexpressed substrate 
Western blotting using anti-TatA antibodies also revealed a change in TatA 
homodimersation caused by overexpressed substrate. As demonstrated in Fig. 5.12 
the level of TatA homodimer increased as L-arabinose was titrated in to induce 
substrate expression, in a similar manner to the increase in TatC homodimerisation 
through M205C and F213C seen in Figs. 5.10 and 5.11. These interactions may 
represent TatA monomers moving into the proximity of each other as they are recruited 
α-GFP 
TatA L9C X TatC M205C 
Figure 5.11) The TatA-TatC heterodimer intensity increases at TM5 as Tat substrate level is 
increased- Anti-TatC Western blot performed on whole cell samples of E. coli strain DADE-P (ΔtatABCD, 
ΔtatE, pcnB1 zad-981::Tn10d) harbouring plasmid pUNITATCC4 expressing wild type TatB and Cys-
substituted TatA L9C and TatC M205C along with pTGS, which encodes the artificial Tat substrate TorAss-
GFP-ssrA. These are shown with “C” untreated conditions, or after oxidation with 1.8 mM copper 
phenanthroline following induction of TorAss-GFP-ssrA production with the indicated concentration of L-
arabinose. Bottom panel shows an anti-GFP Western blot performed on the periplasmic fraction of an 
aliquot of cells taken from each sample after incubation with L-arabinose but before oxidation.  
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to the Tat complex or perhaps more likely TatA interactions within transporting 
oligomers. In the Western blot shown in Fig. 5.12, no TatA-TatC heterodimer band was 
detected corresponding with those observed in Fig. 5.9 (expected migration is ~37 
kDa). The reason for this is unclear. 
 
 
 
 
 
 
 
 
 
 
5.3.7.5 The presence of substrate is linked to the decreased TatA interactions 
through L9C with TatC F213C 
In order to to confirm that the presence of substrate as opposed to L-arabinose itself 
caused the change in crosslinking between TatA and TatC, similar crosslinking 
experiments were performed in the presence of empty pBAD33 (the vector from which 
pTGS is derived). It was observed that for the TatA L9C-TatC F213C samples, the 
intensity of the TatA-C heterodimer and TatC homodimer bands remained constant 
regardless of the L-arabinose concentration (Fig. 5.13). This is in clear contrast to Fig. 
5.10, and thus links the movement of TatA directly to the presence of Tat substrate. 
Figure 5.12) TatA homodimerisation through TatA L9C increases as Tat substrate level is 
increased- Anti-TatA Western blot performed on whole cell samples of E. coli strain DADE-P (ΔtatABCD, 
ΔtatE, pcnB1 zad-981::Tn10d) harbouring plasmid pUNITATCC4 expressing wild type TatB and Cys-
substituted TatA L9C and TatC F213C along with pTGS, which encodes the artificial Tat substrate TorAss-
GFP-ssrA. These are shown with “C” untreated conditions, or after oxidation with 1.8 mM copper 
phenanthroline following induction of TorAss-GFP-ssrA production with the indicated concentration of L-
arabinose. DADE-P harbouring pUNITATCC4 alongside empty pBAD33 was also oxidised, noted by 
“empty pBAD33”.  
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5.3.8 TatA-TatC crosslinks at TatC TM6 are not detected in vivo when the PMF is 
dissipated  
As outlined in Chapter 1, Section 1.11, translocation through the Tat system is driven 
by the PMF, and as such it is reasonable to assume that once the PMF is dissipated 
this may influence TatA-TatC interactions. If this is the case, changes in crosslinking 
patterns between TatA and TatC, associated with PMF dissipation may be revealed.  
In order to dissipate the PMF, initially the uncoupler carbonyl cyanide m-chlorophenyl 
hydrazine (CCCP) was used, as has been employed in previous studies analysing the 
PMF dependence of Tat interactions in live E. coli cells (Alcock et al., 2013, Rose et al., 
2013). However, in these crosslinking experiments it precipitated upon oxidation 
forming a bright yellow solid. Instead, indole was chosen as an uncoupler. Indole is 
composed of a benzene ring fused with a five membered pyrrole and is well distributed 
in the natural environment. It is utilised by both Gram-positive and Gram-negative 
bacteria for signalling purposes (Lee & Lee, 2010) but at high concentrations, in the 
region of 3 to 5 mM, it has been found to dissipate the PMF of E. coli (Chimerel et al., 
2012) and has been utilised in E. coli by Ismail et al. (2015) to characterise biphasic 
electrical forces during Sec translocation.  
Figure 5.13) L-arabinose alone does not affect the TatA L9C TatC F213C crosslink - Anti-TatC 
Western blot of whole cell samples of E. coli strain DADE-P (ΔtatABCD, ΔtatE, pcnB1 zad-981::Tn10d) 
harbouring plasmid pUNITATCC4 expressing wild type TatB, TatA L9C and TatC F213C along with 
empty plasmid vector pBAD33. Varying concentrations of L-arabinose, as indicated, were added to the 
cells, prior to oxidation with 1.8 mM copper phenanthroline for 1 min. C- whole cells of the same strain 
and plasmid combination treated with 0.01% L-arabinose but without addition of copper phenanthroline.  
Empty pBAD33 
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To analyse the effect of PMF dissipation on TatA-TatC interactions, crosslinking 
analysis of TatA L9C with either TatC F213C (the constitutive TatA binding site) or 
TatC M205C (the constitutive TatB binding site) was undertaken in the presence of 5 
mM indole.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 5.14A shows an anti-TatC blot for cells producing TatA L9C and TatC F213C 
alongside wild type TatB. Under oxidising conditions, in the absence of indole, the 
TatA-TatC heterodimer band was clearly detected at ~37 kDa. However, in the 
presence of indole, the TatA-TatC heterodimer was barely detectable and instead a  
α-TatC 
α-TatA 
A 
B 
Figure 5.14) TatA vacates its constitutive site at TatC TM6 in response to PMF dissipation  A 
Anti-TatC or B- Anti-TatA Western blot of whole cell samples from E. coli strain DADE (ΔtatABCD, 
ΔtatE) harbouring pRep4 and pUNITATCC4 expressing wild type TatB and Cys-substituted TatA L9C 
and TatC F213C. Samples were either untreated, oxidised with 1.8 mM copper phenanthroline for 1 
min or incubated with 5 mM indole for 5 mins, followed by either a 1 min oxidation step or washed 
thoroughly to remove the indole followed by a 1 min oxidation step.  
α-TatC 
α-TatA 
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TatC homodimer was observed. To confirm that the effect of indole was reversible, a 
separate sample was loaded onto SDS-PAGE where the cells were first incubated with 
indole then washed thoroughly prior to oxidation. It can clearly be seen that upon indole 
removal the TatA-TatC heterodimer band was again detected and the TatC homodimer 
diminished. These results strongly suggest that a PMF is required to position TatA at its 
constitutive binding site on TM6 of TatC. Similar results were observed when the 
samples were analysed with anti-TatA antibodies, where the band migrating at ~37 
kDa was not detected following indole incubation (Fig 5.14B). Interestingly PMF 
dissipation did not seem to impair TatA homodimerisation, with prominent TatA 
homodimer bands linked through TatA L9C detected in all of oxidised samples.  
The increased homodimer formation through TatC F213C and decreased TatA-TatC 
heterodimer formation through TatA L9C and TatC F213C in response to PMF 
dissipation shows similarities to the findings in the presence of overexpressed 
substrate (Section 5.3.6). It was seen that overexpressed substrate caused TatA to 
move from its constitutive site at TatC TM6 to occupy the TatB constitutive site at TM5 
(Section 5.3.6). 
To investigate whether dissipation of the PMF resulted in the movement of TatA into 
the constitutive TatB binding site, similar experiments were repeated on cells producing 
TatA L9C and TatC M205C alongside wild type TatB. As can be seen in Fig. 5.15, 
under oxidising conditions TatA L9C did not crosslink with TatC M205C, as observed 
previously in Section 4.3.6.1. However, upon PMF dissipation using 5 mM indole, no 
TatA-TatC heterodimer band was detected, although a notable increase in TatC 
homodimer linked through M205C was seen. These findings were confirmed by blotting 
the same samples with an anti-TatA antibody (Fig 5.15B), however interestingly it 
appears that when constructs expressed TatA L9C alongside TatC M205C, TatA 
homodimerisation was increased upon incubation with 5 mM indole. This was not 
observed in Fig. 5.14B where TatA L9C was co-expressed TatC F213C, and may 
represent a discrepancy in protein amounts from different mutations in constructs used.  
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Taken together these findings suggest that as TatA moves away from its constitutive 
site at TatC TM6 when uncoupler is present it is not locating to TM5 as occurred with  
 
	
	
	
	
	
	
	
	
	
	
	
 
overexpressed substrate, instead it is either interacting at an as yet unknown location 
on the Tat complex, or is leaving the complex completely. These findings have 
implications for experiments undertaken in vitro or after Tat protein extraction from 
native membranes, because it implies that once the PMF is dissipated TatA is no 
longer interacting in its constitutive site, found when the complex is in the resting state 
(Section 5.3.3). Indeed it may explain the discrepancy between the amount of TatA 
Figure 5.15) TatA L9C does not crosslink with TatC M205C when the PMF is dissipated- A- Anti-
TatC or B- Anti-TatA Western blot of whole cell samples from E. coli strain DADE (ΔtatABCD, ΔtatE) 
harbouring pRep4 and pUNITATCC4 expressing wild type TatB and Cys-substituted TatA L9C and TatC 
M205C. Samples were either untreated, oxidised with 1.8 mM copper phenanthroline for 1 min or 
incubated with 5 mM indole for 5 mins, followed by either a 1 min oxidation step or washed thoroughly to 
remove the indole followed by a 1 min oxidation step.  
α-TatC 
α-TatA 
A 
B 
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crosslinking TatC in the resting state and the amount co-purified during affinity 
purification; this will be discussed further in Section 5.4.3. 
5.3.9 TatA-TatC crosslinks at TatC TM6 are disrupted in vitro in isolated 
membrane fractions 
Much of the prior disulphide crosslinking work was undertaken on isolated E. coli 
membrane fractions containing Tat proteins, where it was found that TatB could 
interact at TatC TM5, and TatC could self-associate extensively (Rollauer et al., 2012, 
Kneuper et al., 2012, Punginelli et al., 2009). To examine whether the effect of indole 
as an uncoupler mirrors in vitro findings, experiments were performed examining the 
interaction of TatA at the constitutive site at TM6 and at the TatB constitutive site at 
TM5 in isolated membranes. Fig. 5.16A clearly shows that after cell lysis and extraction 
of membrane fractions, TatA L9C could no longer be crosslinked to TatC F213C at the 
constitutive TatA binding site. Additionally a clear TatC homodimer was observed 
through F213C in vitro, mirroring the observations seen after indole treatment (Section 
5.3.8). Interestingly, the control conditions demonstrated that the TatC homodimer 
forms without favourable TatA L9C self-association, as was observed in vivo with 
ionophores (Section 5.3.8).  
Strikingly, when isolated membranes containing TatA L9C and TatC M205C (alongside 
wild type TatB) were oxidised, a clear TatA-TatC heterodimer was observed that was 
not present under control or reducing conditions. This in contrast to the observation 
made in vivo in the presence of indole where no detectable TatA-TatC interaction was 
seen through the same Cys substitutions.  
 
 
 
 
155	
	 	 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5.16) TatA L9C crosslinks to TatC M205C but not F213C in vitro- Anti-TatC and anti-TatA 
Western blots of membrane fractions isolated from E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring 
pRep4 and pUNITATCC4 encoding wild type TatB and Cys-substituted TatA L9C along with A- TatC 
F213C, or B- TatC M205C. Membrane fractions were C untreated, O oxidised with 0.6 mM copper 
phenanthroline for 1 hour or R treated with 10 mM of reductant DTT for 1 hour (following the protocol of 
Punginelli et al. (2009) Rollauer et al. (2012) and Kneuper et al. (2012)). Loading volume was 5 µL.  
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5.4 Discussion 
5.4.1 TatA has constitutive binding site at TatC TM6 in vivo 
Previous disulphide crosslinking experiments performed in plant thylakoids proposed 
that a constitutive binding site for Tha4 (the plant analogue of TatA) exists at the 
equivalent of the P3 loop in cpTatC. This was grounded in observations that a crosslink 
between Tha4 position 9 and cpTatC in this loop region was observed that was 
unchanged with overexpressed substrate, or PMF dissipation using the ionophores 
valinomycin and nigericin (Aldridge et al., 2014). Based on disulphide crosslinking 
between TatA and a Cys scanning region in TatC, covering the periplasmic end of 
TM5, the P3 loop and the periplasmic end of TM6, the work in this thesis identifies that 
a TatA constitutive site is also present on E. coli TatC encompassing the periplasmic 
region of TM6, which may include the extreme C-terminal end of the P3 loop. The 
placement of TatA here is based on TatA L9C crosslinking to TatC residue F213C in 
TM6 in vivo when the Tat system cannot interact with substrate and is therefore in the 
resting state (Section 5.3.3). It is also supported by the finding of weaker crosslinks 
through TatA L10C with V212C and TatA I11C with both V212C and F213C under 
conditions where the Tat system can bind only endogenous substrate (Chapter 4, 
Sections 4.3.3.1-4.3.3.3). Fig. 5.17 shows the proposed position of the TatA 
constitutive site on TatC identified in this work. 
The discrepancy between the placement of Tha4/TatA in plants and E. coli could be 
explained by a number of factors. One reason may be that TatA and the plant 
orthologue, Tha4, occupy constitutive sites with slightly shifted positions, with E. coli 
TatA at TM6 on TatC and Tha4 at the equivalent of the P3 loop in plant cpTatC. It 
should be noted that the work in this thesis was able to detect TatA interactions in the 
TatC P3 loop in E. coli, but these were weak compared to interactions seen at TatC 
TM5 and TM6 and only occurred when TatB was not present (Sections 5.3.1-5.3.3). 
Interestingly, the nature of the crosslinking experiments in Aldridge et al. (2014) has 
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Tha4 in excess of the subunit Hcf-106 (TatB) relative to the native stoichiometry, as it 
requires importing into chloroplasts. Indeed the excess of Tha4 over Hcf-106 could 
potentially lead to interactions similar to those observed in this work where TatB is 
absent. It should also be noted that the equivalent of the periplasmic facing part of 
cpTatC TM6 was not tested for interactions with Tha4 by Aldridge et al. (2014), and it 
remains possible that Tha4 also interacts here in the plant Tat system. 
The placement of TatA at TatC TM6 here is supported by prior photo-crosslinking in E. 
coli INVs whereby Bpa substitutions at positions at the periplasmic region of TatC TM3 
(facing TM6) could photo-crosslink TatA (See Chapter 1, Section 1.10.7 for the positon 
of these Bpa substitutions in TatC TM3; Blummel et al., 2015). However, it should be 
noted that these photo-crosslinks were performed in E. coli INVs which may not have 
any PMF present, and as was observed in Section 5.3.8, this would have an impact on 
TatA-TatC interactions. 
Aldridge et al. (2014) reported that the amount of heterodimer linked through Tha4 to 
the P3 loop of cpTatC was unchanged with substrate overexpression. However, the 
work in this thesis clearly shows that upon substrate overexpression, interactions at the 
proposed constitutive site at the TM6 of TatC decrease (Section 5.3.6). This 
discrepancy could, again, be due to native differences in the Tat translocase of plants 
and bacteria, or it could reflect the fact that Aldridge et al. (2014) used a Tat substrate 
which was able to irreversibly bind to the translocase in plants but was not exported. 
Indeed, interactions in the Tat translocase may be missed if the full translocation cycle 
is not occurring, as movement of TatA could conceivably occur during the transport 
event itself, or after the Tat substrate has moved into the periplasm.  
5.4.2 TatA is able to occupy the TatB constitutive site when TatB is absent and 
during substrate binding and/or transport 
The work in this Chapter demonstrated that TatA-TatC crosslinks at the constitutive 
TatA site were weakened in response to substrate overexpression, and were 
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accompanied by an increase in TatA-TatC interactions at TatC TM5 under the same 
conditions (Section 5.3.6). Further to this, in the absence of TatB it was found that TatA 
could form a crosslinking pattern remarkably similar to that found through TatB at TatC 
TM5 (Sections 5.3.1-5.3.3). Somewhat is support of this, Aldridge et al. (2014) 
demonstrated that Tha4 interactions at cpTatC TM5 and TM4 were increased in 
response to overexpressed substrate. This supports the hypothesis of a “gatekeeper” 
role for TatB, whereby it blocks TatA-TatC interactions associated with transport of 
substrate (in this case by interacting at its constitutive site at TatC TM5) until a point 
where substrate has bound the Tat complex. After transport is triggered by substrate 
binding, TatB may vacate its constitutive site and move to an as yet unknown location 
(based on fluorescence microscopy experiments it is unlikely to leave the complex; 
Alcock et al., 2013), whereby TatA moves in to occupy the TatB binding site. Indeed, Ni 
affinity purification trials in Chapter 3 observed that TatA-TatC associations were 
increased when TatB was not present and may be explained by TatA occupying the 
now vacant TatB sites on TatC further supporting this “gatekeeper” role of TatB.  
If the data here is analysed in the context of Rodriguez et al. (2013), who observed two 
conformations of TatA, one relaxed and one with the TM and AP (amphipathic helix) 
positioned perpendicular to each other (L-Shaped; Chapter 1, Section 1.10.6), a 
representation of these is shown in Fig. 5.17 where it may be the case that interaction 
with TatC F213 (which is higher in the membrane, shown in Fig. 5.17) corresponds to 
the relaxed form of TatA, while interactions at M205C correspond to the more L-shaped 
conformation which is thought to pinch the membrane (Fig. 5.17). This step could 
initiate TatA oligomerisation whereby numerous TatA molecules adopt the L-shaped 
conformation, and large scale membrane disruption allows transport of the Tat 
substrate. Observing Fig 5.17, it is clear that when TatA moves from TM6 to TM5, it 
moves closer to the concave face of TatC. This may then include interactions at TM4, 
which have been observed in plant thylakoids (Aldridge et al., 2014) and proposed in 
bacteria (Rollauer et al., 2012). 
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It is not known whether TatA moves from the TM6 of one TatC to the TM5 of another 
(Fig. 5.18). Given the favourable homodimer formation through residues in this 
TM5/P3/TM6 region in TatC, it could be the situation that two TatC proteins are near to 
each other at this interface allowing a horizontal movement from one TatC to another 
(See Fig 5.18, which explores potential TatA-TatC and TatC-TatC interactions).  
It was observed in Section 5.3.8 that PMF dissipation could be modulated in living E. 
coli cells using indole where these experiments in effect switch on and off TatA-TatC 
constitutive associations by altering the PMF, similar to experiments whereby TatA 
oligomerisation could be recovered after PMF disruption by CCCP, when the uncoupler 
was inactivated (Alcock et al., 2013). This has important implications for experiments 
performed on purified Tat components, since if TatA dissociates from TatC in the 
absence of a PMF, interactions would not be observed in subsequent affinity 
chromatography or gel filtration experiments. This may explain why so little TatA is 
observed co-purifying with TatC (Chapter 3, Section 3.3), despite the strong 
heterodimer band linking TatA to TatC TM6 in the resting state during crosslinking trials 
suggesting a favourable resting state TatA-TatC interaction.  
Figure 5.17) Proposed conformational change of TatA as it moves from TatC TM6 to TM5—Left- 
TatC (red) in vivo with TatA (yellow rectangles), and TatB (not shown for clarity but presumed to be 
occupying TatC TM5) with residues that were mutated to Cys but did not crosslink to TatA shown in grey, 
and those that formed heterodimers with TatA in yellow, indicating the constitutive TatA site. Right- TatA 
occupying the initial constitutive site on Left- as well as a site at TM5 which is occupied after substrate 
overexpression (shown via a change in TatA-TatC crosslink intensity to TatA L9C through residues with 
an asterisk). A weak interaction, relative to those at TM5 and TM6 is found at P210C which is shown in 
dark green. Membrane is shown as a black line, with distortion of the lipids on the periplasmic side of the 
membrane shown on the right.  
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5.4.3 Elucidating the role of PMF in the Tat system 
Though PMF dissipation using ionophores valinomycin and nigericin did not cause 
Tha4 to vacate its proposed constitutive site, at the equivalent of the P3 loop in cpTatC 
(Aldridge et al., 2014), this work found that E. coli TatA vacated its constitutive site at 
TatC TM in response to PMF dissipation with ionophore indole. However, it should be 
noted that during affinity purification studies in plant thylakoids, Cline & Mori (2001) 
observed no Tha4 (TatA) copurifying with the Hcf106-cpTatC complex, which may 
suggest that PMF dissipation does promote some changes between Tha4-cpTatC 
interaction. Despite this discrepancy, both this work and that of Aldridge et al. (2014) 
found that Tha4/TatA did not interact with TatC TM5 in the presence of PMF dissipation 
using ionophores, suggesting a PMF dependence on Tha4/TatA interactions here, or 
perhaps a PMF-dependent TatB dissociation step which would free TatC TM5 for 
interactions with TatA, which may explain increased TatA co-purification with affinity-
tagged TatC in the absence of TatB (Chapter 3, Section 3.3). 
Figure 5.18) Proposed movements of TatA in response to substrate overexpression- A TatA (yellow) 
on TatC (red) moves from the constitutive site at TatC TM6 to the TatB (blue) constitutive site at TM5 on 
the same TatC protein. TatB moves to an as yet unknown location, denoted by “?”, while TatA may 
oligomerise in the face of the same TatC protein. Right- TatA moves from its constitutive site at TatC TM6 
to the TM5 of another TatC as TatB moves to an unknown location. TatA may then oligomerise in the 
concave face of the opposing TatC. 
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Reasons as to why PMF may be important in maintaining constitutive TatA-TatC 
interactions could involve the ionisable conserved residue Q8 in the TM of TatA. 
Protonation (or deprotonation) of this residue may be mediated by an intact PMF. 
Additionally ionisable, conserved residues Q215 in the TM6 or D211 in the P3 loop of 
TatC may also be important in TatA-TatC interactions, though their substitution to Cys 
was tolerated by the Tat system.  
Finally it should be noted that it is not clear whether PMF dissipation causes TatA to 
leave the Tat complex altogether or whether is moves to a different part of the Tat 
complex that has yet to be identified.  
5.4.4 Linking the role of TatA to the TatA-TatC disulphide crosslinks observed in 
this Chapter  
This work has identified a TatA constitutive site at the TM6 of TatC in vivo (Section 
5.3.3). Interactions in this region require an intact PMF (Section 5.3.8 and 5.3.9) and 
were diminshed in response to overexpressed substrate (Section 5.3.6). This 
challenges previous dogma about the TatBC complex and the absence of 
constitutively-bound TatA based on purification experiments whereby no or very little 
TatA is found to co-purify with TatC (outlined in detail in Chapter 3, Section 3.3). 
Indeed, given that a significant amount of TatA was found to be associated with TatC in 
the resting state by crosslinking, it seems likely that TatA is a component part of the Tat 
complex in the absence of substrate binding, presumably before further TatA 
monomers are recruited to the activated Tat complex.  
TatA rearrangement in response to substrate binding has been characterised by Rose 
et al. (2013) and Alcock et al. (2013) where fluorescently labelled TatA was found to 
form florescent clusters thought to correspond to the TatA oligomer which facilitates 
translocation of Tat substrates. Aldridge et al. (2014) were able to identify Tha4 (TatA) 
interacting at cpTatC TM5 and TM4 in a substrate-enhanced manner and this work 
may have identified movement of TatA to the TM5 in the early stages of translocation 
162	
	 	 	
of substrate, with movement of TatA from its constitutive site at TM6, towards TM5 and 
the concave face of TatC. Both these movements preface the start of TatA 
oligomerisation step in Tat export of proteins. 
Two main models exist by which TatA polymerisation is mediated. As stated previously, 
work performed in plants suggests that the TatA transmembrane helix can occupy sites 
in the concave face of TatC upon substrate overexpression (Aldridge et al., 2014), and 
this could form a membrane disrupting oligomer at the centre of the Tat complex 
presented in Blummel et al. (2015) (See Chapter 1, Section 1.10.5). This is supported 
by in silico models proposing an interaction of E. coli TatA transmembrane helix with 
the concave face of TatC (Rollauer et al., 2012). Alternatively, TatA is proposed to form 
a separate ring-shaped oligomer on the outside of the TatBC complex which can vary 
in size depending on the size of the substrate to be translocated. This oligomer may 
have been characterised as a separate entity to the TatBC complex in detergent 
solution following purification (Sargent et al., 2001), using Electron paramagnetic 
resonance (EPR) (White et al., 2010) and electron microscopy (Gohlke et al., 2005), 
with molecular modelling based on the monomer structure (Rodriguez et al., 2013) 
(Chapter 1, Section 1.10.6). However, data in vivo is currently lacking, with 
fluorescence-based studies unable to determine whether fluorescently-labelled TatA 
formed oligomers inside or outside the TatBC complex (Alcock et al., 2013, Rose et al., 
2013). With regard to the crosslinking analysis in this work, the movement of TatA from 
TatC TM6 to TM5 could be compatible with either of these hypotheses. While the 
presumed direction of movement of TatA is towards the TatC concave face, this 
movement could also present the first step in TatA forming a separate oligomer, as 
further TatA monomers are perhaps recruited to form the membrane translocating 
oligomeric ring.  
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Chapter 6: TatA crosslinks to TatC are validated 
with low copy number expression, with TatA and 
TatB interactions observed in the presence of 
substrate 
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6.1 Introduction: 
6.1.1 TatA-TatC crosslinks identified from disulphide crosslinking of TatA to a 
Cys scanning region of TatC  
Chapters 4 and 5 were able to identify two proposed TatA interaction sites within TatC. 
Crosslinks between Cys-substituted residues in the TatA transmembrane helix, L9C 
and I11C, were found with TatC F213C in TM6, along with crosslinks to neighbouring 
V212C through TatA L10C and I11C (Chapter 4, Sections 4.3.3.1-4.3.3.3). Since the 
TatA L9C crosslink to TatC F213C is preserved in a resting Tat system, this suggests it 
is a constitutive interaction (Chapter 5, Section 5.3.5). Reduced interaction at this TatA 
constitutive site were also seen with overexpressed artificial Tat substrate (Chapter 5, 
Section 5.3.6), and interactions at the site were also shown to be PMF dependent 
(Chapter 5, Section 5.3.8). While the TatA L9C crosslink to TatC F213C was the most 
favourable observed in Cys scanning crosslinking of TatC in the presence of TatB, at 
this stage, the importance of weaker interactions through other residues in the TatA 
transmembrane helix with, TatC at this region, still remain to be deciphered. Cys 
substitutions in TatC at the proposed TatA constitutive site are shown in Fig. 6.1. 
Interactions were also observed at a separate site in TatC, between TatA L9C and 
I11C with TatC TM5 through M205C and L206C when TatB was absent, with TatA 
L10C also shown to interact with the latter TatC Cys substitution under the same 
conditions (Chapter 5, Sections 5.3.1-5.3.3). Additional experiments showed TatA L9C 
crosslinks to M205C in the presence of an overexpressed artificial Tat substrate when 
TatB was present (Chapter 5, Section 5.3.7). TatB has previously been proposed to 
interact with TatC TM5 (Rollauer et al., 2012, Kneuper et al., 2012, Blummel et al., 
2015) and this suggested a movement of TatA from its constitutive site to the TatB 
constitutive site during substrate transport, with TatA and TatB able to differentially 
occupy the same site at TatC TM5. Cys substitutions in TatC at the proposed TatA 
transport site are shown in Fig. 6.1. 
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6.1.2 Copy number and substrate overexpression in studying the Tat system 
In Chapters 4 and 5, disulphide crosslinking was performed using Cys-substituted 
proteins expressed from medium copy number plasmid constructs, producing protein 
amounts substantially higher than that found at native level. While this allows for clear 
mapping of subunit interactions because of ease of detection on Western blots, it may 
not reflect the situation with the Tat system in nature and such large amounts of 
protein, especially in the phospholipid bilayer, could present artefacts, such as aberrant 
protein associations, not seen with lower expression of Tat proteins. 
Indeed, it has been observed previously that the TatB substitution E8C could support 
an active Tat system when expressed from medium copy number vectors only, while at 
low copy number the system was not functional when scoring for Tat activity (Johann 
Habersetzer, unpublished). From this it is conceivable that these growth defects may 
reflect a difference in interactions between the subunits- i.e. TatB interactions with TatC 
may be impaired or abolished due to the E8C substitution, but with overexpressed 
subunits, the interaction may be restored to an extent, raising questions about the use 
of medium copy number vectors. 
Figure 6.1) Residues on TatC proposed to interact with TatA through two different sites- Structure 
of TatC shows residues in yellow, F213 and V212 are near the proposed TatA constitutive site, while 
M205 and L206 are shown at the proposed transport site. TM-transmembrane helix. AP- amphipathic 
helix.  
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In order to identify whether the TatA interactions with TatC observed with medium copy 
number expression in Chapter 4 and 5 are an accurate reflection of the state of the Tat 
system in nature, selected crosslinks (see Section 6.1.1) will be further examined in 
this Chapter with expression from a very low copy number vector, pTat101. This vector 
encodes the tatABC operon with the tat promoter, and has been shown to produce 
TatC four times in excess of native TatC, as determined by immunoblotting 
experiments (Kneuper et al., 2012). The residues chosen to examine at a low copy 
number in TatC and TatA are those presented in Section 6.1.1, Fig. 6.1. 
In addition to this, crosslinking performed in Chapter 5, Section 5.3.6 utilised GFP 
fused to a Tat signal sequence as an overexpressed Tat substrate. The substrate itself 
is not a native protein found in E. coli and in the experiments in this Chapter the 
overexpressed native Tat substrate, CueO, will be utilised.  
6.1.3 Identifying TatA-TatB interactions 
Results in Chapters 4 and 5 were able to identify TatA-TatC interactions in vivo which 
demonstrated that TatA interacts with two sites in close proximity. It is assumed that 
one of these sites is normally occupied by TatB. Given that the transmembrane helices 
of TatA and TatB are homologous (Chapter 1, Section 1.10.1) and each protein has a 
propensity to self-interact (Chapter 1, Sections 1.10.2 and 1.10.3), direct interactions 
between the two proteins may be expected at some points in the Tat transport cycle.  
Prior evidence would support this - for example TatB has been shown to co-purify with 
affinity-tagged TatA in trace amounts (Sargent et al., 2001). Blummel et al. (2015) also 
identified TatA-TatB crosslinks with a photo-reactive Bpa residue introduced into the 
flexible N-terminal region of TatB in E. coli inside-out inner membrane vesicles (INVs). 
Though these experiments suggest that TatB and TatA interact, it is difficult to derive 
information regarding residues near to each other in an attempt to map the interface 
between the two proteins.  
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This Chapter will analyse crosslinking between residues L9C, L10C and I11C in the TM 
of TatA with equivalent residues L9C, L10C and L11C in the TM of TatB with 
expression from low copy number vector, pTat101 (Fig. 6.2).  
 
 
 
 
 
 
 
 
 
 
	
	
	
6.2 Aims: 
The aim of the work in this chapter is to build upon the TatA-TatC interactions observed 
in vivo with medium copy number expression levels by repeating the experiments with 
protein expressed from low copy number vectors under conditions much closer to that 
found in nature. The interaction of Tat with the constitutive site at TatC TM6 will be 
examined, along with the accompanying movement of TatA from TatC TM6 to TM5, in 
response to the overexpression of a native Tat substrate. The PMF dependence of 
TatA interacting at TatC TM6 will also be probed with expression at a low copy number. 
Finally, potential sites of TatA-TatB interaction will be investigated.  
	
Figure 6.2) TatA and TatB residues which will be examined for interactions via disulphide 
crosslinking- TatB structure is shown in blue with residues L9C, L10C and I11C shown as sticks in the 
transmembrane helix, along with equivalent residues L9C, L10C and I11C in TatA (yellow). TM- 
transmembrane helix, AP- amphipathic helix. 
TM TM AP 
AP 
AP 
AP 
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Cys substitution   Cys substitution   
TatA  TatC  2% 
SDS 
M9/TMAO/
Glycerol 
TatA  TatB  2% 
SDS 
M9/TMAO/
Glycerol 
Wild type  
 
+ + L9C L9C + + 
Empty pTH19 
vector 
- - L9C L10C + + 
L9C M205C + + L9C L11C + + 
L9C L206C + + L10C L9C + + 
L9C V212C + + L10C L10C + + 
L9C F213C + + L10C L11C + + 
L10C M205C + + I11C L9C + + 
L10C L206C + + I11C L10C + + 
L10C V212C + + I11C L11C + + 
L10C F213C + + 
I11C M205C + + 
I11C L206C + + 
I11C V212C + + 
I11C F213C + + 
 
6.3 Results 
6.3.1 Cys substitutions used in this work do not abolish Tat activity 
In Chapter 4, Section 4.3.2, TatA and TatC Cys-substitutions were analysed to see 
whether they could support an active Tat translocase. Each of the substitutions yielded 
functional protein, however, as discussed above, the levels at which variant Tat 
proteins are produced can affect their activity. Therefore, the Tat-dependent growth 
assays performed in Chapter 4 were repeated for the Cys variants produced at low 
copy number. Table 6.1 shows that each of the constructs were able to support growth 
in the presence of 2% SDS and anaerobically on M9/TMAO minimal medium, 
indicating that they retained Tat function.  
 
	
	
	
 
Table 6.1) Cys substitutions in TatA, TatB and TatC do not abolish Tat activity- E. coli strain DADE 
(ΔtatABCD, ΔtatE) harbouring pTH19 only, or pTH19 encoding TatA, TatB and TatC with the indicated Cys 
substitutions was scored for growth by spotting 5 µL cells at OD600 0.01 onto LB-agar containing 2% SDS or 
M9-glycerol-TMAO. The LB-SDS plates were incubated aerobically and the M9-glycerol-TMAO plates 
anaerobically for 24 hours before analysis.  “+” denotes positive growth, “-“ denotes no growth. 	
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6.3.2 TatA maintains interactions at TatC TM6 with protein expression at a low 
copy number 
Chapter 4, Section 4.3.3.1 demonstrated that residue L9C in TatA could crosslink to 
TatC F213C, and weaker interactions were also observed through TatA L10C with 
TatC V212C and through TatA I11C with both TatC F213C and V212C (Chapter 4, 
Section 4.3.3.1 and 4.3.3.2). To validate these findings with low copy number protein 
expression, Cys substitutions in the TatA transmembrane helix L9C, L10C and I11C 
were crosslinked separately with TatC F213C and V212C. Cys substituted TatA and 
TatC proteins were encoded with wild type TatB on pTat101 vectors described in 
Section 6.1.2. To compensate for a reduced amount of protein using vectors with low 
copy number expression, 25 mL cultures of cells were used for crosslinking (as 
opposed to 2.5 mL with medium copy number expression). As in Chapter 4, cells were 
grown until OD600 0.3 and three separate aliquots were withdrawn and diluted by 
addition of an equivalent volume of fresh LB, one of which was treated with 1.8 mM 
copper phenanthroline and one with 10 mM DTT each for one minute, while the third 
aliquot was left untreated. Samples were subsequently incubated with N-
ethylmaleimide to cap all remaining free disulphides. Unlike crosslinking protocols with 
medium copy number protein expression, in which whole cell samples were loaded 
directly onto SDS-PAGE, for low copy expression, membrane fractions were isolated 
from cells after crosslinking occurred to enrich samples and obtain a better signal on 
Western blots. 
6.3.2.1 TatA L9C interacts with TatC F213C at TatC TM6 in vivo with expression 
from low copy number constructs 
Firstly, crosslinking of TatA L9C, L10C and I11C with TatC F213C in cells containing 
endogenous substrate was examined. Fig. 6.3A clearly demonstrates that on anti-TatC 
Western blots, a heterodimer band at ~37 kDa was detected for TatA L9C crosslinked 
through TatC F213C. As a band migrating ~37 kDa was not observed under control or 
reducing conditions, this indicates that it represents a disulphide link. A direct 
comparison of the relative intensity between the TatA-TatC heterodimer band linked 
170	
	 	 	
through TatA L9C with TatC F213C and TatC homodimer band linked through F213C, 
with medium copy number expression (Chapter 4, Fig 4.5A) and with low copy number 
expression in Fig 6.3A demonstrates that from low copy number vectors, the TatA-TatC 
crosslink is weaker than the TatC homodimer. This may be explained by a higher 
fraction of Tat translocases at low copy number interacting with endogenous substrates 
produced by the cell.  
With expression from medium copy number constructs a crosslink through TatA L10C 
to TatC F213C could not be detected (Chapter 4, Section 4.3.3.2), and this is also the 
case with low copy number expression in Fig 6.3A. Notably however, a crosslink 
through TatA I11C to TatC F213C which was weaker than that observed through TatA  
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B C 
Figure 6.3) TatA L9C interacts with F213C in vivo A- Anti-TatC Western blots performed on isolated 
membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pTat101 producing wild type 
TatB along with the indicated Cys substitutions in TatA and TatC, after exposure to experimental conditions 
in vivo noted by “C”-corresponding to control cells which were untreated, “O”- cells were oxidised with 1.8 
mM copper phenanthroline for 1 min and “R”- cells were treated with 10 mM of the reductant DTT for 1 min. 
The positions of the TatC monomer, TatC dimer and TatAC heterodimer are indicated. B- Anti-TatA 
Western blots of samples from “O” and “R” from A. Loading volume in each case was 5 µL. C- denotes 
positions of Cys substitutions in TatC examined in this experiment. 
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L9C to TatC F213C (Chapter 4, Section 4.3.3.3) could not be detected with low copy 
number expression in Fig. 6.3A, suggesting that the interaction is either too weak to be 
detected, or is artefactual due to the high levels of protein from medium copy number 
vectors. 
TatC homodimerisation through F213C was present with all three Cys substitutions in 
TatA in Fig 6.3A, with a population present in all control, oxidised and reduced samples 
(with the exception of the reduced lane of TatA L9C crosslinked to TatC F213C). This 
self-interaction indicates the favourability of this disulphide linkage as seen throughout 
Chapter 4, when expressed from medium copy number constructs, which is 
unsurprising given the proximity of F213 to the oxidising periplasm (Section 6.1.1, Fig. 
6.1).  
Fig 6.3B shows that the TatA-TatC heterodimer linking TatA L9C and TatC F213C 
could not be detected with anti-TatA antibodies (TatA is in great excess of TatC, 
meaning subpopulations associated with TatC are much more difficult to detect as 
discussed in Chapter 4). Given that the band on anti-TatA Western blots denoting a 
TatA-TatC interaction linked through TatA L9C and TatC F213C at ~37 kDa can be 
seen weakly relative to the corresponding anti-TatC Western blots with expression at a 
medium copy number (Chapter, Section 4.3.3.1, Fig 4.5D), it is likely the absence of 
the band with low copy number expression is due to the sensitivity of the Western 
blotting method. It is notable that TatA homodimer bands were more intense with TatA 
self-crosslinks through TatA L9C and I11C, when compared to TatA L10C. A similar 
result was obtained with medium copy number expression (Chapter 4, Sections 
4.3.3.1-4.3.3.3) and is in line with TatA crosslinks in vitro in Greene et al. (2007), who 
found more favourable TatA homodimer formation through L9C than L10C under 
oxidising conditions.  
It should be noted that a band in the oxidised fractions on anti-TatA Western blots 
migrating at a higher molecular weight than the TatA-TatC heterodimer was observed 
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with medium copy number expression of the Tat proteins, and was proposed to be a 
TatA oligomer conserved on SDS PAGE (Chapter 4, Section 4.3.3.1). This was not 
detected at low copy number expression. 
6.3.2.2 No crosslinks are observed through TatA L9C, L10C or I11C to TatC 
V212C in vivo with expression from low copy number constructs 
In Chapter 4, weak crosslinks between Cys residues at L10 and I11 in the TatA 
transmembrane helix with TatC V212C were seen. At low copy number expression, no 
detectable interaction between TatA L10C and TatC V212C was observed (Fig. 6.4A).  
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
 
 
A 
B C 
Figure 6.4) TatA L9C, L10 and I11 do not  interact with V212C in vivo- A- Anti-TatC Western blots 
performed on isolated membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring 
pTat101 producing wild type TatB along with the indicated Cys substitutions in TatA and TatC, after 
exposure to experimental conditions in vivo noted by “C”-corresponding to control cells which were 
untreated, “O”- cells were oxidised with 1.8 mM copper phenanthroline for 1 min and “R”- cells were 
treated with 10 mM of the reductant DTT for 1 min. The positions of the TatC monomer, TatC dimer and 
TatAC heterodimer are indicated. B- Anti-TatA Western blots of samples from “O” and “R” from A. 
Loading volume in each case was 5 µL. C- denotes positions of Cys substitutions in TatC examined in 
this experiment. 
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Likewise, no crosslink between TatA I11C to TatC V212C was detected Fig. 6.4A. As 
expected, no TatA-TatC crosslink was detected through TatA L9C and TatC V212C, in 
agreement with the lack of crosslinking at these residues for medium copy number 
expression. No TatA-TatC heterodimer band at ~37 kDa was detected on the 
corresponding anti-TatA Western blots in Fig. 6.4B. It can be concluded that TatA-TatC 
interactions previously detected at the extreme C-terminal region of the P3 loop are 
either weak or artefactual due to high copy number expression.  
6.3.3 TatA L9, L10 and I11 do not associate with M205C or L206C in TatC TM5 in 
vivo at low copy number expression 
It was seen in Chapter 4 that no TatA-TatC crosslinks were detected between the 
transmembrane helix of TatA and TM5 of TatC when TatB was present. These 
previous findings are fully supported at low copy number expression level as Figs. 6.5 
and 6.6 show no detectable crosslink between any of TatA L9C, L10C and I11C with 
TatC M205C or L206C in either the anti-TatC or the anti-TatA blots. It is interesting to 
note that TatC homodimers linked though M205C were detected in all conditions in 
anti-TatC formation through TatC M205C under similar conditions in vivo with wild type 
TatA was not seen. It cannot be ruled out that the NEM capping of free Cys residues 
was not complete, leaving TatC M205C free to self-crosslink, especially if TatA is lost 
from the complex Western blots in Fig. 6.5A yet Cleon et al. (2015) reported that 
homodimer during the membrane preparation stage (note that Chapter 5, Section 5.3.8 
and 5.3.9 demonstrated no TatA crosslinking at TM5 or TM6 of TatC after PMF 
dissipation with indole). Given that the homodimer can be seen under reducing 
conditions this crosslink may form after DTT is removed in the cell fractionation step.  
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Homodimerisation through TatC L206C is either not present or very weak (Fig. 6.6A) 
and may reveal that this residue is in less of a position to associate with equivalent 
residues in other TatC subunits, perhaps indicating an interaction with another 
component. 
 
 
Figure 6.5) TatA L9C, L10 and I11 do not  interact with M205C in vivo- A- Anti-TatC Western blots 
performed on isolated membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pTat101 
producing wild type TatB along with the indicated Cys substitutions in TatA and TatC, after exposure to 
experimental conditions in vivo noted by “C”-corresponding to control cells which were untreated, “O”- cells 
were oxidised with 1.8 mM copper phenanthroline for 1 min and “R”- cells were treated with 10 mM of the 
reductant DTT for 1 min. The positions of the TatC monomer, TatC dimer and TatAC heterodimer are 
indicated. B- Anti-TatA Western blots of samples from “O” and “R” from A. Loading volume in each case 
was 5 µL. C- denotes positions of Cys substitutions in TatC examined in this experiment. 
A 
B C 
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6.3.4 TatA interacts constitutively with TatC TM6 with low copy number 
expression 
Work in Chapter 5 demonstrated that the Cys crosslink between TatA L9C and TatC 
F213C at the periplasmic facing part of TM6 was maintained when TatC was unable to 
bind substrate, i.e. when the Tat system was in the resting state (Chapter 5, Section 
5.3.5). Using the formation of this crosslink in the Tat resting state as a diagnosis for 
constitutive TatA interactions, the following section will examine whether the same 
A 
B C 
Figure 6.6) TatA L9C, L10 and I11 do not  interact with L206C in vivo- A- Anti-TatC Western blots 
performed on isolated membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring 
pTat101 producing wild type TatB along with the indicated Cys substitutions in TatA and TatC, after 
exposure to experimental conditions in vivo noted by “C”-corresponding to control cells which were 
untreated, “O”- cells were oxidised with 1.8 mM copper phenanthroline for 1 min and “R”- cells were 
treated with 10 mM of the reductant DTT for 1 min. The positions of the TatC monomer, TatC dimer and 
TatAC heterodimer are indicated. B- Anti-TatA Western blots of samples from “O” and “R” from A. 
Loading volume in each case was 5 µL. C- denotes positions of Cys substitutions in TatC examined in 
this experiment. 
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behaviour is seen at low copy number protein expression. Furthermore, interactions 
between TatA and TatC TM5 in the resting state will be also examined, where 
crosslinking at with medium copy number expression found no interaction (Chapter 5, 
Section 5.3.5). 
6.3.4.1 TatA L9C crosslinks TatC F213C the TM6 in the resting state in vivo 
To examine constitutive interactions in the Tat translocase, the mutations F94A and 
E103A were introduced into TatC to prevent substrate binding (as outlined in Chapter 
5, Section 5.3.5). Crosslinking analysis of TatA L9C to TatC F213C at the proposed 
TatA constitutive site (Fig. 6.7) demonstrates a clear band migrating at ~37 kDa 
corresponding to a TatA-TatC heterodimer which was not present under control or 
reduced conditions and which is detectable on anti-TatC and, faintly, on anti-TatA 
Western blots. This is in full agreement with observations made with medium copy 
number expression (Chapter 5, Section 5.3.5).  
Comparison of anti-TatC Western blots in Fig 6.3A with Fig 6.7 demonstrates that the 
ratio of TatA-TatC heterodimer and TatC-TatC homodimer changes to favour TatA-
TatC interactions in the resting state (as opposed to Tat systems able to bind 
endogenous substrate) further showing that TatA movement away from its constitutive 
site and increasing TatC homodimerisation is influenced by substrate. It is also notable 
that the higher molecular weight band on anti-TatA Western blots, migrating above the 
TatA-TatC heterodimer (thought to correspond to TatA oligomers, Chapter 4, Section 
4.3.3.1), was present, while it was either absent or extremely weak when crosslinking 
without the TatC F94A/E103A substitutions (Chapter 4, Section, 4.3.3.1-4.3.3.3 and 
Sections 6.3.2.1-6.3.2.2). 
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6.3.4.2 TatA L9C does not crosslink TatC M205C in TM5 in vivo in the resting 
state 
Chapter 5, Section 5.3.5 demonstrated that TatA L9C could not crosslink TatC M205C 
also harbouring the F94A/E103A substitutions at medium copy number expression, 
indicating that TatA was unlikely to occupy the TatB constitutive site at TM5 in the 
resting state. Unsurprisingly, no interactions were observed with very low copy number 
expression when TatA L9C was oxidised alongside TatC M205C, with no bands 
corresponding to the size of a TatA-TatC heterodimer on anti-TatC or anti-TatA 
Western blots (Fig 6.8). As expected no TatC homodimers could be detected that 
formed through M205C the resting state, further confirming that homodimersation 
observed in Section 6.3.3 is likely due to endogenous substrate.  
 
 
Figure  6.7) TatA L9C crosslinks with TatC F94A, E103A, F213C when expressed from low copy 
number vectors – A and B show anti-TatC/anti-TatA Western blots (as indicated) of isolated membrane 
fractions E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pTat101 expressing wild type TatB, TatA L9C 
and TatC F213C with the F94A and E103A substitutions. Prior to membrane fractionation, cells were O- 
oxidised with 1.8 mM copper phenanthroline, C- untreated or R- treated with 10 mM of the reductant DTT 
for 1 min. Loading volume in each case was 5 µL. 
A B 
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6.3.5 TatA vacates its constitutive site at TatC TM6 and moves to TM5 at low 
copy number expression in the presence of overexpressed substrate 
The work in Chapter 5, Section 5.3.6, found that the crosslink between TatA L9C and 
TatC F213C decreased in intensity on anti-TatC Western blots in response to substrate 
overexpression, indicating that TatA may be vacating this site. This was accompanied 
by an increase in TatA-TatC heterodimer intensity through TatA L9C crosslinked to 
TatC M205C at TM5 with overexpressed substrate, indicating a potential movement of 
TatA to occupy the TatB constitutive site. In those experiments, the Tat proteins were 
expressed from medium copy number vectors, and the substrate used was an artificial 
Tat substrate comprising GFP fused to the TorA signal sequence.  
To validate these findings, low copy number expression of Tat proteins was used, 
alongside an overexpressed native Tat substrate. The substrate chosen was CueO, a 
multi-copper oxidase, which has been utilised previously in fluorescence microscopy 
experiments where TatA was found to form fluorescent clusters when it was 
Figure 6.8) TatA L9C does not crosslink with TatC F94A, E103A, F213C at low copy number 
expression- A and B show anti-TatC/anti-TatA Western blots (as indicated) of isolated membrane 
fractions E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pTat101 expressing wild type TatB, TatA L9C 
and TatC M205C with the F94A and E103A substitutions. Cells were O- oxidised with 1.8 mM copper 
phenanthroline, C- untreated or R- treated with 10 mM of the reductant DTT for 1 min. Loading volume in 
each case was 5 µL. 
A B 
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overexpressed (Alcock et al., 2013), and in disulphide crosslinking experiments (Cleon 
et al., 2015). Crosslinking was performed as before using residues L9C, L10C and 
I11C in the transmembrane helix of TatA and each of; TatC F213C at TM6 to analyse 
potential constitutive TatA-TatC interactions, and TatC M205C to analyse interactions 
at the TatB constitutive site, each in the presence of overproduced His-tagged CueO 
(CueOH). For CueO expression, 1 mM IPTG was included during growth of cells and in 
vivo crosslinking was performed as in Section 6.3.2.1. 
6.3.5.1 TatA L9C crosslinks to TatC F213C at TatC TM6 are greatly decreased 
with low copy number protein expression and overexpressed substrate 
Fig. 6.9A demonstrates that when Tat substrate CueOH was overexpressed, the 
heterodimeric crosslink between TatA L9C and TatC F213C was extremely faint on the 
anti-TatC Western blots, accompanied by a large increase in the amount of TatC 
homodimer (compare Fig 6.9 with Figs. 6.3 and 6.7). With medium copy number 
expression in Chapter 5, TatA L10C and I11C crosslinks with F213C were not tested 
with overexpressed substrate, however, Fig. 6.9A demonstrates that with low copy 
number expression of Tat proteins and overexpressed CueOH, TatA-TatC 
heterodimers were not detected, though increased TatC homodimerisation was 
observed compared to conditions with endogenous substrate (Sections 6.3.2.2 and 
6.3.2.3). Corresponding anti-TatA Western blots in Fig 6.9B demonstrate TatA 
homodimerisation was similar to that seen without overexpressed CueOH (Fig. 6.3B), 
with favourable homodimer interactions through TatA L9C and I11C and no TatA-TatC 
heterodimer band at ~37 kDa present, as expected.   
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Anti-His Western blots (Fig. 6.9A, bottom panel) demonstrate that the signal sequence 
of CueOH (~3 kDa) was cleaved successfully, with the precursor and mature forms of 
the protein present. A clear band migrating at a lower molecular weight than both the 
precursor and mature forms of CueOH was found under oxidising conditions. This band 
was observed previously by Cleon et al. (2015) and is thought to result from an intra-
disulphide link in the protein changing its migration pattern on SDS-PAGE. 
These data support observations in Chapter 5, where overexpression of TorA-GFP 
Figure 6.9) TatA L9C, L10 and I11 do not  interact with F213C in vivo with overexpressed CueOH - 
A- Anti-TatC Western blots performed on isolated membrane fractions from E. coli strain DADE 
(ΔtatABCD, ΔtatE) harbouring pTat101 producing wild type TatB along with the indicated Cys 
substitutions in TatA and TatC alongside His-Tagged CueO produced from pQE80 after exposure to 
experimental conditions in vivo noted by “C”-corresponding to control cells which were untreated, “O”- 
cells were oxidised with 1.8 mM copper phenanthroline for 1 min and “R”- cells were treated with 10 mM 
of the reductant DTT for 1 min. The positions of the TatC monomer, TatC dimer and TatAC heterodimer 
are indicated. Anti-His Western blots are shown corresponding to the soluble fraction following the 
membrane fractionation of each sample, showing “p” precursor and “m” mature forms of CueOH. B- 
Anti-TatA Western blots of samples from “O” and “R” from A. Loading volume in each case was 5 µL. C- 
denotes positions of Cys substitutions in TatC examined in this experiment. 
A 
B C 
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caused a similar decrease in interaction through TatA L9C and TatC F213C. 
6.3.5.2 TatA L9C, L10C and I11C do not crosslink TatC V212C with low copy 
number in the presence of overexpressed substrate 
Crosslinking of Cys residues in the TatA TM with TatC V212C at the C-terminal end of 
the P3 loop was not tested using medium copy number constructs in the presence of 
overexpressed substrate in Chapter 5, however TatA L10C and I11C were both found 
to crosslink this position TatC with endogenous substrate in Chapter 4, Sections 
4.3.3.2 and 4.3.3.3. Fig 6.10A and B demonstrates that at low copy number 
expression, none of TatA L9C, L10C and I11C crosslinked with TatC V212C. TatC 
homodimerisation was clear with constructs expressing all three TatA Cys substitutions 
(Fig. 6.10A) indicating a propensity to homodimerise through V212C as was seen in 
Chapter 4, Sections 4.3.3.2-4.3.3.3. Again anti-His Western blots in Fig. 6.10A is 
indicative of CueO transport to the periplasm. 
6.3.5.3 TatA crosslinks through L9C, L10C and I11C to M205C appear at low copy 
number in the presence of overexpressed substrate 
Chapter 5, Section 5.3.7.3 demonstrated that TatA L9C - TatC M205C crosslinks 
appeared in response to overexpressed Tat substrate. From this, it was proposed that 
TatA was moving from its constitutive site to occupy the TatB constitutive site, 
presumably once TatB has moved, in response to Tat substrate overexpression. To 
confirm this interaction with low copy number expression of the Tat subunits and with a 
native Tat substrate, TatA L9C, L10C and I11C were crosslinked to TatC M205C with 
overexpressed CueOH as in Section 6.3.5.1. As clearly demonstrated in Fig 6.11A 
TatA-TatC interactions were detected in the presence of overexpressed CueOH 
through TatA L9C and I11C with TatC M205C, along with a weaker association through 
TatA L10C with a TatA-TatC heterodimer appearing at ~37 kDa under oxidising 
conditions. TatC homodimerisation was also notably increased through M205C with 
overexpressed CueOH (compare Fig. 6.5 with Fig. 6.11) as was observed by Cleon et 
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al. (2015) and in Chapter 5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
demonstrate that a proportion of the CueOH had its signal sequence cleaved,  
The corresponding TatA-TatC heterodimer band at ~37 kDa was not detected on anti-
TatA Western blots in Fig 6.11B, which may be due to the sensitivity of the Western 
blotting method, as was found in Section 6.3.2.1 where the TatA-TatC heterodimer 
linked through TatA L9C and TatC F2123C could be detected on anti-TatC but not anti-
TatA  
Figure 6.10) TatA L9C, L10 and I11 do not  interact with V212C in vivo with overexpressed CueOH - 
A- Anti-TatC Western blots performed on isolated membrane fractions from E. coli strain DADE 
(ΔtatABCD, ΔtatE) harbouring pTat101 producing wild type TatB along with the indicated Cys 
substitutions in TatA and TatC alongside His-Tagged CueO produced from pQE80, after exposure to 
experimental conditions in vivo noted by “C”-corresponding to control cells which were untreated, “O”- 
cells were oxidised with 1.8 mM copper phenanthroline for 1 min and “R”- cells were treated with 10 mM 
of the reductant DTT for 1 min. The positions of the TatC monomer, TatC dimer and TatAC heterodimer 
are indicated. Anti-His Western blots are shown corresponding to the soluble fraction following the 
membrane fractionation of each sample, showing “p” precursor and “m” mature forms of CueOH. B- Anti-
TatA Western blots of samples from “O” and “R” from A. Loading volume in each case was 5 µL. C- 
denotes positions of Cys substitutions in TatC examined in this experiment.  
A 
B 
C 
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Western blots. Anti-His Western blots (Fig. 6.11A) demonstrated the presence of 
precursor and mature forms of CueOH. 
The observations in this Section combined with data showing reduced crosslink 
intensity through TatA L9C and TatC F213C with overexpressed CueOH at the TM6 in 
Section 6.3.7.1, clearly demonstrates that at a low copy number with overexpressed 
substrate TatA may be moving from its constitutive site at TM6 to the TatB constitutive 
Figure 6.11) TatA L9C and I11 interact favourably with TatC M205C while TatA L10C interacts 
weakly in vivo with overexpressed CueOH- A- Anti-TatC Western blots performed on isolated 
membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pTat101 producing wild 
type TatB along with the indicated Cys substitutions in TatA and TatC alongside His-Tagged CueO 
produced from pQE80, after exposure to experimental conditions in vivo noted by “C”-corresponding to 
control cells which were untreated, “O”- cells were oxidised with 1.8 mM copper phenanthroline for 1 
min and “R”- cells were treated with 10 mM of the reductant DTT for 1 min. The positions of the TatC 
monomer, TatC dimer and TatAC heterodimer are indicated. Anti-His Western blots are shown 
corresponding to the soluble fraction following the membrane fractionation of each sample, showing “p” 
precursor and “m” mature forms of CueOH (His-tagged CueO)  B- Anti-TatA Western blots of samples 
from “O” and “R” from A. Loading volume in each case was 5 µL. C- denotes positions of Cys 
substitutions in TatC examined in this experiment. 
A 
B C 
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site at TM5. Interestingly the crosslinking pattern between TatA L9C, L10C and I11C 
and TatC M205C is similar to that observed for disulphide crosslinking experiments 
with the equivalent conserved residues in TatB (L9, L10 and L11) crosslinking TatC 
M205C in vitro in Rollauer et al. (2012) suggesting it is differentially occupying the 
same site as TatB at TatC TM5. 
6.3.5.4 TatA does not crosslink through L9C, L10C or I11C to L206C with low 
copy number expression and overexpressed substrate 
Interactions between TatA L9C, L10C and I11C and TatC L206C were seen only when 
TatB was removed from the system and with medium copy number expression of the 
Tat proteins (Chapter 5, Sections 5.3.1-5.3.3). However TatA interactions were not 
tested at this position in TatC in the presence of overexpressed substrate, and given 
that Section 6.3.5.3 demonstrated TatA interactions with neighbouring TatC M205C in 
the presence of overexpressed substrate, it is conceivable that interaction may appear 
here under the same conditions.  
Fig. 6.12 demonstrates that TatA L9C, L10C and I11C did not form detectable 
heterodimers with TatC L206C, indicating that TatA is not interacting here at low copy 
number expression and in the presence of overexpressed substrate. TatC 
homodimerisation through L206C (Fig. 6.12A) was weak compared to 
homodimerisation through M205C (Fig. 6.11), similar to observations at medium copy 
number expression in Chapter 4, and may allude to the presence of an interaction site 
which does not involve TatA or another TatC, which will be discussed further in Section 
6.4.2. Multiple bands are present above the TatC homodimer on anti-TatC Western 
blots in Fig. 6.12A, especially in the presence of TatA I11C, which cannot be assigned. 
It is plausible that these correspond to non-specific interactions or perhaps different 
conformations of TatC.  
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6.3.6 TatA vacates its constitutive binding site on TatC in response to PMF 
dissipation with indole with expression from low copy number vectors 
Chapter 5, Section 5.3.8 previously demonstrated that with expression from medium 
copy number vectors, TatA may occupy its constitutive site at TatC TM6 in a PMF-
dependent manner, as the TatA L9C crosslink to TatC F213C found in vivo, denoting 
interactions at the TatA constitutive site, was greatly diminished upon incubation with 5 
mM of the uncoupler indole. TatA was also not found at TatC TM5 with dissipated 
Figure 6.12) TatA L9C, L10 and I11 do not  interact with TatCL206C in vivo with overexpressed 
CueOH- A- Anti-TatC Western blots performed on isolated membrane fractions from E. coli strain DADE 
(ΔtatABCD, ΔtatE) harbouring pTat101 producing wild type TatB along with the indicated Cys substitutions 
in TatA and TatC alongside His-Tagged CueO produced from pQE80, after exposure to experimental 
conditions in vivo noted by “C”-corresponding to control cells which were untreated, “O”- cells were 
oxidised with 1.8 mM copper phenanthroline for 1 min and “R”- cells were treated with 10 mM of the 
reductant DTT for 1 min. The positions of the TatC monomer, TatC dimer and TatAC heterodimer are 
indicated. Anti-His Western blots are shown corresponding to the soluble fraction following the membrane 
fractionation of each sample, showing “p” precurson and “m” mature forms of CueOH (His-tagged CueO)  
B- Anti-TatA Western blots of samples from “O” and “R” in A- to detect corresponding TatA-TatC 
heterodimer band at 37 kDa. Loading volume in each case was 5 µL. C- denotes positions of Cys 
substitutions in TatC examined in this experiment. 
A 
B C 
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PMF,and it was therefore speculated to either change its interaction within the Tat 
complex or leave the Tat complex completely.  
6.3.6.1 The TatA L9C crosslink to TatC F213C at TM6 is greatly diminished after 
PMF dissipation in vivo 
Fig. 6.13 shows experiments similar to those performed with high copy number 
expression in Chapter 5, Section 5.3.8 with indole incubation, however here the Tat 
proteins are expressed at a low copy number as in Section 6.3.2.1. It can be seen on 
anti-TatC Western blots in Fig. 6.13A that the TatA-TatC heterodimer linked through 
TatA L9C and TatC F213C was present under oxidising conditions only, as was seen in 
Fig. 6.13A. 
Upon PMF dissipation in the cells using 5 mM indole, the heterodimer was not seen 
after oxidation, as observed with medium copy number expression in Chapter 5. At 
medium copy expression this was accompanied by an increase in the amount of TatC 
homodimer (Section 5.3.8) and a similar pattern was also seen in Fig 6.13A. As 
expected, the TatA-TatC heterodimer band was restored after washing away the indole 
prior to oxidising. No corresponding heterodimer was observed on the anti-TatA 
Western blots with any of the conditions analysed (Fig. 6.13B), probably due to 
sensitivity issues.  
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6.3.6.2 TatA L9C does not crosslink TatC M205C after PMF dissipation in vivo 
With expression from medium copy number constructs, TatA L9C did not crosslink with 
TatC M205C in vivo after PMF dissipation (Chapter 5, Section 5.3.8). At low copy 
number expression, no TatA L9C-TatC M205C heterodimer was detected, regardless 
of whether indole was present (Fig. 6.14). In the experiment in Fig 6.14A it was seen 
that the TatC homodimer appeared as a double band, in the presence of indole. This 
type of behaviour was not seen with TatC on other Western blots with indole incubation 
(e.g.  Fig. 6.13) and it is difficult to determine whether it is merely a non-specific band 
or a manifestation of TatC behaviour. 
Figure 6.13) TatA vacates its constitutive site at TatC TM6 in response to PMF dissipation with 5 
mM indole- A Anti-TatC or B- Anti-TatA Western blot of isolated membrane fractions from E. coli strain 
DADE (ΔtatABCD, ΔtatE) harbouring pTat101  expressing wild type TatB and Cys-substituted TatA L9C 
and TatC F213C. Cells, prior to isolation of the membrane fractions, were either untreated, oxidised with 
1.8 mM copper phenanthroline for 1 min or incubated with 5 mM indole for 5 mins, followed by either a 1 
min oxidation step or washed thoroughly to remove the indole followed by a 1 min oxidation step. Loading 
volume in each case was 5 µL. 
A 
B 
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TatB L9C under oxidising conditions, no TatA-TatB heterodimer was observed, which  
6.3.7 Assessing TatA-TatB interactions by disulphide crosslinking in vivo  
As discussed in Section 6.1.3, to assess whether crosslinks could be detected between 
the transmembrane helices of TatA and TatB, crosslinking reactions were carried out 
using substitutions L9C, L10C and I11C in the TM of TatA with equivalent residues 
L9C, L10C and L11C in the TM of TatB as described in Sections 6.3.2.1, except in this 
case Western blot analysis used antibodies raised against TatA and TatB to identify 
potential heterodimer formation.  
 
Figure 6.14) TatA does not interact with TatC TM5 in response to PMF dissipation with 5 mM 
indole- A Anti-TatC or B- Anti-TatA Western blot of isolated membrane fractions from E. coli strain DADE 
(ΔtatABCD, ΔtatE) harbouring pTat101 expressing wild type TatB and Cys-substituted TatA L9C and TatC 
M205C. Cells, prior to isolation of the membrane fractions, were either untreated, oxidised with 1.8 mM 
copper phenanthroline for 1 min or incubated with 5 mM indole for 5 mins, followed by either a 1 min 
oxidation step or washed thoroughly to remove the indole followed by a 1 min oxidation step. Loading 
volume in each case was 5 µL. 
A 
B 
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6.3.7.1 TatA L9C does not crosslink to TatB L9C, L10C or L11C in vivo with 
endogenous substrate levels 
Examining anti-TatB Western blots in Fig. 6.15A, when TatA L9C is present alongside 
it would be expected to migrate just above 37 kDa (an estimation based on the 
combined apparent molecular weight of the monomers on SDS-PAGE). This is also the 
case when TatA L9C was present alongside TatB L10C or I11C in Fig. 6.15A. 
 
 
 
 
 
 
 
 
 
 
	
	
	
	
	
	
Faint TatB homodimer bands were seen under oxidising conditions at ~50 kDa through 
all Cys substitutions tested in TatB. This is consistent with observations in Lee et al. 
Figure 6.15) TatA L9C does not interact with TatB L9C, L10C or L11C in vivo with endogenous 
substrate– A- Anti-TatB Western blots performed on isolated membrane fractions from E. coli strain 
DADE (ΔtatABCD, ΔtatE) harbouring pTat101 producing Cysless TatC along with the indicated Cys 
substitutions in TatA and TatB, after exposure to experimental conditions in vivo noted by “C”-
corresponding to control cells which were untreated, “O”- cells were oxidised with 1.8 mM copper 
phenanthroline for 1 min and “R”- cells were treated with 10 mM of the reductant DTT for 1 min. The 
positions of the TatB monomer and TatB homodimer are indicated. B- Anti-TatA Western blots of samples 
from “O” and “R” in A. Loading volume in each case was 5 µL. C- denotes positions of Cys substitutions in 
TatA and TatB examined in this experiment. 
	
B C 
A 
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(2006), whereby in vitro disulphide crosslinking of TatB gave homodimers through all 
three of these Cys substitutions. A double band was detected for the TatB monomer, 
with an upper fainter band that seems more prominent in untreated and reducing 
conditions and may reflect different conformations of TatB in vivo. As expected, TatA 
homodimers were detected under oxidising conditions for all samples (Fig 6.15B).  
6.3.7.2 TatA L10C does not crosslink to TatB L9C, L10C or L11C in vivo with 
endogenous substrate levels 
TatA L10C has been consistently shown to self-interact at a much lower level than 
TatA L9C and I11C and has demonstrated no interactions with TatC at any Cys 
positions examined at low copy number expression (Sections 6.3.2.1-6.3.2.2 and 6.3.3) 
and this may leave TatA L10C free to interact with TatB. However, anti-TatB Western 
blots in Fig. 6.16A show that no TatA-TatB heterodimer was detected through TatA 
L10C with any of the three Cys substitutions in TatB. TatB homodimers were detected, 
similar those seen in Fig 6.15A. Unsurprisingly, anti-TatA Western blots demonstrated 
no TatA-TatB crosslink band with only weak TatA homodimerisation (compared to TatA 
L9C).  
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Figure 6.16) TatA L10C does not  interact with TatB L9C, L10C or L11C in vivo with endogenous 
substrate–A-  Anti-TatB Western blots performed on isolated membrane fractions from E. coli strain 
DADE (ΔtatABCD, ΔtatE) harbouring pTat101 producing Cysless TatC along with the indicated Cys 
substitutions in TatA and TatB, after exposure to experimental conditions in vivo noted by “C”-
corresponding to control cells which were untreated, “O”- cells were oxidised with 1.8 mM copper 
phenanthroline for 1 min and “R”- cells were treated with 10 mM of the reductant DTT for 1 min. The 
positions of the TatB monomer and TatB homodimer are indicated. B- Anti-TatA Western blots of 
samples from “O” and “R” in A. Loading volume in each case was 5 µL. C- denotes positions of Cys 
substitutions in TatA and TatB examined in this experiment. 
A 
B C 
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6.3.7.3 TatA I11C does not crosslink to TatB L9C, L10C or L11C in vivo with 
endogenous substrate levels 
Given that TatA I11C did not interact with TatC at endogenous substrate levels, it was 
another potential interaction candidate for TatB. TatA I11C was examined for its ability 
to crosslink with the three consecutive Cys substitutions in TatB, however no TatA-
TatB heterodimer was observed on anti-TatB Western blots (Fig 6.17A). TatB 
homodimerisation was similar to that observed in Figs 6.15 and 6.16 with a 50 kDa 
band forming with each TatB Cys substitution under oxidising conditions only. Anti-
TatA alongside favourable TatA homodimerisation through I11C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
Figure 6.17) TatA I11C does not  interact with TatB L9C, L10C or L11C in vivo with 
endogenous substrate–A- Anti-TatB Western blots performed on isolated membrane fractions from 
E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pTat101 producing Cysless TatC along with the 
indicated Cys substitutions in TatA and TatB, after exposure to experimental conditions in vivo noted 
by “C”-corresponding to control cells which were untreated, “O”- cells were oxidised with 1.8 mM 
copper phenanthroline for 1 min and “R”- cells were treated with 10 mM of the reductant DTT for 1 
min. The positions of the TatB monomer and TatB homodimer are indicated. B- Anti-TatA Western 
blots of samples from “O” and “R” in A. Loading volume in each case was 5 µL. C- denotes positions 
of Cys substitutions in TatA and TatB examined in this experiment. 
A 
B C 
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Western blots shown in Fig 6.17B also demonstrated a lack of TatA-TatB crosslinks  
6.3.7.4 Summary of TatA-TatB crosslinks in vivo with low copy number 
expression and endogenous substrate 
Based on the lack of TatA-TatB crosslinks in Section 6.3.7.1-6.3.7.3, it seems very 
unlikely that TatA and TatB are interacting at any significant level in the presence 
endogenous substrate. While it is feasible that the two proteins could be associated 
through residues at different heights to those tested in each transmembrane helix, or 
perhaps through the flexible N-terminal region or the amphipathic helices, it is also 
plausible that TatA and TatB can occupy TM6 and TM5 on TatC without being in 
contact with each other.  
6.3.8 TatA-TatB interactions are observed in vivo with overexpressed substrate 
To examine whether interactions between TatA and TatB appear at different stages of 
the Tat cycle, the crosslinking experiments described in Section 6.3.7.1-6.3.7.3 were 
repeated in the presence of overexpressed substrate CueOH. 
6.3.8.1 TatA L9C crosslinks TatB L11C in vivo with overexpressed CueOH 
substrate 
When crosslinking experiments from Section 6.3.7.1, Fig 6.15 were repeated in the 
presence of overexpressed CueOH, anti-TatB Western blots revealed no TatA-TatB 
heterodimerisation through TatA L9C with TatB L9C or L10C (Fig 6.18A). However, a 
distinct heterodimer band was detected, migrating just above 37 kDa, when TatA L9C 
was present with TatB L11C, suggesting that the presence of substrate brings TatB 
and TatA into close proximity. TatB homodimerisation was more pronounced through 
TatB L9C and L11C, in line with observations in vitro made Lee et al. (2006), whereby 
TatB L10C formed weaker self-crosslinks than TatB L9 or L11C. Interestingly there 
seems to be a lack of any TatB L10C homodimersation at all in Fig. 6.18 while in Fig. 
6.16, without overexpressed substrate, it was present. However it is unclear whether 
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substrate overexpression decreases TatB homodimerisation through TatB L10C 
without a direct comparison between the two conditions using for Western blotting.  
The corresponding TatA-TatB heterodimer band was not detected on anti-TatA 
Western blots (Fig. 6.18B), which may not be surprising given that the limit-of-detection 
of this Western blotting protocol did not allow the detection of TatA-TatC heterodimers 
on anti-TatA Western blots when proteins were expressed at a low copy number in 
Sections 6.3.2.1 and 6.3.5.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.18) TatA L9C interacts with TatB L11C  in vivo with overexpressed substrate - A- Anti-TatB 
Western blots performed on isolated membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) 
harbouring pTat101 producing Cysless TatC along with the indicated Cys substitutions in TatA and TatB 
alongside His-Tagged CueO produced from pQE80, after exposure to experimental conditions in vivo 
noted by “C”-corresponding to control cells which were untreated, “O”- cells were oxidised with 1.8 mM 
copper phenanthroline for 1 min and “R”- cells were treated with 10 mM of the reductant DTT for 1 min. 
The positions of the TatB monomer, TatB homodimer and TatAB heterodimer are indicated. Anti-His 
Western blots are shown corresponding to the soluble fraction following the membrane fractionation of 
each sample, showing “p” precursor and “m” mature forms of CueOH. B- Anti-TatA Western blots of  
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TatA homodimersation through TatA L9C was prominent, as it was when 
overexpressed substrate was not present, though it is unclear whether crosslinking with 
overexpressed substrate promoted TatA self-interactions, without comparing TatA 
homodimer intensity on the same Western blot 
Anti-His Western blots (Fig.6.18A) confirmed the presence of precursor and mature 
forms of CueOH. For the oxidised TatA L9C - TatB L9C sample a very strong band 
migrating at a lower molecular weight was observed, which likely corresponds to an 
intra-disulphide linked form of CueOH (See Section 6.3.5.1). This form was not 
observed with constructs expressing TatA L9C and TatB L10C or L11C. It is not clear 
why CueOH behaves differently between these samples. 
6.3.8.2 TatA L10C does not crosslink TatB L9C, L10C or L11C in vivo with 
overexpressed CueOH substrate 
TatA L10C was discussed as a candidate for TatB interactions in Section 6.3.7.2 due to 
its lack of self-association or interaction with TatC, and it was seen that there was no 
interaction with the Cys residues in TatB that were tested. Similar results were also 
seen in the presence of overexpressed substrate as no TatA-TatB heterodimer was 
detectable through TatA L10C and any of the Cys positions tested in TatB under 
oxidising conditions on anti-TatB Western blots (Fig 6.19A). TatB homodimerisation 
was seen, similar to that in Section 6.3.8.1 with stronger TatB homodimerisation 
through TatB L9C and L11C than L10C. Anti-TatA Western blots (Fig. 6.19B) 
demonstrated, as expected, no TatA-TatB heterodimer band, and that TatA 
homodimerisation was not present or was very weakly detected. Anti-His Western blots 
(Fig. 6.19A) confirmed the presence of CueOH, in all of these experiments, with the 
protein migrating faster in all of the oxidised samples, as explained in Section 6.3.5.1. 
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Figure 6.19) TatA L10C does not interact with TatB L9C, L10C or  L11C in vivo with 
overexpressed substrate - A- Anti-TatB Western blots performed on isolated membrane fractions 
from E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pTat101 producing Cysless TatC along with 
the indicated Cys substitutions in TatA and TatB alongside His-Tagged CueO produced from pQE80, 
after exposure to experimental conditions in vivo noted by “C”-corresponding to control cells which 
were untreated, “O”- cells were oxidised with 1.8 mM copper phenanthroline for 1 min and “R”- cells 
were treated with 10 mM of the reductant DTT for 1 min. The positions of the TatB monomer and TatB 
homodimer are indicated. Anti-His Western blots are shown corresponding to the soluble fraction 
following the membrane fractionation of each sample, showing “p” precursor and “m” mature forms of 
CueOH. B- Anti-TatA Western blots of samples from “O” and “R” in A. Loading volume in each case 
was 5 µL. C- denotes positions of Cys substitutions in TatA and TatB examined in this experiment. 
A 
B C 
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6.3.8.3 TatA I11C crosslinks TatB L11C in vivo with overexpressed CueOH 
substrate 
Crosslink analysis between TatA I11C and TatB L9C demonstrated no detectable 
TatA-TatB heterodimer on anti-TatB Western blots in Fig. 6.20A, as was the case with 
TatA I11C oxidised alongside TatB L10C. However a distinct heterodimer band just 
above 37 kDa was seen through TatA I11C and TatB L11C with overexpressed 
substrate indicating that, as with TatA L9C and TatB L11C in Section 6.3.8.1, substrate 
overexpression brings TatB and TatA into close proximity.  
A TatA-TatB heterodimer band above 37 kDa is seen through TatA I11C and TatB 
L11C with overexpressed substrate indicating that, as with residues TatA L9C and 
TatB L11C in Section 6.3.8.1 substrate overexpression is bringing these two residues 
closer together.  
TatB homodimerisation seems to be present through all Cys substitutions in TatB, at a 
somewhat higher level than those performed without overexpressed substrate (Fig. 
6.18), likely due to the sensitivity of the Western blotting method. TatA 
homodimerisation through I11C was distinct on anti-TatA Western blots in Fig. 6.20B. 
Anti-His Western blots demonstrate CueOH is produced in all of the samples tested. 
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Figure 6.20) TatA I11C interacts with TatB L11C in vivo with overexpressed substrate - A- Anti-TatB 
Western blots performed on isolated membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) 
harbouring pTat101 producing Cysless TatC along with the indicated Cys substitutions in TatA and TatB 
alongside His-Tagged CueO produced from pQE80, after exposure to experimental conditions in vivo 
noted by “C”-corresponding to control cells which were untreated, “O”- cells were oxidised with 1.8 mM 
copper phenanthroline for 1 min and “R”- cells were treated with 10 mM of the reductant DTT for 1 min. 
The positions of the TatB monomer, TatB homodimer and TatAB heterodimer are indicated. Anti-His 
Western blots are shown corresponding to the soluble fraction following the membrane fractionation of 
each sample, showing “p” precursor and “m” mature forms of CueOH. B- Anti-TatA Western blots of 
samples from “O” and “R” in A. Loading volume in each case was 5 µL. C- denotes positions of Cys 
substitutions in TatA and TatB examined in this experiment. 
	
A 
B C 
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6.3.9 TatA and TatB are able to interact following PMF dissipation, suggesting 
that TatA does not leave the Tat complex 
Chapter 5, Section 5.3.8 previously established that TatA was not present in its 
constitutive site at TatC TM6 nor in the TatB constitutive site at TatC TM5 after PMF 
dissipation. From this it was hypothesised that either TatA left the Tat complex 
completely in response to PMF dissipation or interacted at a different region of the 
complex. Interactions between TatA L9C and I11C were observed with TatB L11C in 
the presence but not in the absence of overexpressed substrate. To determine whether 
PMF dissipation (in the absence of overexpressed substrate) influenced TatA-TatB 
interactions, the TatA L9C - TatB L11C pair were chosen. As shown in Fig. 6.21 on 
anti-TatB Western blots under conditions of endogenous substrate no TatA – TatB 
crosslink was detected (as expected, since data in Sections 6.3.7.1 and 6.3.8.1 
showed interactions were only seen with overexpressed Tat substrate). However, upon 
PMF dissipation with 5 mM indole, a characteristic band just above 37 kDa was 
detected, corresponding to TatA-TatB heterodimer formation. When cells were 
thoroughly washed following indole treatment, the crosslink was no longer seen, 
indicating that it is reversible and does not arise because indole is lethal to cells. From 
this finding, it seems that TatA does not leave the Tat complex in response to PMF 
dissipation, but rather associates with TatB, while losing or adjusting its association 
with TatC (lack of interactions between Cys positions tested with TatC with dissipated 
PMF is shown in Sections 6.3.6.1 and 6.3.6.2).  
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Figure 6.21) TatA L9C interacts with TatB L11C in response to PMF dissipation with 5 mM indole- 
Anti-TatB Western blot of isolated membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) 
harbouring pTat101 expressing Cysless TatC and Cys-substituted TatA L9C and TatB L11C. Cells, prior to 
isolation of the membrane fractions, were either untreated, oxidised with 1.8 mM copper phenanthroline for 
1 min or incubated with 5 mM indole for 5 mins, followed by either a 1 min oxidation step or washed 
thoroughly to remove the indole followed by a 1 min oxidation step. Loading volume in each case was 5 µL. 
α-TatB 
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6.4 Discussion  
6.4.1 Mapping constitutive interactions between TatA and TatB with TatC 
informed by crosslinking proteins at low copy number expression 
The aim of using low copy number constructs in the crosslinking experiments in this 
Chapter was to validate findings in Chapter 4 and 5, which were performed at medium 
copy number, due to concerns over artefacts caused by the large amount of Tat 
proteins present in the cell membrane. Medium copy number crosslinking in Chapter 5 
identified a site on TatC where TatA interacted constitutively. This involved a crosslink 
through TatA L9C to TatC F213C at the periplasmic part of TatC TM6, which was 
preserved in the resting state of the Tat system. Comparatively weaker associations 
through TatA L10C and TatC V212C, at the extreme C-terminal region of the P3 loop 
and through TatA 11C and both TatC V213C and F213C, were also found with a Tat 
system able to bind endogenous substrate (Chapter 4, Sections 4.3.3.1-4.3.3.3). The 
results in this Chapter confirmed that the TatA L9C crosslink to TatC F213C was 
detected at low copy number expression, and replicated the preservation of this 
crosslink in the resting state (Section 6.3.4.1). The weaker interactions seen between 
TatA L10C/I11C with TatC F213C/V212C, in Chapter 4, were not seen with low copy 
number expression in Sections 6.3.2.1 and 6.3.2.2, and therefore may be too faint to 
detect at lower copy number, or could be explained as artefacts due to high copy 
number.  
In addition to the constitutive site occupied by TatA at TatC TM6 being identified in this 
thesis, crosslinking experiments between TatB and TatC performed by Johann 
Habersetzer have produced data that supports the placement of a constitutive TatB at 
TatC TM5 (previously identified in Rollauer et al., (2012), Kneuper et al. (2012) and 
Blummel et al., 2015) where a TatB-TatC crosslink was seen at native copy number 
expression in vivo through residues L9C in TatB and M205C in TatC TM5. This was 
preserved in a resting Tat system imparted by TatC mutations F94A and E103A which 
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prevent substrate binding (as was performed using TatA in Section 6.3.4.2). These 
data are shown in Fig. 6.22. 
 
 
 
 
 
 
 
 
 
 
 
 
 
A model proposing interactions between TatA and TatB with TatC that may be 
occurring in a resting Tat system, based on the TatA-TatC crosslinking results 
generated in this thesis, is given in Fig 6.23. It should be noted that no TatA-TatB Cys 
crosslinks were detected in Sections 6.3.7.1-6.3.7.3 with only endogenous substrate 
present, therefore TatA and TatB are shown not to be in contact in Fig. 6.23. Indeed 
the TatA L9C crosslink to TatC F213C seen in the resting state could still be observed 
with endogenous levels of substrate present (Section 6.3.2.1, Fig. 6.3), meaning that it 
is largely constitutive Tat interactions being detected when endogenous substrates are 
being expressed by the cell. 
 
 
 
Figure 6.22) Crosslinking data from Johann Habersetzer shows TatB interacting with TatC TM5 in 
the resting state- anti-TatB Western blots produced by Johann Habersetzer (unpublished), in vivo 
disulphide crosslinking was performed on E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pC*TatABC, 
a construct encoding wild type TatA with Cys substituted TatB and TatC as noted. “C” denotes untreated 
control and O denotes cells oxidised with 1.8 mM copper phenanthroline with membrane fractions of 
crosslinked cells loaded. TatC contained substitutions F94A and E103A to prevent substrate binding as in 
Section 6.3.6.1. 	
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6.4.2 TatA and TatB swap sites during transport 
The results presented here and in Chapter 5 both identified TatA movement from TatC 
TM6 to TM5 in response to the expression of two different Tat substrates; one artificial 
and one native, with Tat subunits expressed at both high and low copy number 
(Chapter 5, Sections 5.3.7.1-5.3.7.4 and this Chapter, Sections 6.3.5.1-6.3.5.4). This is 
again, supported by crosslinking from Johann Habersetzer (unpublished), who showed 
that in vivo TatB crosslinks at its constitutive site at TatC TM5 decrease in response to 
increasing amounts of substrate, CueOH (Fig. 6.24). Further to this, Johann 
Habersetzer also identified a crosslink of TatB at TatC TM6, the TatA constitutive site, 
in response to overexpression of the same substrate, through TatB L9C and TatC 
F213C (Fig. 6.24). This indicates that TatA and TatB are swapping sites in response to 
substrate overexpression and given the similarity of the residues found to crosslink (i.e. 
TatA L9C is conserved in homologous TatB), it is likely they are interacting with TatC in 
a similar manner. Indeed, while previous studies have identified TatB present at TM5 of 
TatC (Rollauer et al., 2012, Kneuper et al., 2012, Blummel et al., 2015), with TatA 
Figure 6.23) Proposed TatA and TatB interactions with TatC in the resting state based on 
crosslinking- Shows residue in TatC (red) F213 in contact with L9 of the TatA (yellow) TM, with M205C 
of TatC in contact with TatB (blue) L9C. 	
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nearby (Aldridge et al., 2014, Blummel et al., 2015), the work presented in this thesis, 
combined with that of Johann Habersezter demonstrates that TatA and TatB interact at  
 
 
 
 
 
 
 
 
 
 
 
 
TM6 and TM5 of TatC in the resting state with a subsequent swapping movement of 
TatA and TatB during translocation which has not been observed in the prior literature. 
This helps clarify data discussed previously in Chapter 5, Section 5.4.2 whereby TatB 
was hypothesised to move to an unknown location in the Tat complex to allow TatA to 
interact at TM5. Indeed Alcock et al. (2013) noted that fluorescently labelled TatB did 
not leave the Tat complex in vivo in response to overexpressed substrate and in these 
experiments a population of TatA may occupy TatC TM5 with a corresponding 
population of TatB at TM6. 
Figure 6.24) Western blots to show movement of TatB from TatC TM5 to TM6 in response to Tat 
substrate overexpression-A- anti-TatB Western blot produced by Johann Habersetzer (unpublished) 
showing in vivo disulphide crosslinking performed on isolated membrane fractions E. coli strain DADE 
(ΔtatABCD, ΔtatE) harbouring pC*TatABC, a construct encoding wild type TatA with Cys substituted 
TatB and TatC as noted along with pQE80 expressing His-tagged Tat substrate CueO. Prior to 
membrane preparations, cells were treated as follows: “Non-oxidised” denotes the untreated control 
with remaining lanes all containing samples oxidised with 1.8 mM copper phenanthroline. Sample with 
endogenous substrate is noted, alongside cells expressing CueOH from pQE80 vector with increasing 
concentrations of the inducer, IPTG. The TatB monomer and homodimer are the TatBC heterodimer is 
noted with a red triangle. B- Shows anti-TatC Western blot produced by Johann Habersetzer showing 
TatB crosslinked to TatC at positions noted, in the same manner as in A-, however 1 mM IPTG only 
was used to induce expression of CueOH. TatBC heterodimer is noted with red triangle, while TatC 
homodimer and monomer are also noted.  
N
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oxidised 
N
on-
oxidised 
1 mM 
IPTG 
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This swapping movement strengthens the proposition that TatB acts as a “gatekeeper” 
controlling TatA access to TatC by demonstrating that TatB is moving away from its 
constitutive site in response to Tat substrate overexpression, allowing TatA to move in 
to interact with TM5. The purpose of this movement is discussed in Chapter 5, Section 
5.4.4 and may facilitate further TatA polymerisation steps. 
The stage of Tat transport subsequent to TatB dissociation from TatC TM5 may include 
polymerisation of TatA forming an oligomer through which the substrate can be 
translocated, perhaps through scaffolding of TatA in the TatC concave face as 
suggested by crosslinking in plant thylakoids (Aldridge et al., 2014), or outside the 
complex (discussed previously in Chapter 5, Section 5.4.4). Indeed, TatA is proposed 
to exhibit membrane disrupting behaviour, which would otherwise be damaging to the 
cell unless coupled to Tat export, so therefore, control of this process is imperative. 
Further to this, these data may potentially explain why overexpression of TatB is toxic 
to the E. coli Tat system (Sargent et al., 1999), if it is competing for interaction sites 
with TatA, TatB may block TatA-TatC interactions which are required to allow transport. 
Interestingly, residue L206C in TM5 of TatC was not found to interact with any 
positions tested in the TatA TM. Indeed, homodimerisation through this residue was 
also very weak compared with neighbouring M205C (Section 6.3.3) this leaves open 
the question as to what, if anything, may be interacting here during the substrate 
transport stages of the Tat export cycle. Based on crosslinking studies in both bacteria 
(Blummel et al., 2015) and plants (Aldridge et al., 2014) it is plausible that this is an 
interaction site for the Tat signal sequence, located deep in the Tat complex, perhaps 
representing a deeper binding site discussed in plant models (Gerard and Cline, 2007). 
This could involve interaction of the signal sequence with once face of TM5 in TatC, 
near L206, with TatA interacting at the other face near M205 after TatB has moved. 
Crosslinking could be performed between the Tat signal sequence and TatC in vivo to 
analyse a deeper binding site which may be near TatC TM5, using disulphide 
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crosslinking which would be informed by photo-crosslinks seen in Blummel et al. 
(2015). 
Table 6.2 outlines crosslinks observed between Tat subunits seen in this Chapter and 
seen by Johann Habersetzer in the presence of overexpressed substrate, while Fig. 
6.25 and Fig. 6.26 represent two potential Tat subunit organisations that satisfy these 
observations. Fig. 6.25A demonstrates an arrangement which attempts to satisfy TatA 
heterodimerisation through TatA I11C to TatB L11C, (Sections 6.3.8.3) along with TatA 
heterodimerisation through Tat L9C to TatC M205C (Section 6.3.5.3). The TatB L9C 
crosslink to TatC F213C, as demonstrated by Johann Habersetzer, in the presence of 
overexpressed substrate (Fig. 6.24), is also shown, along with TatC homodimerisation 
through TatC M205C increased in the presence of substrate (Section 6.3.5.3). Fig 6.25 
A and B represents speculative TatA movement into the concave face of TatC 
(informed by crosslinked seen in plant thylakoids by Aldridge et al. (2014) and in silico 
data presented in Rollauer et al. (2012)) showing a TatA subunit satisfying the TatA 
L9C crosslink to TatB L11C in the presence of overexpressed substrate (Section 
6.3.8.1). The Tat signal sequence is shown binding at TatC TM5. 
Fig. 6.26A outlines a subunit arrangement which satisfies heterodimerisation of TatA 
L9C and I11C to TatB L11C (Sections 6.3.8.1 and 6.3.8.3), while also satisfying 
crosslinks between TatB L9C and TatC F213C (Fig. 6.24), along with TatA L9C to TatC 
M205C (Section 6.3.5.3). In this case, Fig. 6.26B demonstrates TatA I11C crosslinking 
to TatC M205C as a TatA subunit is proposed to move into the TatC concave face. As 
in Fig. 6.25 the Tat signal sequence is shown binding to TatC TM5. 
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Heterodimer crosslinks observed with 
overexpressed substrate 
Cys Substitutions 
TatA TatC TatB TatC TatA TatB 
L9C M205C L9C F213C L9C L11C 
I11C M205C 
	 	
L11C L11C 
Table 6.2) Cys positions of residues which form heterodimers between TatA, Tat and TatC- Cys 
substitution combinations are listed between each protein which were able to form significant 
heterodimers between the proteins with low copy number protein expression and overexpressed Tat 
substrate, CueOH. 
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Fig. 6.25) A proposed arrangement of Tat subunits to satisfy heterodimerisation of Tat subunits through in vivo crosslinking experiments performed with overexpressed 
substrate –A-Two TatC monomers (red) are shown linked through M205C at TM5. TatA (yellow) is shown interacting at TatC M205C while simultaneously interacting through I11C with 
TatB L11C. TatB is shown interacting at TatC F213C at TM6 through L9C.The signal peptide binding a proposed interaction site near TatC TM5 is shown as a green circle. B- shows 
another TatA monomer in the concave face  of TatC interacting with TatB L11C via L9C. 
A B 
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Fig. 6.26) A proposed arrangement of Tat subunits to satisfy heterodimerisation of Tat subunits through in vivo crosslinking experiments performed with overexpressed 
substrate –A-Two TatC monomers (red) are shown with residues M205C in the TM5 and F213C in the TM6 noted. The TatA transmembrane helix (TM) (yellow) is shown at TatC TM5 
interacting with M205C via L9C, while L9C is simultaneously in contact with TatB L11C (blue). TatB L9C is shown in contact with TatC F213C at TM6. L1C-L11C crosslinks between 
TatA-TatB form between subunits interacting with the adjacent TatC monomer. The signal peptide binding a proposed interaction site near TatC TM5 is shown as a green circle. B- 
shows another TatA monomer in the concave face  of TatC interacting with TatC M205C via I11C. 
A B 
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It should be noted that Fig. 6.25 and Fig. 6.26 both assume movement of TatA into the 
TatC concave face, which, as stated previously, is informed through crosslinks in the 
plant Tat system (Aldridge et al., 2014) and in silico data presented in Rollauer et al. 
(2012) however, no crosslinks to the concave face of TatC have been attempted in this 
Chapter. Furthermore it is not known whether TatA is moving from TatA TM6 to TM5, 
then to the concave face of TatC with another TatA monomer filling the space as each 
TatA vacates its site, essentially ratcheting a TatA polymer into the face of TatC, or 
whether the subunit arrangement allows TatA subunits to be recruited to the concave 
face of TatC to form an oligomer directly. It should be noted that neither Fig. 6.25 nor 
6.26 accounts for TatC homodimerisation observed through F213C in the presence of 
substrate, which may occur at another stage of the Tat cycle.  
A drawback of performing crosslinks in vivo in the presence of overexpressed substrate 
is that a “snapshot” of the protein arrangement in all stages of Tat transport is captured. 
Although the bias will be towards steps involved in the binding and/or export of 
substrates, if multiple steps are occurring in this process, it is difficult to assign specific 
interactions to specific stages. All the crosslinks observed in this Chapter could be 
occurring during Tat transport, but at different stages of the Tat cycle, and therefore 
cannot be incorporated into one subunit arrangement. Alternatively, an asymmetric 
arrangement of Tat subunits may be able to explain all the crosslinks observed in this 
Chapter, with some TatC monomers associated through M205C and others through 
F213C for example.  
To clarify this subunit arrangement further, crosslinking could be performed to analyse 
potential interactions between TatA and the TatC concave face in response to 
overexpressed substrate. Chapter 5, Section 5.4.3 outlined the two proposed models 
for TatA oligomerisation, one involving a separate TatA oligomer forming outside the 
Tat complex and another involving the transmembrane helices of TatA scaffolding in 
the concave face of TatC within the centre of the Tat complex (as was proposed in 
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Aldridge et al., 2014). Crosslinking in the concave face of TatA would help shed light on 
this TatA arrangement.  
6.4.3 PMF dissipation and the effect of Tat interactions 
Chapter 5, Section 5.3.8 found that with medium copy number expression of Tat 
proteins, TatA vacated its constitutive site at TatC TM6 in response to PMF dissipation 
but did not move to the TatB constitutive site at TatC TM5. While this was confirmed 
with low copy number expression (Sections 6.3.6.1-6.3.6.2) it was further found that 
interactions between TatA and TatB could still be seen with PMF dissipation (Section 
6.3.9). Indeed, this may correspond to residues such as Q8 in the TatA TM, or 
ionisable residues in TatC being required for interactions and adversely affected by 
PMF dissipation, with hydrophobic interactions between TatA and TatB not affected.  
The above data sugguests that TatA was not leaving the Tat complex in response to 
PMF dissipation, but rather, either vacating its interaction sites with TatC or 
repositioning itself on TatC but still remaining in contact with TatB. Further to this, it 
seems that instead of vacating the TatB constitutive site at TM5, TatB remains there 
with PMF dissipation (based on crosslinks performed by Johann Habersetzer, 
unpublished and shown Fig. 6.27A) with TatA peripherally associated with TatB L11C 
through TatA L9C. Further to this, TatB crosslinking from Johann Habersetzer also 
observed TatB occupying the TatA constitutive site at TatC after incubation with 
uncoupler (Fig 6.27B), presumably after TatA has vacated the constitutive site. This 
has significant consequences with regard to Tat co-purification experiments (i.e. devoid 
of PMF) whereby TatB is found to strongly favour TatC interactions in detergent 
solution while TatA is co-eluted with TatC only in small amounts (Chapter 3, Section 
3.3.1). Indeed it is tempting to propose that when the Tat subunits are purified with 
affinity-tagged TatC, TatB occupies both TatA and TatB constitutive sites on TatC with 
TatA only peripherally associated via an interaction with TatB. Though TatA has been 
shown to co-purify with TatC directly (Chapter 3, Section and Fritsch et al., 2012), this 
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is only when TatB is absent, and as such, the usual TatA sites may be blocked by TatB 
after PMF dissipation.  
 
 
 
 
 
	
	
	
	
	
 
 
 
 
 
 
 
 
 
 
 
Figure 6.27) TatB occupies both TatC TM5 and TM6 after PMF dissipation with chemical 
uncouplers-A shows anti-TatB and TatC Western blots produced by Johann Habersetzer (unpublished) 
of isolated membrane fractions from E. coli strain DADE (ΔtatABCD, ΔtatE) harbouring pTat101  
expressing wild type TatA and Cys-substituted TatBL9C and TatC M205C. Cells, prior to isolation of the 
membrane fractions, were either “C”- untreated, “R” reduced with 10 mM of reductant DTT, “O”- oxidised 
with 1.8 mM copper phenanthroline for 1 min or ”I”  incubated with 5 mM indole for 5 mins, followed by 
either a 1 min oxidation step or “W” washed thoroughly to remove the indole followed by a 1 min 
oxidation step. B- as with A- showing TatB Cys substitution L9C and TatC Cys substitution F213C. 
TatBC band was exposed separately in lower panels as it was difficult to detect. 
A 
B 
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Chapter 7: Conclusion and perspectives 
  
214	
	 	 	
7.1 Building a model of the membrane-bound resting Tat complex 
Prior to the work performed in this thesis, the body of literature pointed to the TatBC 
complex playing a central role in the recognition of Tat substrates, with TatA having a 
peripheral or non-existent interaction with the complex in the resting state, being 
recruited only upon substrate binding. However, the work in this thesis has discovered 
a TatA-TatC interaction through TM6 of TatC, which is strongly detected when the Tat 
system is resting and diminished in the presence of overexpressed substrate (Chapters 
5 and 6). Initially, this appeared to be incompatible with co-purification data presented 
in Chapter 3, which demonstrated only modest amounts of TatA co-purifying with 
affinity-tagged TatC (and only if digitonin was used to solubilise Tat components), 
however an explanation for this became apparent in further crosslinking experiments 
where the PMF was modulated. Indeed, dissipation of PMF using both chemical 
ionophores and via cell lysis (Chapter 5 and 6), caused TatA to vacate its constitutive 
site on TatC TM6, and be replaced with a weaker association with TatB and perhaps a 
reorientation on TatC. Co-purification experiments in Chapter 3 required Tat 
components to be solubilised, dissipating the PMF entirely, and likely explaining why so 
little TatA was found to be associated with TatBC in this context. Indeed, it appears that 
the constitutive TatA interaction at TatC TM6 requires an active PMF to be held in 
place.  
It is conceivable that the experimental conditions where the Tat system was examined 
in de-energised membranes or detergent solution, as was the case in many of the early 
studies examining interactions between Tat subunits (See Chapter 3, Section 3.1.2), 
present a bias towards TatB-TatC interactions that would not necessarily be found in 
vivo with an intact PMF. Indeed, this work demonstrated that TatA required the PMF to 
interact with its constitutive site at TatC TM6, while crosslinking performed by Johann 
Habersetzer showed that TatB could still interact with its constitutive site at TatC TM5 
with PMF dissipation, while also associating with the presumably vacated TatA 
constitutive site (Chapter 6, Section 6.4.3). Taking the discrepancy between in vitro and 
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in vivo experiments into account, in E. coli living cells with an intact PMF, it appears 
that TatA constitutively occupies a site at TatC TM6 (Chapters 5 and 6), while TatB 
constitutively occupies a site at TatC TM5 (data from Johann Habersetzer in Section 
6.4.3).  
A model proposed by Blummel et al. (2015) (here referred to as the Muller model) 
suggested a tetrameric state of TatC, based on the number of TatC linked via photo-
crosslinking, with four TatB proteins associated at the centre of the complex (Chapter 
1, Section 1.10.5), though the work acknowledges that the model would be compatible 
with further oligomeric states of TatC. The proposed schematic complex shown in Fig. 
7.1 is compatible with dimeric, trimeric and tetrameric etc. states of the Tat complex 
and has taken the schematic diagram of the TatBC complex adapted from the Muller 
model and inserted TatA based on crosslinks seen in this work. A trimeric form of the 
complex is also shown alongside this.  
 
 
 
 
 
 
 
 
No significant TatC homodimerisation has been observed through Cys substitutions 
F213C in TM6 and M205C in TM5 in this work in the resting state, and this is in 
agreement with the model presented in Fig. 7.1. Indeed, no other study to date has 
crosslinked E. coli TatC to itself in vivo in a Tat system unable to bind substrate, and as 
Figure 7.1) Schematic organisation of tetrameric and trimeric Tat complexes viewed from the 
periplasm- A- shows TatA (yellow), TatB (blue) and TatC (red) arranged with four TatC proteins, with TatB 
interacting with TatC TM5 and TM2. TatA is at TatC TM6. Based on a model presented by Blummel et al. 
(2015). B- a trimeric representation of A   
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such, it is difficult to incorporate what little data on TatC-TatC interactions seen under 
these conditions into the model in Fig. 7.1. While Cleon et al. (2015) did perform 
crosslinking in vivo observing TatC self-interactions through the periplasmic cap, given 
the presence of endogenous substrates binding the Tat system in these experiments, it 
is difficult to determine whether these would still be present in a Tat system unable to 
bind substrate.  
Two models are proposed for a resting Tat system which were produced by Dr Phillip 
Stansfeld (University of Oxford) using HADDOCK (High Ambiguity Driven protein-
protein DOCKing) software, informed by the crosslinks found in this study combined 
with those observed by Johann Habersetzer (presented in Chapter 6, Section 6.4.1). A 
tetrameric model (four of each Tat subunit) reminiscent of the Muller model, but 
incorporating TatA, is shown in Fig. 7.2. Here the transmembrane helix of TatA can be 
seen associated with TM6 of each TatC monomer in the complex, with TatB associated 
with TatC TM5 and relatively near the TM2 of another TatC monomer. The four TatC 
monomers arrange in a square-shape, leaning inwards slightly forming a dome with the 
TatB transmembrane helices inside. As in the Muller model, this arrangement leaves a 
groove between the TM6 of one TatC and the TM1/2 of another. Molecular modelling, 
performed by Dr Stansfeld, was able to place TatA in this groove based on crosslinks 
performed in this work, which is presented in Fig. 7.2. Notably, a cavity is present in the 
complex at the periplasmic facing part, which would allow access to the cytoplasm 
unless blocked. Regions proposed to be important in binding signal sequence are 
freely accessible at the cytoplasmic facing part of the complex. This includes the inner 
concave face, cytoplasmic parts of TM1 and TM2, the second cytoplasmic loop and 
part of TM5 of each TatC monomer where the Tat signal sequence has been proposed 
to bind in previous literature (Rollauer et al., 2012, Zoufaly et al., 2012, Blummel et al., 
2012, Alcock et al., 2012, Holzapfel et al., 2006). This would indicate that the Tat signal 
sequence interacts deep within the centre of the Tat complex, explaining extensive 
signal sequence-TatB crosslinks observed previously (Blummel et al., 2015).  
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View from periplasm Side-view View from cytoplasm 
Figure 7.2) Model of tetrameric resting state Tat system- produced by Dr Phillip Stansfeld (University of Oxford) using HADDOCK (High Ambiguity Driven protein-protein 
DOCKing) software informed by the crosslinks found in this study. Top- cartoon representations of TatA (yellow), TatB (blue) and TatC (red) show three orientations of the 
complex. Bottom- shows surface representations of the proteins. Figures made using pyMOL. 
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View from periplasm Side-view View from cytoplasm 
Figure 7.3) Model of trimeric resting state Tat system- produced by Dr Phillip Stansfeld (University of Oxford) using HADDOCK (High Ambiguity Driven protein-protein 
DOCKing) software informed by the crosslinks found in this study. Top- cartoon representations of TatA (yellow), TatB (blue) and TatC (red) show three orientations of the 
complex. Bottom- shows surface representations of the proteins. Figures made using pyMOL. 
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Fig. 7.3 shows a trimeric version of the model presented in Fig. 7.2, here the subunit 
arrangement is tighter, as expected, however, the proposed signal sequence binding 
sites on TatC are still freely accessible from the cytoplasm. The base of the complex is 
triangular, however, the dome shape is still retained. Although the 3-dimensional 
electron microscopy structures of the TatBC complex present a much larger structure, 
the hemicircular dome shape was shared with the complexes proposed in this study, 
along with a hollow inner cavity (Tarry et al., 2009).  
Indeed, the disparity between the reported or proposed sizes of the Tat resting 
complex (Chapter 1, Section 1.10.5) is a key factor that needs to be addressed in 
updating the proposed models. While they do not directly address the number of 
subunits in a resting Tat complex, the models presented in Fig. 7.2 and 7.3 provide a 
guideline for the development of crosslinking experiments to potentially link the 
complex together through Cys mutations. Future attempts at linking the complex 
together in this manner would benefit from having the complex in the resting state by 
blocking binding to substrate and preventing subunit rearrangement steps. Performing 
experiments in vivo would also remove any potential detergent effects or effects 
derived from PMF dissipation. 
7.2 Subunit rearrangement during Tat export 
Evidence presented in Chapter 6 indicates that TatA and TatB swap sites in response 
to substrate overexpression, implying that substrate binding causes TatB to vacate its 
constitutive site at TatC TM5, allowing TatA to move from TM6 to occupy TM5. While a 
simple remapping of TatA/B interactions with TatC can be performed to demonstrate 
an organisation of subunit in during this stage (as shown in Chapter 6, Section 6.4.2), it 
is difficult to factor in the increased TatC-TatC homodimerisation which occurs through 
Cys residues incorporated at TM5 and TM6. The presence of TatA and TatB on TatC 
would very likely preclude TatC self-interactions through this region (Dr Stansfeld, 
personal correspondence). Chapter 6, Fig. 6.25 attempted to factor in the TatC self-
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interaction through M205C while accommodating TatB and TatA, however, this 
proposed arrangement was a diagram of crosslinks, as opposed to a model derived 
from a docking program, as used in this Section. Indeed, the diagram in Chapter 6, Fig 
6.25 did not satisfy crosslinks between TatC TM6 and did not take into account the 
interaction energy between the proteins, so it is unknown how favourable this 
interaction would be. The difficulty in reconciling all crosslinks observed during 
substrate overexpression into one model may result from multi-step interactions 
occurring during Tat transport, or perhaps an asymmetry within the complex at this 
stage of the Tat cycle.  
With regard to further TatA associations with the Tat recognition complex after 
substrate binding, the formation of TatA oligomers within the centre of the Tat complex, 
or as a separate entity is discussed in Chapter 5, Section 5.4.4. With regard to the 
models presented in Fig. 7.2 and 7.3, TatA may oligomerise in the centre of the Tat 
complex, scaffolding on the face of each TatC monomer to disrupt a localised area of 
membrane as a one-size-fits-all for each Tat substrate to be transported across the 
membrane. It should be noted, however, that this localised area of membrane 
disruption would be too small to transport all Tat substrates (e.g. Formate 
dehydrogenase), and as such the complex may expand outwards or accommodate 
further Tat subunits, though Alcock et al. (2013) found no evidence of an increase in 
TatB and TatC subunits within the Tat complex upon overexpression of substrate. An 
advantage of the hypothesis that TatA forms a separate oligomeric ring is that 
polymerisation can occur indefinitely until the ring size matches that of the substrate.  
7.3 An updated Tat cycle 
While many questions still remain to be addressed, the work presented in this thesis 
can inform a proposed updated Tat cycle. A comparison can be made between the 
proposed Tat cycle before this work was undertaken in Chapter 1, Section 1.12, and 
after in Fig. 7.4. This updated cycle begins with a TatABC recognition complex with the 
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TatA transmembrane helix further towards the periplasm unable to exert its membrane-
disputing behaviour. Then the following steps occur: 1) The Tat signal sequence binds 
TatC within the concave face (as proposed in Blummel et al., 2015, Ramasamy et al., 
2013, Aldridge et al., 2014), which leads to TatA and TatB swapping sites on TatC 
(though, as discussed in Chapter 6, Section 6.4.2, this may involve movement across 
two TatC monomers, not shown for clarity). 2) TatA moves towards the concave face of 
TatC and begins to disrupt the membrane. 3) Further TatA monomers join the complex 
(Fig. 7.4 acknowledges that the TatA multimer may be scaffolding within the Tat 
complex as opposed to forming a discrete ring-shaped oligomer as discussed in 
Chapter 5, Section 5.4.4) forming a membrane-disrupting multimer. 4) Once the 
membrane is sufficiently disrupted the substrate is able to be translocated. 5) The 
signal sequence is cleaved and the substrate is released into the periplasm. 6) The 
system falls back into its resting state.  
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4) Updated Model of Tat transport- TatA (yellow), TatB (blue) and TatC (red) are shown in the 
membrane, with substrate (green) containing the twin arginine (RR) signal peptide.   
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7.4 Perspectives 
When the work in this thesis began, a crystal structure of TatC from Aquifex aeolicus 
had just been published (Rollauer et al., 2012), while the latest Tat transport models 
assumed that TatA was primarily involved in forming an oligomeric pore which 
transported substrates bound to a discrete TatBC recognition complex. Over the 
course of this work, NMR structures of E. coli TatA (Rodrigues et al., 2013) and TatB 
(Zhang et al., 2014) emerged, which allowed for the detailed models presented in this 
Chapter. Not only have the crosslinks presented in this thesis built on previous 
literature (primarily Blummel et al., 2015 and Aldridge et al., 2014), leading to the 
modelling of proposed resting state Tat complexes, but the role of TatA has expanded 
beyond “pore-forming”, taking on significance in the resting Tat complex which was 
previously thought to contain primarily/only TatBC. While the above represents 
significant steps taken in characterising the mechanism of Tat transport, many 
questions still remain. For example, the specific manner in which TatA oligomerises 
and how the substrate is translocated through the Tat system is still unknown. 
Furthermore, precise oligomerisation states of TatC are still contentious, with models 
ranging from dimer to octamer, though with improvements in electron microscopy 
technology and a resting state Tat complex model to identify TatC self-interaction 
faces, there is well-placed optimism that this will be settled in the future. Finally, 
through a comparison of Tat protein interaction data in detergent solution and in vivo, 
the work presented in this thesis could perhaps serve as cautionary tale for studying 
any membrane protein interactions, providing a case study whereby removing 
membrane proteins from their native environment can drastically alter their properties.  
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Figure S1- shows Figure 4.5D anti-TatA Western blots with TatA monomer 
Figure S2- shows Figure 4.6D anti-TatA Western blots with TatA monomer 
Figure S3- shows Figure 4.7D anti-TatA Western blots with TatA monomer 
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Figure S4- shows Figure 5.2 anti-TatA Western blots with TatA monomer 
Figure S5- shows Figure 5.4 anti-TatA Western blots with TatA monomer 
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Figure S6-shows Figure 5.6 anti-TatA Western blots with TatA monomer 
